EP2376464A1 - Fungicide hydroximoyl-heterocycles derivatives - Google Patents

Fungicide hydroximoyl-heterocycles derivatives

Info

Publication number
EP2376464A1
EP2376464A1 EP09784075A EP09784075A EP2376464A1 EP 2376464 A1 EP2376464 A1 EP 2376464A1 EP 09784075 A EP09784075 A EP 09784075A EP 09784075 A EP09784075 A EP 09784075A EP 2376464 A1 EP2376464 A1 EP 2376464A1
Authority
EP
European Patent Office
Prior art keywords
substituted
alkyl
halogen atoms
group
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP09784075A
Other languages
German (de)
French (fr)
Inventor
Christian Beier
Jürgen BENTING
David Bernier
Pierre-Yves Coqueron
Philippe Desbordes
Christophe Dubost
Stéphanie Gary
Pierre Genix
Daniela Portz
Ulrike Wachendorff-Neumann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Intellectual Property GmbH
Original Assignee
Bayer CropScience AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer CropScience AG filed Critical Bayer CropScience AG
Priority to EP09784075A priority Critical patent/EP2376464A1/en
Publication of EP2376464A1 publication Critical patent/EP2376464A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/06—1,2,3-Thiadiazoles; Hydrogenated 1,2,3-thiadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Definitions

  • the present invention relates to hydroximoyl-heterocycle derivatives, their process of preparation, their use as fungicide active agents, particularly in the form of fungicide compositions, and methods for the control of phytopathogenic fungi, notably of plants, using these compounds or compositions.
  • A represents a tetrazolyl group
  • Het represents either a particular pyridinyl group or a particular thiazolyl group.
  • Q can be selected in a list of 15 various heterocycle groups.
  • the present invention provides hydroximoyl-heterocycle derivatives of formula (I) (I) wherein
  • T represents a substituted or non-substituted heterocyclyl group that is selected in the list consisting of T 1 to T 9 :
  • X 1 represents a hydrogen atom, a halogen atom, a nitro group, a hydroxy group, a cyano group, an amino group, a sulphenyl group, a formyl group, a substituted or non-substituted carbaldehyde O-(Ci-C 8 -alkyl)oxime, a formyloxy group, a formylamino group, a carbamoyl group, a N-hydroxycarbamoyl group, a pentafluoro- ⁇ 6 -sulphenyl group, a formylamino group, substituted or non-substituted Ci-C 8 -alkoxyannino group, substituted or non-substituted N-Ci-C 8 -alkyl-(d-C 8 - alkoxy)-amino group, substituted or non-substituted (d-C 8 -alkylamino)-amino group,
  • W 1 represents a hydrogen atom, a formyl group, substituted or non-substituted Ci-C 8 -alkyl, substituted or non-substituted tri(C 1 -C 8 -alkyl)silyl-Ci-C 8 -alkyl, substituted or non-substituted Ci-C 8 - cycloalkyl, substituted or non-substituted tri(C 1 -C 8 -alkyl)silyl-Ci-C 8 -cycloalkyl, substituted or non- substituted Ci-C 8 -halogenoalkyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-C 8 - halogenocycloalkyl having 1 to 5 halogen atoms, a C 2 -C 8 -alkenyl, substituted or non-substituted C 2 - C 8 -alkynyl, substituted or non-substituted
  • L 1 represents a direct bond or a divalent group selected in the list consisting of
  • n 1 , 2, 3 or 4 ; • m and p independently represent 0, 1 , 2 or 3;
  • R 1 and R 2 independently represent a hydrogen atom, a halogen atom, a cyano group, substituted or non-substituted Ci-C 8 -alkyl, substituted or non-substituted C 3 -C 8 -cycloalkyl, substituted or non-substituted Ci-C 8 -halogenoalkyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-C 8 -halogenocycloalkyl having 1 to 5 halogen atoms, a C 2 -C 8 -alkenyl, substituted or non- substituted C 2 -C 8 -alkynyl, substituted or non-substituted Ci-C 8 -alkoxy, substituted or non-substituted
  • Ci-C 8 -halogenoalkoxy having 1 to 5 halogen atoms substituted or non-substituted C 2 -C 8 -alkenyloxy, substituted or non-substituted C 2 -C 8 -halogenoalkenyloxy having 1 to 5 halogen atoms, substituted or non-substituted C 3 -C 8 -alkynyloxy, or a substituted or non-substituted C 3 -C 8 -halogenoalkynyloxy having 1 to 5 halogen atoms.
  • A is selected int he list consisting of A to A 66 :
  • Z 1 represents a halogen atom, a nitro group, a hydroxy group, a cyano group, a sulphenyl group, a formyl group, a substituted or non-substituted carbaldehyde O-(Ci-C 8 -alkyl)oxime, a formyloxy group, a carbamoyl group, a N-hydroxycarbamoyl group, a pentafluoro- ⁇ 6 -sulphenyl group, substituted or non-substituted C-i-Cs-alkoxyamino group, substituted or non-substituted N-C- ⁇ -C 8 -alkyl- (Ci-C 8 -alkoxy)-amino group, substituted or non-substituted (d-C 8 -alkylamino)-amino group, substituted or non-substituted N-Ci-C 8 -alkyl-(Ci
  • Z 2 , Z 3 , Z 4 Z 5 , Z 6 and Z 7 independently represent a hydrogen atom, a halogen atom, a nitro group, a hydroxy group, a cyano group, an amino group, a sulphenyl group, a formyl group, a substituted or non-substituted carbaldehyde O-(C- ⁇ -C 8 -alkyl)oxime, a formyloxy group, a formylamino group, a carbamoyl group, a N-hydroxycarbamoyl group, a pentafluoro- ⁇ 6 -sulphenyl group, substituted or non-substituted Ci-C 8 -alkoxyamino group, substituted or non-substituted N-C- ⁇ -C 8 -alkyl-
  • (Ci-C 8 -alkoxy)-amino group substituted or non-substituted (Ci-C 8 -alkylamino)-amino group, substituted or non-substituted N-Ci-C 8 -alkyl-(Ci-C 8 -alkylamino)-amino group, a substituted or non- substituted (hydroxyimino)-Ci-C 6 -alkyl group, substituted or non-substituted Ci-C 8 -alkyl, substituted or non-substituted tri(C- ⁇ -C 8 -alkyl)silyl-C- ⁇ -C 8 -alkyl, substituted or non-substituted d-C 8 -cycloalkyl, substituted or non-substituted tri(C- ⁇ -C 8 -alkyl)silyl-C- ⁇ -C 8 -cycloalkyl, substituted or non-substituted C
  • C 3 -C 8 -halogenoalkynyloxy having 1 to 5 halogen atoms, substituted or non-substituted C 1 -C 8 - alkylcarbonyl, substituted or non-substituted N-(C 1 -C 8 -alkoxy)-C 1 -C 8 -alkanimidoyl, substituted or non- substituted N-(C 1 -C 8 -alkoxy)-C 1 -C 8 -halogenoalkanimidoyl having 1 to 5 halogen atoms, substituted or non-substituted C- ⁇ -C 8 -halogenoalkylcarbonyl having 1 to 5 halogen atoms, substituted or non- substituted C- ⁇ -C 8 -alkylcarbamoyl, substituted or non-substituted di-C- ⁇ -C 8 -alkylcarbamoyl, substituted or non-substituted N-C-
  • Z 1 , Z 2 , Z 3 , Z 4 Z 5 , Z 6 and Z 7 independently cannot represent a hydrogen atom, a halogen atom, a cyano group, an amino group, a sulphenyl group, a formylamino group, substituted or non-substituted Ci-C 8 -alkyl, substituted or non-substituted d-C 8 -halogenoalkyl having 1 to 5 halogen atoms, substituted or non- substituted d-C 8 -alkoxy, substituted or non-substituted d-C 8 -halogenoalkoxy having 1 to 5 halogen atoms, substituted or non-substituted d-C 8 -alkylsulphenyl, substituted or non-substituted C
  • Z ⁇ Z 2 , Z 3 , Z 4 , Z 5 , Z 6 and Z 7 independently cannot represent a hydrogen atom, a halogen atom, a cyano group, an amino group, a sulphenyl group, a formylamino group, a carbamoyl group, substituted or non-substituted d-C 8 -alkyl, substituted or non-substituted d-C 8 -cycloalkyl, substituted or non-substituted d-C 8 -halogenoalkyl having 1 to 5 halogen atoms, substituted or non-substituted d-C 8 -halogenocycloalkyl having 1 to 5 halogen atoms, a C 2 -C 8 -alkenyl, substituted or non-substituted C 2 -C 8 -alkynyl, substituted
  • K 1 represents a hydrogen atom, a formyl group, a carbamoyl group, a N-hydroxycarbamoyl group, a formylamino group, substituted or non-substituted Ci-C 8 -alkyl, substituted or non-substituted tri(Ci-C 8 -alkyl)silyl-Ci-C 8 -alkyl, substituted or non-substituted Ci-C 8 -cycloalkyl, substituted or non- substituted tri(Ci-C 8 -alkyl)silyl-Ci-C 8 -cycloalkyl, substituted or non-substituted Ci-C 8 -halogenoalkyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-C 8 -halogenocycloalkyl having 1 to 5 halogen atoms, a C 2 -C 8 -alkenyl, substituted or non-substi
  • Q is selected in the list consisting of Q 1 to Q 19
  • Y 1 to Y 5 independently represent a hydrogen atom, a nitro group, a hydroxy group, a cyano group, an amino group, a sulphenyl group, a formyl group, a substituted or non-substituted carbaldehyde O-(C- ⁇ -C 8 -alkyl)oxime, a formyloxy group, a formylamino group, a carbamoyl group, a N-hydroxycarbamoyl group, a pentafluoro- ⁇ 6 -sulphenyl group, a formylamino group, substituted or non-substituted C-i-Cs-alkoxyamino group, substituted or non-substituted N-Ci-C 8 -alkyl-(Ci-C 8 - alkoxy)-amino group, substituted or non-substituted (d-C 8 -alkylamino)-amino group,
  • W 1 represents a group as defined for T ; as well as salts, N-oxides, metallic complexes and metalloidic complexes thereof or (E) and (Z) isomers and mixtures thereof.
  • any of the compounds according to the invention can exist as one or more stereoisomers depending on the number of stereogenic units (as defined by the IUPAC rules) in the compound.
  • the invention thus relates equally to all the stereoisomers, and to the mixtures of all the possible stereoisomers, in all proportions.
  • the stereoisomers can be separated according to the methods which are known per se by the man ordinary skilled in the art.
  • stereostructure of the oxime moiety present in the heterocyclyloxime derivative of formula (I) includes (E) or (Z) isomer, and these stereoisomers form part of the present invention.
  • halogen means fluorine, chlorine, bromine or iodine ;
  • heteroatom can be nitrogen, oxygen or sulphur ;
  • a group or a substituent that is substituted according to the invention can be substituted by one or more of the following groups or atoms: a halogen atom, a nitro group, a hydroxy group, a cyano group, an amino group, a sulphenyl group, a pentafluoro- ⁇ 6 - sulphenyl group, a formyl group, a substituted or non-substituted carbaldehyde O-(Ci-C 8 -alkyl)oxime, a formyloxy group, a formylamino group, a carbamoyl group, a N-hydroxycarbamoyl group, a formylamino group, a (hydroxyimino)-Ci-C 6 -alkyl group, a Ci-C 8 -alkyl, a tri(C 1 -C 8 -alkyl)silyl-C 1 -C 8 - alkyl
  • heterocyclyl means saturated or unsaturated A-, 5-, 6- or 7-membered heterocyclyl comprising up to 4 heteroatoms selected in the list consisting of N, O, S
  • Preferred compounds of formula (I) according to the invention are those wherein L 1 represents a direct bond or a divalent group selected in the list consisting of
  • n 1 or 2 ;
  • R 1 and R 2 independently represent a hydrogen atom, a halogen atom, a cyano group, substituted or non-substituted C- ⁇ -C 8 -alkyl, substituted or non-substituted C- ⁇ -C 8 -cycloalkyl, substituted or non-substituted C- ⁇ -C 8 -halogenoalkyl having 1 to 5 halogen atoms, substituted or non-substituted C- ⁇ -C 8 -halogenocycloalkyl having 1 to 5 halogen atoms, a C 2 -C 8 -alkenyl, substituted or non- substituted C 2 -C 8 -alkynyl, substituted or non-substituted d-C 8 -alkoxy, substituted or non-substituted
  • Ci-C 8 -halogenoalkoxy having 1 to 5 halogen atoms substituted or non-substituted C 2 -C 8 -alkenyloxy, substituted or non-substituted C 2 -C 8 -halogenoalkenyloxy having 1 to 5 halogen atoms, substituted or non-substituted C 3 -C 8 -alkynyloxy, substituted or non-substituted C 3 -C 8 -halogenoalkynyloxy having 1 to 5 halogen atoms.
  • X 1 represents a hydrogen atom, a halogen atom, a cyano group, an amino group, a sulphenyl group, a pentafluoro- ⁇ 6 - sulphenyl group, substituted or non-substituted d-C 8 -alkyl, substituted or non-substituted tri(Ci-C 8 -alkyl)silyl- d-C 8 -alkyl, substituted or non-substituted d-C 8 -cycloalkyl, substituted or non-substituted tri(Ci-C 8 -alkyl)silyl- C- ⁇ -C 8 -cycloalkyl, substituted or non-substituted d-C 8 -halogenoalkyl having 1 to 5 halogen atoms, substituted or non-substituted d-Cs-halogenocycloalkyl
  • X 1 represents a hydrogen atom, a halogen atom, methyl, isopropyl, isobutyl, tertbutyl, trifluoromethyl, difluoromethyl, allyl, ethynyl, propargyl, cyclopropyl, benzyl, phenethyl, methoxy, trifluoromethoxy, acetyl, trifluoroacetyl or cyano.
  • W 1 represents a hydrogen atom, a halogen atom, a cyano group, substituted or non-substituted d-C 8 -alkyl, substituted or non-substituted Ci-C 8 -cycloalkyl, substituted or non-substituted Ci-C 8 -halogenoalkyl having 1 to 5 halogen atoms, a C 2 -C 8 -alkenyl, substituted or non-substituted C 2 -C 8 -alkynyl, substituted or non-substituted Ci-C 8 - alkoxy, substituted or non-substituted Ci-C 8 -halogenoalkoxy having 1 to 5 halogen atoms, substituted or non- substituted phenoxy, substituted or non-substituted aryl, or a substituted or non-substituted aryl-[Ci-C
  • W 1 represents a hydrogen atom, a halogen atom, methyl, ethyl, isopropyl, isobutyl, terbutyl, trifluoromethyl, difluoromethyl, allyl, ethynyl, propargyl, cyclopropyl, methoxy, trifluoromethoxy or cyano.
  • Z 1 represents a halogen atom, an amino group, a formylamino group, substituted or non-substituted Ci-C 8 -alkoxyamino group, substituted or non-substituted N-Ci-C 8 -alkyl-(Ci-C 8 -alkoxy)-amino group, substituted or non- substituted Ci-C 8 -alkyl, substituted or non-substituted Ci-C 8 -cycloalkyl, a C 2 -C 8 -alkenyl, substituted or non- substituted C 2 -C 8 -alkynyl, substituted or non-substituted Ci-C 8 -alkylamino, substituted or non-substituted di- Ci-C 8 -alkylamino, substituted or non-substituted Ci-C 8 -alkoxy, substituted or non-substituted
  • More preferred compounds of formula (I) according to the invention are those wherein Z 1 represents an amino group, a formylamino group, substituted or non-substituted Ci-C 8 -alkoxyamino group, substituted or non-substituted Ci-C 8 -alkyl, substituted or non-substituted Ci-C 8 -cycloalkyl, a C 2 -C 8 -alkenyl, substituted or non-substituted C 2 -C 8 -alkynyl, substituted or non-substituted Ci-C 8 -alkylamino, substituted or non-substituted di-Ci-C 8 -alkylamino, substituted or non-substituted (Ci-C 8 -alkoxycarbonyl)amino, substituted or non- substituted (C 2 -C 8 -alkenyloxycarbonyl)amino, substituted or non-substituted (C
  • Z 2 to Z 9 independently represent a hydrogen atom, a halogen atom, a cyano group, substituted or non-substituted Ci-C 8 -alkyl, substituted or non-substituted Ci-C 8 -cycloalkyl, substituted or non-substituted Ci-C 8 -halogenoalkyl having 1 to 5 halogen atoms, a C 2 -C 8 -alkenyl, substituted or non-substituted C 2 -C 8 -alkynyl, substituted or non- substituted Ci-C 8 -alkoxy, substituted or non-substituted Ci-C 8 -halogenoalkoxy having 1 to 5 halogen atoms, substituted or non-substituted phenoxy, substituted or non-substituted aryl, or a substituted or non-substituted aryl-[C
  • Z 2 to Z 9 are independently selected in the list consisting of hydrogen, halogen, methyl, ethyl, isopropyl, isobutyl, terbutyl, trifluoromethyl, difluoromethyl, allyl, ethynyl, propargyl, cyclopropyl, methoxy, trifluoromethoxy, acetyl, and cyano.
  • K 1 is selected in the list consisting of hydrogen, methyl, ethyl, isopropyl, isobutyl, terbutyl, allyl, propargyl, cyclopropyl, acetyl, trifluoroacetyl and mesyl.
  • Y 1 to Y 5 independently represent a hydrogen atom, a halogen atom, a cyano group, an amino group, a sulphenyl group, a pentafluoro- ⁇ 6 -sulphenyl group, substituted or non-substituted C- ⁇ -C 8 -alkyl, substituted or non-substituted tri(C- ⁇ -C 8 -alkyl)silyl-C- ⁇ -C 8 -alkyl, substituted or non-substituted C- ⁇ -C 8 -cycloalkyl, substituted or non-substituted tri(Ci-C 8 -alkyl)silyl-Ci-C 8 -cycloalkyl, substituted or non-substituted Ci-C 8 -halogenoalkyl having 1 to 5
  • Y 1 to Y 5 independently represent a hydrogen atom, a halogen atom, methyl, isopropyl, isobutyl, tertbutyl, trifluoromethyl, difluoromethyl, allyl, ethynyl, propargyl, cyclopropyl, methoxy, trifluoromethoxy or cyano.
  • the present invention also relates to a process for the preparation of compounds of formula (I),
  • a process P1 for the preparation of compounds of formula (I) as herein-defined as illustrated by the following reaction schemes.
  • T, A, Q and L 1 are as herein-defined and LG represents a leaving group.
  • Suitable leaving groups can be selected in the list consisting of a halogen atom or other customary nucleofugal groups such as triflate, mesylate, or tosylate.
  • Z 1 , Z 2 , Z 3 , Z 4 Z 5 , Z 6 or Z 7 represents a hydroxyl group, a sulphenyl group, an amino group, substituted or non-substituted C-i-Cs-alkylamino, substituted or non-substituted Ci-C 8 -halogenoalkylannino having 1 to 5 halogen atoms, a formylamino group, substituted or non-substituted C- ⁇ -C 8 -alkoxyamino group, substituted or non-substituted N-C-rCs-alkyl ⁇ C-rCs- alkoxy)-amino group, substituted or non-substituted (C- ⁇ -C 8 -alkylamino)-amino group, substituted or non- substituted N-C- ⁇ -C 8 -alkyl-(C- ⁇ -C 8 -alkyla
  • T, A, Q and L 1 are as herein-defined, LG' represents a leaving group, J 1 optionally represents a hydrogen atom, a formyl group, substituted or non-substituted Ci-C 8 -alkyl, substituted or non- substituted Ci-C 8 -halogenoalkyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-C 8 - alkylamino, substituted or non-substituted di-Ci-C 8 -alkylamino, substituted or non-substituted Ci-C 8 - alkoxy, substituted or non-substituted Ci-C 8 -halogenoalkoxy having 1 to 5 halogen atoms, substituted or non-substituted Ci-C 8 -alkylcarbonyl, substituted or non-substituted Ci-C 8 -halogenoalkylcarbonyl having 1 to 5 halogen atoms, substituted or non
  • halogen atoms substituted or non-substituted di-Ci-Cs-alkylcarbamoylamino, substituted or non- substituted Ci-Cs-alkylthioylamino, substituted or non-substituted Ci-Cs-halogenoalkylthioylamino having 1 to 5 halogen atoms, substituted or non-substituted (Ci-Cs-alkyl-carbamothioy ⁇ -amino, substituted or non-substituted (di-Ci-Cs-alkyl-carbamothioy ⁇ -amino, • G represents an oxygen atom or a sulphur atom ;
  • Z b represents a formyloxy group, a formylamino group, a formylamino group, substituted or non-substituted N-Ci-C 8 -alkyl-(Ci-C 8 -alkoxy)-amino group, substituted or non-substituted (Ci-C 8 - alkylamino)-amino group, substituted or non-substituted N-Ci-C 8 -alkyl-(Ci-C 8 -alkylamino)-amino group, substituted or non-substituted Ci-C 8 -alkylamino, substituted or non-substituted di-Ci-C 8 - alkylamino, substituted or non-substituted Ci-C 8 -alkoxy, substituted or non-substituted Ci-C 8 -alkoxy having 1 to 5 halogen atoms, substituted or non-substituted
  • Suitable leaving groups can be selected in the list consisting of a halogen atom or other customary nucleofugal groups such as 440, 44, 46, 47, 48, 49, 50, 51, 52, 52, 53, 52, 53, 52, 53, 52, 53, 52, 53, 52, 53, 54, 55, 56, 55, 56, 56, 56, 56, 56, 56, 56, 56, 56, 56, 57, 58, 59, 59, 59, 59, 59, 59, 59, 59, 59, 59, 59, 59, 59, 59, 60, 60, 60, 60, 60, 60, 61, 61, 61, 61, 61, 61, 61, 61, 61, 61, 61, 61, 61, 61, 61, 61, 61, 61, 61, 61, 61, 61, 61, 61, 61, 61, 61, 61, 61, 61,
  • Z ⁇ Z 2 , Z 3 , Z 4 Z 5 , Z 6 or Z 7 represent a substituted or non-substituted d-Cs-alkylcarbamothioyl, substituted or non-substituted di-d-C 8 - alkylcarbamothioyl, substituted or non-substituted N-d-Cs-alkyloxycarbamothioyl, substituted or non- substituted C-i-Cs-alkoxycarbamothioyl, substituted or non-substituted N-Ci-C 8 -alkyl-Ci-C 8 - alkoxycarbamothioyl, substituted or non-substituted C- ⁇ -C 8 -alkylthioylamino, substituted or non-substituted C-i-Cs-halogenoalkylthioylamino having 1 to 5
  • Z c represents a substituted or non-substituted CrC 8 - alkylcarbamoyl, substituted or non-substituted di-d-Cs-alkylcarbamoyl, substituted or non-substituted N-d-Cs-alkyloxycarbamoyl, substituted or non-substituted d-Cs-alkoxycarbamoyl, substituted or non-substituted N-d-Cs-alkyl-d-Cs-alkoxycarbamoyl, substituted or non-substituted CrC 8 - alkylcarbonylamino, substituted or non-substituted d-Cs-halogenoalkylcarbonylamino having 1 to 5 halogen atoms, substituted or non-substituted (d-C 8 -alkyl-carbannoyl)-oxy
  • Z ⁇ Z 2 , Z 3 , Z 4 Z 5 , Z 6 or Z 7 represent a hydroxy group, a cyano group, an amino group, a sulphenyl group, a formyloxy group, a formylamino group, a carbamoyl group, a N-hydroxycarbamoyl group, a formylamino group, substituted or non-substituted C 1 -C 8 - alkoxyamino group, substituted or non-substituted N-C- ⁇ -C 8 -alkyl-(C- ⁇ -C 8 -alkoxy)-amino group, substituted or non-substituted (C- ⁇ -C 8 -alkylamino)-amino group, substituted or non-substituted N-C-rCs-alkyl ⁇ C-rCs- alkylamino)-amino group, substituted or non-substituted N-C-rCs
  • the palladium complex is directly generated in the reaction mixture by separately adding to the reaction mixture a palladium salt and a complex ligand such as a phosphine, for example triethylphosphine, tri-tert-butylphosphine, tricyclohexylphosphine, 2- (dicyclohexylphosphine)biphenyl, 2-(di-tert-butylphosphin)biphenyl, 2-(dicyclohexylphosphine)-2'-(N,N- dimethylamino)-biphenyl, triphenylphosphine, tris-(o-tolyl)phosphine, sodium 3-
  • a complex ligand such as a phosphine, for example triethylphosphine, tri-tert-butylphosphine, tricyclohexylphosphine, 2- (dicyclohexylphosphine)bipheny
  • Z e represents a halogen atom.
  • Z f represents a hydroxy group, a cyano group, an amino group, a sulphenyl group, a formyloxy group, a formylamino group, a carbamoyl group, a N-hydroxycarbamoyl group, a formylamino group, substituted or non-substituted Ci-C 8 -alkoxyannino group, substituted or non-substituted N-Ci-C 8 -alkyl- (Ci-C 8 -alkoxy)-amino group, substituted or non-substituted (Ci-C 8 -alkylamino)-annino group, substituted or non-substituted N-Ci-C 8 -alkyl-(Ci-C 8 -alkylamino)-annino group, substituted or
  • Z 1 , Z 2 , Z 3 , Z 4 Z 5 , Z 6 or Z 7 represent a protected amino group
  • carrying out process P2 would previously require a deprotection step in order to yield the amino group.
  • Amino-protecting groups and related methods of cleavage thereof are known and can be found in T. W. Greene and P. G. M. Wuts, Protective Group in Organic Chemistry, 3 rd ed., John Wiley & Sons.
  • processes P1 and P2 may be performed if appropriate in the presence of a solvent and if appropriate in the presence of a base.
  • processes P1 and P2 may be performed if appropriate in the presence of a catalyst.
  • Suitable catalyst may be chosen as being 4-dimethyl-aminopyridine, 1-hydroxy-benzotriazole or dimethylformamide.
  • LG' represents a hydroxy group
  • the process P2 according to the present invention may be performed in the presence of condensing agent.
  • Suitable condensing agent may be chosen as being acid halide former, such as phosgene, phosphorous tribromide, phosphorous trichloride, phosphorous pentachloride, phosphorous trichloride oxide or thionyl chloride; anhydride former, such as ethyl chloroformate, methyl chloroformate, isopropyl chloroformate, isobutyl chloroformate or methanesulfonyl chloride; carbodiimides, such as N.N'-dicyclohexylcarbodiimide (DCC) or other customary condensing agents, such as phosphorous pentoxide, polyphosphoric acid, N,N'-carbonyl-diimidazole, 2-ethoxy-N-ethoxycarbonyl-1 ,2-dihydroquinoline (EEDQ), triphenylphosphine/tetrachloromethane, 4-(4,6-dimethoxy[1.3.5
  • Suitable solvents for carrying out processes P1 to P4 according to the invention are customary inert organic solvents. Preference is given to using optionally halogenated aliphatic, alicyclic or aromatic hydrocarbons, such as petroleum ether, hexane, heptane, cyclohexane, methylcyclohexane, benzene, toluene, xylene or decalin ; chlorobenzene, dichlorobenzene, dichloromethane, chloroform, carbon tetrachloride, dichlorethane or trichlorethane ; ethers, such as diethyl ether, diisopropyl ether, methyl tert-butyl ether, methyl tert-amyl ether, dioxane, tetrahydrofuran, 1 ,2-dimethoxyethane, 1 ,2-diethoxyethane or anisole ; nitriles, such as
  • Suitable bases for carrying out processes P1 and P2 according to the invention are inorganic and organic bases which are customary for such reactions.
  • alkaline earth metal alkali metal hydride, alkali metal hydroxides or alkali metal alkoxides, such as sodium hydroxide, sodium hydride, calcium hydroxide, potassium hydroxide, potassium tert-butoxide or other ammonium hydroxide
  • alkali metal carbonates such as sodium carbonate, potassium carbonate, potassium bicarbonate, sodium bicarbonate, cesium carbonate
  • alkali metal or alkaline earth metal acetates such as sodium acetate, potassium acetate, calcium acetate
  • tertiary amines such as trimethylamine, triethylamine, diisopropylethylamine, tributylamine, ⁇ /, ⁇ /-dimethylaniline, pyridine, ⁇ /-methylpiperidine, ⁇ /, ⁇ /-dimethylaminopyridine
  • reaction temperature can independently be varied within a relatively wide range.
  • process P1 according to the invention is carried out at temperatures between -8O 0 C and 16O 0 C.
  • Processes P1 to P4 according to the invention are generally independently carried out under atmospheric pressure. However, it is also possible to operate under elevated or reduced pressure.
  • reaction mixture is treated with water and the organic phase is separated off and, after drying, concentrated under reduced pressure. If appropriate, the remaining residue can be freed by customary methods, such as chromatography or recrystallization, from any impurities that may still be present.
  • the compounds of formula (II), useful as a starting material can be prepared, for example, by reacting hydroxylamine with the corresponding ketones that can be prepared, for example, according to the method described in WO99/02689.
  • the present invention relates to compounds of formula (II) useful as intermediate compounds or materials for the process of preparation according to the invention.
  • the present invention thus provides compounds of formula (II) wherein T and Q are as herein-defined:
  • the present invention also relates to a fungicide composition
  • a fungicide composition comprising an effective and non-phytotoxic amount of an active compound of formula (I).
  • fungicide composition comprising, as an active ingredient, an effective amount of a compound of formula (I) as herein defined and an agriculturally acceptable support, carrier or filler.
  • the term "support” denotes a natural or synthetic organic or inorganic compound with which the active compound of formula (I) is combined or associated to make it easier to apply, notably to the parts of the plant.
  • This support is thus generally inert and should be agriculturally acceptable.
  • the support can be a solid or a liquid.
  • suitable supports include clays, natural or synthetic silicates, silica, resins, waxes, solid fertilisers, water, alcohols, in particular butanol organic solvents, mineral and plant oils and derivatives thereof. Mixtures of such supports can also be used.
  • composition according to the invention can also comprise additional components.
  • the composition can further comprise a surfactant.
  • the surfactant can be an emulsifier, a dispersing agent or a wetting agent of ionic or non-ionic type or a mixture of such surfactants.
  • polyacrylic acid salts lignosulphonic acid salts, phenolsulphonic or naphthalenesulphonic acid salts
  • polycondensates of ethylene oxide with fatty alcohols or with fatty acids or with fatty amines substituted phenols (in particular alkylphenols or ary
  • surfactant content can be comprised from 5% to 40% by weight of the composition.
  • additional components can also be included, e.g. protective colloids, adhesives, thickeners, thixotropic agents, penetration agents, stabilisers, sequestering agents.
  • the active compounds can be combined with any solid or liquid additive, which complies with the usual formulation techniques.
  • composition according to the invention can contain from 0.05 to 99% by weight of active compound, preferably 10 to 70% by weight.
  • compositions according to the invention can be used in various forms such as aerosol dispenser, capsule suspension, cold fogging concentrate, dustable powder, emulsifiable concentrate, emulsion oil in water, emulsion water in oil, encapsulated granule, fine granule, flowable concentrate for seed treatment, gas (under pressure), gas generating product, granule, hot fogging concentrate, macrogranule, microgranule, oil dispersible powder, oil miscible flowable concentrate, oil miscible liquid, paste, plant rodlet, powder for dry seed treatment, seed coated with a pesticide, soluble concentrate, soluble powder, solution for seed treatment, suspension concentrate (flowable concentrate), ultra low volume (ULV) liquid, ultra low volume (ULV) suspension, water dispersible granules or tablets, water dispersible powder for slurry treatment, water soluble granules or tablets, water soluble powder for seed treatment and wettable powder.
  • These compositions include not only compositions which are ready to be applied to the plant or seed to
  • the compounds according to the invention can also be mixed with one or more insecticide, fungicide, bactericide, attractant, acaricide or pheromone active substance or other compounds with biological activity.
  • the mixtures thus obtained have a broadened spectrum of activity.
  • the mixtures with other fungicide compounds are particularly advantageous.
  • the composition according to the invention comprising a mixture of a compound of formula (I) with a bactericide compound can also be particularly advantageous
  • fungicide mixing partners can be selected in the following lists:
  • Inhibitors of the nucleic acid synthesis for example benalaxyl, benalaxyl-M, bupirimate, clozylacon, dimethirimol, ethirimol, furalaxyl, hymexazol, metalaxyl, metalaxyl-M, ofurace, oxadixyl and oxolinic acid.
  • Inhibitors of the mitosis and cell division for example benomyl, carbendazim, chlorfenazole, diethofencarb, ethaboxam, fluopicolide, fuberidazole, pencycuron, thiabendazole, thiophanate-methyl, thiophanate, zoxamide and 5-chloro-7-(4-methylpiperidin-1-yl)-6-(2,4,6-trifluorophenyl)[1 ,2,4]triazolo[1 ,5- a]pyrimidine.
  • inhibitors of the respiratory chain at complex I or II for example diflumetorim as Cl-respiration inhibitor; bixafen, boscalid, carboxin, diflumetorim, fenfuram, fluopyram, flutolanil, furametpyr, furmecyclox, isopyrazam (mixture of syn-epimeric racemate 1 RS,4SR,9RS and anti-epimeric racemate 1 RS, 4SR, 9SR), isopyrazam (anti-epimeric racemate 1 RS, 4SR, 9SR), isopyrazam (anti-epimeric enantiomer 1 R,4S,9S), isopyrazam (anti- epimeric enantiomer 1S,4R,9R), isopyrazam (syn epimeric racemate 1 RS, 4SR, 9RS), isopyrazam (syn- epimeric enantiomer 1 R,4S,9R), isopyrazam (syn- epimeric
  • Inhibitors of the ATP production for example fentin acetate, fentin chloride, fentin hydroxide and silthiofam.
  • Inhibitors of the amino acid and/or protein biosynthesis for example andoprim, blasticidin-S, cyprodinil, kasugamycin, kasugamycin hydrochloride hydrate, mepanipyrim and pyrimethanil .
  • Inhibitors of the signal transduction for example chlozolinate, fenpiclonil, fludioxonil, iprodione, procymidone, quinoxyfen and vinclozolin.
  • Inhibitors of the lipid and membrane synthesis for example biphenyl, chloroneb, dicloran, edifenphos, etridiazole, iodocarb, iprobenfos, isoprothiolane, propamocarb, propamocarb hydrochloride, prothiocarb, pyrazophos, quintozene, tecnazene and tolclofos-methyl.
  • Inhibitors of the ergosterol biosynthesis for example aldimorph, azaconazole, bitertanol, bromuconazole, cyproconazole, diclobutrazole, difenoconazole, diniconazole, diniconazole-M, dodemorph, dodemorph acetate, epoxiconazole, etaconazole, fenarimol, fenbuconazole, fenhexamid, fenpropidin, fenpropimorph, fluquinconazole, flurprimidol, flusilazole, flutriafol, furconazole, furconazole-cis, hexaconazole, imazalil, imazalil sulfate, imibenconazole, ipconazole, metconazole, myclobutanil, naftifine, nuarimol, oxpoconazole, paclobutra
  • Inhibitors of the cell wall synthesis for example benthiavalicarb, dimethomorph, flumorph, iprovalicarb, mandipropamid, polyoxins, polyoxorim, validamycin A and valifenalate.
  • Inhibitors of the melanine biosynthesis for example carpropamid, diclocymet, fenoxanil, phthalide, pyroquilon and tricyclazole,
  • a method for controlling the phytopathogenic fungi of plants, crops or seeds characterized in that an agronomically effective and substantially non-phytotoxic quantity of a pesticide composition according to the invention is applied as seed treatment, foliar application, stem application, drench or drip application (chemigation) to the seed, the plant or to the fruit of the plant or to soil or to inert substrate (e.g. inorganic substrates like sand, rockwool, glasswool; expanded minerals like perlite, vermiculite, zeolite or expanded clay), Pumice, Pyroclastic materials or stuff, synthetic organic substrates (e.g. polyurethane) organic substrates (e.g.
  • the method according to the invention can either be a curing, preventing or eradicating method.
  • a composition used can be prepared beforehand by mixing the two or more active compounds according to the invention.
  • the doses herein indicated are given as illustrative Examples of method according to the invention.
  • a person skilled in the art will know how to adapt the application doses, notably according to the nature of the plant or crop to be treated. Under specific conditions, for example according to the nature of the phytopathogenic fungus to be treated or controlled, a lower dose can offer adequate protection. Certain climatic conditions, resistance or other factors like the nature of the phytopathogenic fungi or the degree of infestation, for example, of the plants with these fungi, can require higher doses of combined active ingredients. The optimum dose usually depends on several factors, for example on the type of phytopathogenic fungus to be treated, on the type or level of development of the infested plant, on the density of vegetation or alternatively on the method of application.
  • the crop treated with the pesticide composition or combination according to the invention is, for example, grapevine, but this could be cereals, vegetables, lucerne, soybean, market garden crops, turf, wood, tree or horticultural plants.
  • the method of treatment according to the invention can also be useful to treat propagation material such as tubers or rhizomes, but also seeds, seedlings or seedlings pricking out and plants or plants pricking out. This method of treatment can also be useful to treat roots.
  • the method of treatment according to the invention can also be useful to treat the over-ground parts of the plant such as trunks, stems or stalks, leaves, flowers and fruit of the concerned plant.
  • cotton Among the plants that can be protected by the method according to the invention, mention can be made of cotton; flax; vine; fruit or vegetable crops such as Rosaceae sp. (for instance pip fruit such as apples and pears, but also stone fruit such as apricots, almonds and peaches), Ribesioidae sp., Juglandaceae sp., Betulaceae sp. , Anacardiaceae sp. , Fagaceae sp. , Moraceae sp. , Oleaceae sp. , Actinidaceae sp. , Lauraceae sp., Musaceae sp.
  • Rosaceae sp. for instance pip fruit such as apples and pears, but also stone fruit such as apricots, almonds and peaches
  • Ribesioidae sp. Juglandaceae sp.
  • Betulaceae sp.
  • Rubiaceae sp. for instance banana trees and plantins
  • Rubiaceae sp. Theaceae sp., Sterculiceae sp., Rutaceae sp. (for instance lemons oranges and grapefruit); Solanaceae sp. (for instance tomatoes), ⁇ liaceae sp., Asteraceae sp. (for instance lettuces), Umbelliferae sp., Cruciferae sp., Chenopodiaceae sp., Cucurbitaceae sp., Papilionaceae sp. (for instance peas), Rosaceae sp. (for instance strawberries); major crops such as Graminae sp.
  • Asteraceae sp. for instance sunflower
  • Cruciferae sp. for instance colza
  • Fabacae sp. for instance peanuts
  • Papilionaceae sp. for instance soybean
  • Solanaceae sp. for instance potatoes
  • Chenopodiaceae sp. for instance beetroots
  • horticultural and forest crops as well as genetically modified homologues of these crops.
  • composition according to the invention can also be used in the treatment of genetically modified organisms with the compounds according to the invention or the agrochemical compositions according to the invention.
  • Genetically modified plants are plants into genome of which a heterologous gene encoding a protein of interest has been stably integrated.
  • the expression "heterologous gene encoding a protein of interest” essentially means genes which give the transformed plant new agronomic properties or genes for improving the agronomic quality of the modified plant.
  • the composition according to the invention can also be used against fungal diseases liable to grow on or inside timber.
  • the term "timber" means all types of species of wood and all types of working of this wood intended for construction, for example solid wood, high-density wood, laminated wood and plywood.
  • the method for treating timber according to the invention mainly consists in contacting one or more compounds according to the invention or a composition according to the invention; this includes for example direct application, spraying, dipping, injection or any other suitable means.
  • Powdery mildew diseases such as :
  • Blumeria diseases caused for example by Blumeha graminis ;
  • Podosphaera diseases caused for example by Podosphaera leucothcha ;
  • Sphaerotheca diseases caused for example by Sphaerotheca fuliginea ;
  • Uncinula diseases caused for example by Uncinula necator ;
  • Rust diseases such as :
  • Gymnosporangium diseases caused for example by Gymnosporangium sabinae ;
  • Hemileia diseases caused for example by Hemileia vastathx ;
  • Phakopsora diseases caused for example by Phakopsora pachyrhizi or Phakopsora meibomiae ;
  • Puccinia diseases caused for example by Puccinia recondite, Puccini ⁇ graminis or
  • Uromyces diseases caused for example by Uromyces appendiculatus ;
  • Oomycete diseases such as : Albugo diseases caused for example by Albugo c ⁇ ndid ⁇ ;
  • Bremia diseases caused for example by Bremia lactucae ; Peronospora diseases, caused for example by Peronospora pisior P. brassicae ; Phytophthora diseases, caused for example by Phytophthora infestans ; Plasmopara diseases, caused for example by Plasmopara viticola ; Pseudoperonospora diseases, caused for example by Pseudoperonospora humuli or
  • Pythium diseases caused for example by Pythium ultimum ;
  • Leafspot, leaf blotch and leaf blight diseases such as :
  • Alternaria diseases caused for example by Alternaria solani ; Cercospora diseases, caused for example by Cercospora beticola ;
  • Cladiosporum diseases caused for example by Cladiosporium cucumerinum ;
  • Cochliobolus diseases caused for example by Cochliobolus sativus (Conidiaform:
  • Drechslera Syn: Helminthosporium) or Cochliobolus miy ⁇ be ⁇ nus ; Colletotrichum diseases, caused for example by Colletotrichum lindemuthanium ; Cycloconium diseases, caused for example by Cycloconium oleaginum ;
  • Diaporthe diseases caused for example by Diaporthe citri ; Elsinoe diseases, caused for example by Elsinoe fawcettii ; Gloeosporium diseases, caused for example by Gloeospohum laeticolor ; Glomerella diseases, caused for example by Glomerella cingulata ; Guignardia diseases, caused for example by Guignardia bidwelli ;
  • Leptosphaeria diseases caused for example by Leptosphaeria maculans ; Leptosphaeria nodorum ;
  • Magnaporthe diseases caused for example by Magnaporthe grisea ;
  • Mycosphaerella diseases caused for example by Mycosphaerella graminicola ; Mycosphaerella arachidicola ; Mycosphaerella fijiensis ;
  • Phaeosphaeria diseases caused for example by Phaeosphaeria nodorum ;
  • Pyrenophora diseases caused for example by Pyrenophora teres, or Pyrenophor ⁇ tritici repentis;
  • Ramularia diseases caused for example by Ramularia collo-cygni , or R ⁇ mul ⁇ ri ⁇ areola
  • Rhynchosporium diseases caused for example by Rhynchosporium secalis ;
  • Septoria diseases caused for example by Septoria apii or Septoria lycopercisi ;
  • Typhula diseases caused for example by Typhula incarnata ;
  • Venturia diseases caused for example by Venturia inaequalis ; Root, Sheath and stem diseases such as : Corticium diseases, caused for example by Corticium graminearum ;
  • Fusarium diseases caused for example by Fusarium oxysporum ;
  • Gaeumannomyces diseases caused for example by Gaeumannomyces graminis ;
  • Rhizoctonia diseases caused for example by Rhizoctonia solani ;
  • Sarocladium diseases caused for example by S ⁇ rocl ⁇ dium oryz ⁇ e
  • Sclerotium diseases caused for example by Sclerotium oryz ⁇ e
  • Tapesia diseases caused for example by Tapesia acuformis ;
  • Thielaviopsis diseases caused for example by Thielaviopsis basicola ; Ear and panicle diseases such as :
  • Alternaria diseases caused for example by Alternaria spp. ; Aspergillus diseases, caused for example by Aspergillus flavus ;
  • Cladosporium diseases caused for example by Cladosporium spp. ;
  • Claviceps diseases caused for example by Claviceps purpurea ;
  • Fusarium diseases caused for example by Fusarium culmorum ;
  • Gibberella diseases caused for example by Gibberella zeae ;
  • Monographella diseases caused for example by Monographella nivalis ;
  • Smut and bunt diseases such as :
  • Sphacelotheca diseases caused for example by Sphacelotheca reiliana ;
  • Tilletia diseases caused for example by Tilletia caries ;
  • Urocystis diseases caused for example by Urocystis occulta
  • Ustilago diseases caused for example by Ustilago nuda ;
  • Aspergillus diseases caused for example by Aspergillus flavus ;
  • Botrytis diseases caused for example by Botrytis cinerea ;
  • Penicillium diseases caused for example by Penicillium expansum ;
  • Rhizopus diseases caused by example by Rhizopus stolonifer
  • Sclerotinia diseases caused for example by Sclerotinia sclerotiorum ; Verticilium diseases, caused for example by Verticilium alboatrum ;
  • Seed and soilborne decay, mould, wilt, rot and dam ping-off diseases Seed and soilborne decay, mould, wilt, rot and dam ping-off diseases :
  • Aphanomyces diseases caused for example by Aphanomyces euteiches
  • Ascochyta diseases caused for example by Ascochyta lentis Aspergillus diseases, caused for example by Aspergillus flavus
  • Cladosporium diseases caused for example by Cladosporium herbarum
  • Cochliobolus diseases caused for example by Cochliobolus sativus
  • Colletotrichum diseases caused for example by Colletotrichum coccodes
  • Fusarium diseases caused for example by Fusarium culmorum
  • Gibberella diseases caused for example by Gibberella zeae
  • Macrophomina diseases caused for example by Macrophomina phaseolina
  • Monographella diseases caused for example by Monographella nivalis
  • Penicillium diseases caused for example by Penicillium expansum Phoma diseases, caused for example by Phoma lingam
  • Phomopsis diseases caused for example by Phomopsis sojae
  • Phytophthora diseases caused for example by Phytophthora cactorum
  • Pyrenophora diseases caused for example by Pyrenophora graminea
  • Pyricularia diseases caused for example by Pyricularia oryzae
  • Pythium diseases caused for example by Pythium ultimum
  • Rhizoctonia diseases caused for example by Rhizoctonia solani;
  • Rhizopus diseases caused for example by Rhizopus oryzae
  • Sclerotium diseases caused for example by Sclerotium rolfsii;
  • Septoria diseases caused for example by Septoria nodorum
  • Typhula diseases caused for example by Typhula incarnata
  • Verticillium diseases caused for example by Verticillium dahliae ; Canker, broom and dieback diseases such as :
  • Nectria diseases caused for example by Nectria galligena ; Blight diseases such as : Monilinia diseases, caused for example by Monilinia laxa ;
  • Leaf blister or leaf curl diseases such as :
  • Exobasidium diseases caused for example by Exob ⁇ sidium vex ⁇ ns
  • Taphrina diseases caused for example by Taphrina deformans ; Decline diseases of wooden plants such as : Esca diseases, caused for example by Phaemoniella clamydospora ; Eutypa dyeback, caused for example by Eutypa lata ; Ganoderma diseases caused for example by G ⁇ noderm ⁇ boninense; Rigidoporus diseases caused for example by Rigidoporus lignosus
  • Botrytis diseases caused for example by Botrytis cinere ⁇ ;
  • Rhizoctonia diseases caused for example by Rhizoctoni ⁇ sol ⁇ ni;
  • Helminthosporium diseases caused for example by Helminthosporium sol ⁇ ni;
  • Plasmodiophora diseases cause for example by Pl ⁇ modiophor ⁇ br ⁇ ssic ⁇ e.
  • Xanthomonas species for example X ⁇ nthomon ⁇ s c ⁇ mpestris pv. oryzae
  • Pseudomonas species for example Pseudomon ⁇ s syring ⁇ e pv. lachrymans
  • Erwinia species for example Erwini ⁇ ⁇ mylovor ⁇ .
  • the compounds according to the invention can also be used for the preparation of composition useful to curatively or preventively treat human or animal fungal diseases such as, for example, mycoses, dermatoses, trichophyton diseases and candidiases or diseases caused by Aspergillus spp., for example Aspergillus fumigatus.
  • fungal diseases such as, for example, mycoses, dermatoses, trichophyton diseases and candidiases or diseases caused by Aspergillus spp., for example Aspergillus fumigatus.
  • M+H means the molecular ion peak, plus or minus 1 a.m.u. (atomic mass unit) respectively, as observed in mass spectroscopy and M (Apcl+) means the molecular ion peak as it was found via positive atmospheric pressure chemical ionisation in mass spectroscopy.
  • Double bond geometry In the IUP AC -Names of the Examples 20, 21, 22, 23, 24, 25, 26, 27, 28 double bond geometry is labeled as Z. Double bond geometry of all other examples is not specified, but all potential mixtures of E, Z and the pure E- and Z-isomers are claimed.
  • Step 1 Preparation of tert-butyl hexyl[6-(hydroxymethyl)pyridin-2-yl]carbamate
  • Step 2 Preparation of tert-butyl (6- ⁇ [(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)oxy]methyl ⁇ pyridin-2- yl)hexylcarbamate
  • N-hydroxyphthalimide (1.46 g, 8.96 mmol)
  • cesium carbonate (5.58 g, 17.1 mmol)
  • potassium iodide (135 mg, 0.81 mmol) were sequentially added, followed by acetonitrile (10 ml_).
  • the heterogenous mixture was stirred at room temperature for 2Oh, then N-hydroxyphthalimide (0.33 g, 2.0 mmol) was added and the mixture was stirred at 5O 0 C for 7h.
  • the cooled reaction mixture was filtered and the filtrate was concentrated in vacuo.
  • Step 3 Preparation of tert-butyl ⁇ 6-[(aminooxy)methyl]pyridin-2-yl ⁇ hexylcarbamate
  • Step 4 Preparation of 6-[( ⁇ [(3-fluorophenyl)(5-methyl-1,2,3-thiadiazol-4-yl)methylene]amino ⁇ oxy) methyl]-N-hexylpyridin-2 -amine
  • Example 1 Preparation of 1-(3-chlorophenyl)-N- ⁇ [2-(hex-1-yn-1-yl)-1,3-thiazol-4-yl]methoxy ⁇ -1-(5- methyl-1,2,3-thiadiazol-4-yl)methanimine (Example 6)
  • Step 1 Preparation of 2-[(2-amino-1,3-thiazol-4-yl)methoxy]-1H-isoindole-1,3(2H)-dione
  • Step 2 Preparation of 2-[(2-bromo-1,3-thiazol-4-yl)methoxy]-1H-isoindole-1,3(2H)-dione
  • Step 3 Preparation of 2- ⁇ [2-(hex-1-yn-1-yl)-1,3-thiazol-4-yl]methoxy ⁇ -1H-isoindole-1,3(2H)-dione
  • Step 4 Preparation of 4-[(aminooxy)methyl]-2-(hex-1-yn-1-yl)-1,3-thiazole
  • Step 1 Preparation of ⁇ /-hydroxy-1-(4-methyl-1,2,5-thiadiazol-3-yl)-1-phenylmethanimine
  • Step 2 Preparation of 2- ⁇ 6-[( ⁇ [(Z)-(4-methyl-1,2,5-thiadiazol-3-yl)(phenyl)methylene]amino ⁇ - oxy)methyl]pyridin-2-yl ⁇ -1H-isoindole-1,3(2H)-dione
  • Step 3 Preparation of 6-[( ⁇ [(Z)-(4-methyl-1,2,5-thiadiazol-3-yl)(phenyl)methylene]amino ⁇ oxy)- methyl]pyridin-2 -amine
  • Step 4 Preparation of but-2-yn-1-yl ⁇ 6-[( ⁇ [(4-methyl-1,2,5-thiadiazol-3-yl)(phenyl)methylidene]- amino ⁇ oxy)methyl]pyridin-2-yl ⁇ carbamate
  • Example 3 Preparation of ⁇ /-hexyl-6-[( ⁇ [(4-methyl-1,2,5-thiadiazol-3-yl)(phenyl)methylidene]amino ⁇ oxy)methyl]-pyridin-2-amine (Example 31)
  • Step 1 Preparation of tert-butyl ⁇ 6-[( ⁇ [(4-methyl-1,2,5-thiadiazol-3-yl)(phenyl)methylene]- amino ⁇ oxy)methyl]pyridin-2-yl ⁇ carbamate
  • Step 2 Preparation of ⁇ /-hexyl-6-[( ⁇ [(4-methyl-1,2,5-thiadiazol-3-yl)(phenyl)methylene]amino ⁇ - oxy)methyl]pyridin-2 -amine
  • Example A Phytophthora test (tomato) / preventive
  • Emulsifier 1 part by weight of Alkylarylpolyglycolether
  • active compound 1 part by weight of active compound is mixed with the stated amounts of solvent and emulsifier, and the concentrate is diluted with water to the desired concentration.
  • the test is evaluated 7 days after the inoculation. 0% means an efficacy which corresponds to that of the control, while an efficacy of 100% means that no disease is observed.

Abstract

The present invention relates to hydroximoyl-heterocycle derivatives of formula (I) wherein T represents a substituted or non-substituted heterocyclyl group, Q represents a carbo or heterocyclic group, A represent a carbo or heterocyclic group or a carbo or hetero-polycylic group, and L1 represents various linking groups, their process of preparation, intermediate compounds for their preparation, their use as fungicide active agents, particularly in the form of fungicide compositions, and methods for the control of phytopathogenic fungi, notably of plants, using these compounds or compositions.

Description

FUNGICIDE HYDROXIMOYL-HETEROCYCLES DERIVATIVES DESCRIPTION
The present invention relates to hydroximoyl-heterocycle derivatives, their process of preparation, their use as fungicide active agents, particularly in the form of fungicide compositions, and methods for the control of phytopathogenic fungi, notably of plants, using these compounds or compositions.
In European patent application n°1426371 , there are disclosed certain tetrazoyloxime derivatives of the following chemical structure:
wherein A represents a tetrazolyl group, Het represents either a particular pyridinyl group or a particular thiazolyl group.
In Japanese patent application n°2004-131392, there are disclosed certain tetrazolyloxime derivatives of the following chemical structure:
wherein Q can be selected in a list of 15 various heterocycle groups.
Nevertheless, the compounds disclosed in these two documents do not provide a comparable utility than the compounds according to the invention.
It is always of high-interest in agriculture to use novel pesticide compounds in order to avoid or to control the development of resistant strains to the active ingredients. It is also of high-interest to use novel compounds being more active than those already known, with the aim of decreasing the amounts of active compound to be used, whilst at the same time maintaining effectiveness at least equivalent to the already known compounds. We have now found a new family of compounds which possess the above mentioned effects or advantages.
Accordingly, the present invention provides hydroximoyl-heterocycle derivatives of formula (I) (I) wherein
• T represents a substituted or non-substituted heterocyclyl group that is selected in the list consisting of T1 to T9 :
wherein
• X1 represents a hydrogen atom, a halogen atom, a nitro group, a hydroxy group, a cyano group, an amino group, a sulphenyl group, a formyl group, a substituted or non-substituted carbaldehyde O-(Ci-C8-alkyl)oxime, a formyloxy group, a formylamino group, a carbamoyl group, a N-hydroxycarbamoyl group, a pentafluoro-λ6-sulphenyl group, a formylamino group, substituted or non-substituted Ci-C8-alkoxyannino group, substituted or non-substituted N-Ci-C8-alkyl-(d-C8- alkoxy)-amino group, substituted or non-substituted (d-C8-alkylamino)-amino group, substituted or non-substituted N-Ci-C8-alkyl-(Ci-C8-alkylamino)-amino group, a substituted or non-substituted (hydroxyimino)-Ci-C6-alkyl group, substituted or non-substituted Ci-C8-alkyl, substituted or non- substituted tri(Ci-C8-alkyl)silyl-Ci-C8-alkyl, substituted or non-substituted Ci-C8-cycloalkyl, substituted or non-substituted tri(C-ι-C8-alkyl)silyl-C-ι-C8-cycloalkyl, substituted or non-substituted C1-C8- halogenoalkyl having 1 to 5 halogen atoms, substituted or non-substituted d-C8-halogenocycloalkyl having 1 to 5 halogen atoms, a C2-C8-alkenyl, substituted or non-substituted C2-C8-alkynyl, substituted or non-substituted d-C8-alkylamino, substituted or non-substituted di-d-C8-alkylamino, substituted or non-substituted d-C8-alkoxy, substituted or non-substituted d-C8-halogenoalkoxy having 1 to 5 halogen atoms, substituted or non-substituted d-C8-alkylsulphenyl, substituted or non- substituted d-C8-halogenoalkylsulphenyl having 1 to 5 halogen atoms, substituted or non-substituted C2-C8-alkenyloxy, substituted or non-substituted C2-C8-halogenoalkenyloxy having 1 to 5 halogen atoms, substituted or non-substituted C3-C8-alkynyloxy, substituted or non-substituted C3-C8- halogenoalkynyloxy having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-alkylcarbonyl, substituted or non-substituted N-(d-C8-alkoxy)-Ci-C8-alkanimidoyl, substituted or non-substituted N- (d-C8-alkoxy)-d-C8-halogenoalkanimidoyl having 1 to 5 halogen atoms, substituted or non- substituted d-Cs-halogenoalkylcarbonyl having 1 to 5 halogen atoms, substituted or non-substituted C-i-Cs-alkylcarbamoyl, substituted or non-substituted di-d-Cs-alkylcarbamoyl, substituted or non- substituted N-C-i-Cs-alkyloxycarbamoyl, substituted or non-substituted d-C8-alkoxycarbamoyl, substituted or non-substituted N-Ci-C8-alkyl-Ci-C8-alkoxycarbannoyl, substituted or non-substituted d-Cs-alkoxycarbonyl, substituted or non-substituted d-Cs-halogenoalkoxycarbonyl having 1 to 5 halogen atoms, substituted or non-substituted d-Cs-alkylcarbonyloxy, substituted or non-substituted C-i-Cs-halogenoalkylcarbonyloxy having 1 to 5 halogen atoms, substituted or non-substituted C1-C8- alkylcarbonylamino, substituted or non-substituted d-Cs-halogenoalkylcarbonylamino having 1 to 5 halogen atoms, substituted or non-substituted d-Cs-alkylcarbamoylamino, substituted or non- substituted d-Cs-halogenoalkylcarbamoylamino having 1 to 5 halogen atoms, substituted or non- substituted di-d-Cs-alkylcarbamoylamino, substituted or non-substituted di-d-C8- halogenoalkylcarbamoylamino having 1 to 5 halogen atoms , substituted or non-substituted N-C1-C8- alkyl-(C-ι-C8-alkylcarbamoyl)amino, substituted or non-substituted N-C1-C8-alkyl-(C1-C8- halogenoalkylcarbamoyl)amino having 1 to 5 halogen atoms, substituted or non-substituted N-C1-C8- alkyl-(di-C-ι-C8-alkylcarbamoyl)amino, substituted or non-substituted N-d-C8-alkyl-(di-d-C8- halogenoalkylcarbamoyl)amino having 1 to 5 halogen atoms, substituted or non-substituted C1-C8- alkylaminocarbonyloxy, substituted or non-substituted di-d-Cs-alkylaminocarbonyloxy, substituted or non-substituted d-Cs-alkylcarbamothioyl, substituted or non-substituted di-C-i-Cs-alkylcarbamothioyl, substituted or non-substituted N-d-Cs-alkyloxycarbamothioyl, substituted or non-substituted C1-C8- alkoxycarbamothioyl, substituted or non-substituted N-d-Cs-alkyl-d-Cs-alkoxycarbamothioyl, substituted or non-substituted d-C8-alkylthioylannino, substituted or non-substituted C1-C8- halogenoalkylthioylamino having 1 to 5 halogen atoms, substituted or non-substituted (d-C8-alkyl- carbamothioyl)-oxy, substituted or non-substituted substituted or non-substituted (di-d-C8-alkyl- carbamothioyl)-oxy, substituted or non-substituted d-C8-alkylsulphenyl, substituted or non- substituted d-C8-halogenoalkylsulphenyl having 1 to 5 halogen atoms, substituted or non-substituted d-C8-alkylsulphinyl, substituted or non-substituted d-C8-halogenoalkylsulphinyl having 1 to 5 halogen atoms, substituted or non-substituted d-C8-alkylsulphonyl, substituted or non-substituted C-i-Cs-halogenoalkylsulphonyl having 1 to 5 halogen atoms, substituted or non-substituted C1-C8- alkylaminosulfamoyl, substituted or non-substituted di-C-i-Cs-alkylaminosulfamoyl, substituted or non- substituted (d-C6-alkoxyinnino)-d-C6-alkyl, substituted or non-substituted (d-C6-alkenyloxyinnino)- d-C6-alkyl, substituted or non-substituted (d-C6-alkynyloxyinnino)-d-C6-alkyl, substituted or non- substituted (benzyloxyimino)-d-C6-alkyl, substituted or non-substituted benzyloxy, substituted or non-substituted benzylsulphenyl, substituted or non-substituted benzylamino, substituted or non- substituted phenoxy, substituted or non-substituted phenylsulphenyl, substituted or non-substituted phenylamino, substituted or non-substituted aryl, substituted or non-substituted aryl-[d-C8]-alkyl, substituted or non-substituted tri(d-C8-alkyl)-silyloxy, substituted or non-substituted C1-C8- alkylsulfenylamino, substituted or non-substituted d-Cs-halogenoalkylsulphinylamino having 1 to 5 halogen atoms, substituted or non-substituted d-C8-alkylsulphonylannino, substituted or non- substituted d-Cs-halogenoalkylsulphonylamino having 1 to 5 halogen atoms, substituted or non- substituted Ci-C8-alkoxysulphonylannino, substituted or non-substituted Ci-C8- halogenoxysulphonylamino having 1 to 5 halogen atoms, substituted or non-substituted tri(d-C8- alkyl)-silyl, substituted or non-substituted (Ci-C6-alkylideneamino)oxy, substituted or non-substituted (Ci-C6-alkenylideneamino)oxy, substituted or non-substituted (Ci-C6-alkynylideneannino)oxy, or a substituted or non-substituted (benzylideneamino)oxy ;
• W1 represents a hydrogen atom, a formyl group, substituted or non-substituted Ci-C8-alkyl, substituted or non-substituted tri(C1-C8-alkyl)silyl-Ci-C8-alkyl, substituted or non-substituted Ci-C8- cycloalkyl, substituted or non-substituted tri(C1-C8-alkyl)silyl-Ci-C8-cycloalkyl, substituted or non- substituted Ci-C8-halogenoalkyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8- halogenocycloalkyl having 1 to 5 halogen atoms, a C2-C8-alkenyl, substituted or non-substituted C2- C8-alkynyl, substituted or non-substituted Ci-C8-alkylamino, substituted or non-substituted Ci-C8- alkylcarbonyl, substituted or non-substituted Ci-Cs-halogenoalkylcarbonyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-Cs-alkylcarbamoyl, substituted or non-substituted di-Ci-C8- alkylcarbamoyl, substituted or non-substituted N-Ci-C8-alkyloxycarbamoyl, substituted or non- substituted Ci-C8-alkoxycarbamoyl, substituted or non-substituted N-Ci-C8-alkyl-Ci-C8- alkoxycarbamoyl, substituted or non-substituted Ci-C8-alkoxycarbonyl, substituted or non-substituted Ci-C8-halogenoalkoxycarbonyl having 1 to 5 halogen atoms, substituted or non-substituted aryl, or a substituted or non-substituted aryl-[Ci-C8]-alkyl ;
• L1 represents a direct bond or a divalent group selected in the list consisting of
-(CR1 R2)n- -(CR1 R2)m-C(=0)-(CR1 R2)p-
-(CR1 R2)m-(CR1 =CR2)-(CR1 R2)p- -(CR1 R2)m-C(=0)-0-(CR1 R2)p
-(CR1 R2)m-C≡C-(CR1 R2)p- -(CR1 R2)m-0-C(=0)-(CR1 R2)p-
-(CR1 R2)m-0-(CR1 R2)p- -(CR1 R2)m-C(=O)-NH-(CR1 R2)p-
-(CR1 R2)m-NH-(CR1 R2)p- -(CR1 R2)m-NH-C(=O)-(CR1 R2)p- wherein
• n represents 1 , 2, 3 or 4 ; • m and p independently represent 0, 1 , 2 or 3;
• R1 and R2 independently represent a hydrogen atom, a halogen atom, a cyano group, substituted or non-substituted Ci-C8-alkyl, substituted or non-substituted C3-C8-cycloalkyl, substituted or non-substituted Ci-C8-halogenoalkyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-halogenocycloalkyl having 1 to 5 halogen atoms, a C2-C8-alkenyl, substituted or non- substituted C2-C8-alkynyl, substituted or non-substituted Ci-C8-alkoxy, substituted or non-substituted
Ci-C8-halogenoalkoxy having 1 to 5 halogen atoms, substituted or non-substituted C2-C8-alkenyloxy, substituted or non-substituted C2-C8-halogenoalkenyloxy having 1 to 5 halogen atoms, substituted or non-substituted C3-C8-alkynyloxy, or a substituted or non-substituted C3-C8-halogenoalkynyloxy having 1 to 5 halogen atoms. A is selected int he list consisting of A to A66 :
wherein
• Z1 represents a halogen atom, a nitro group, a hydroxy group, a cyano group, a sulphenyl group, a formyl group, a substituted or non-substituted carbaldehyde O-(Ci-C8-alkyl)oxime, a formyloxy group, a carbamoyl group, a N-hydroxycarbamoyl group, a pentafluoro-λ6-sulphenyl group, substituted or non-substituted C-i-Cs-alkoxyamino group, substituted or non-substituted N-C-ι-C8-alkyl- (Ci-C8-alkoxy)-amino group, substituted or non-substituted (d-C8-alkylamino)-amino group, substituted or non-substituted N-Ci-C8-alkyl-(Ci-C8-alkylamino)-amino group, a substituted or non- substituted (hydroxyimino)-Ci-C6-alkyl group, substituted or non-substituted Ci-C8-alkyl, substituted or non-substituted tri(C1-C8-alkyl)silyl-Ci-C8-alkyl, substituted or non-substituted Ci-C8-cycloalkyl, substituted or non-substituted tri(C-ι-C8-alkyl)silyl-C-ι-C8-cycloalkyl, substituted or non-substituted C1- C8-halogenoalkyl having 1 to 5 halogen atoms, substituted or non-substituted C1-C8- halogenocycloalkyl having 1 to 5 halogen atoms, a C2-C8-alkenyl, substituted or non-substituted C2- C8-alkynyl, substituted or non-substituted C-ι-C8-alkylamino, substituted or non-substituted CIi-C1-C8- alkylamino, substituted or non-substituted C-ι-C8-alkoxy, substituted or non-substituted (C1-C8- alkoxycarbonyl)amino,, substituted or non-substituted (C2-C8-alkenyloxycarbonyl)amino, substituted or non-substituted (C3-C8-alkynyloxycarbonyl)amino, substituted or non-substituted C1-C8- alkylcarbonylamino, substituted or non-substituted C-ι-C8-halogenoalkylcarbonylamino having 1 to 5 halogen atoms, substituted or non-substituted C-ι-C8-halogenoalkoxy having 1 to 5 halogen atoms, substituted or non-substituted C-ι-C8-alkylsulphenyl, substituted or non-substituted C1-C8- halogenoalkylsulphenyl having 1 to 5 halogen atoms, substituted or non-substituted C2-C8- alkenyloxy, substituted or non-substituted C2-C8-halogenoalkenyloxy having 1 to 5 halogen atoms, substituted or non-substituted C3-C8-alkynyloxy, substituted or non-substituted C3-C8- halogenoalkynyloxy having 1 to 5 halogen atoms, substituted or non-substituted d-Cs-alkylcarbonyl, substituted or non-substituted N-(Ci-C8-alkoxy)-Ci-C8-alkaninnidoyl, substituted or non-substituted N- (Ci-C8-alkoxy)-Ci-C8-halogenoalkaninnidoyl having 1 to 5 halogen atoms, substituted or non- substituted d-Cs-halogenoalkylcarbonyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-Cs-alkylcarbamoyl, substituted or non-substituted di-d-Cs-alkylcarbamoyl, substituted or non- substituted N-Ci-Cs-alkyloxycarbamoyl, substituted or non-substituted d-Cs-alkoxycarbamoyl, substituted or non-substituted N-d-Cs-alkyl-d-Cs-alkoxycarbamoyl, substituted or non-substituted d-C8-alkoxycarbonyl, substituted or non-substituted d-Cs-halogenoalkoxycarbonyl having 1 to 5 halogen atoms, substituted or non-substituted d-Cs-alkylcarbonyloxy, substituted or non-substituted d-Cs-halogenoalkylcarbonyloxy having 1 to 5 halogen atoms, substituted or non-substituted C1-C8- alkylcarbamoylamino, substituted or non-substituted d-Cs-halogenoalkylcarbamoylamino having 1 to 5 halogen atoms, substituted or non-substituted di-d-Cs-alkylcarbamoylamino, substituted or non- substituted di-d-Cs-halogenoalkylcarbamoylamino having 1 to 5 halogen atoms , substituted or non- substituted N-d-C8-alkyl-(d-C8-alkylcarbamoyl)amino, substituted or non-substituted N-d-C8-alkyl- (d-C8-halogenoalkylcarbamoyl)amino having 1 to 5 halogen atoms, substituted or non-substituted N- d-C8-alkyl-(di-d|-C8-alkylcarbamoyl)amino, substituted or non-substituted N-Ci-C8-alkyl-(di-d-C8- halogenoalkylcarbamoyl)amino having 1 to 5 halogen atoms, substituted or non-substituted C1-C8- alkylaminocarbonyloxy, substituted or non-substituted di-d-Cs-alkylaminocarbonyloxy, substituted or non-substituted d-Cs-alkylcarbamothioyl, substituted or non-substituted di-d-Cs-alkylcarbamothioyl, substituted or non-substituted N-d-Cs-alkyloxycarbamothioyl, substituted or non-substituted C1-C8- alkoxycarbamothioyl, substituted or non-substituted N-d-Cs-alkyl-d-Cs-alkoxycarbamothioyll, substituted or non-substituted d-C8-alkylthioylamino, substituted or non-substituted C1-C8- halogenoalkylthioylamino having 1 to 5 halogen atoms, substituted or non-substituted (C1-C8- alkoxythiocarbonyl)amino, substituted or non-substituted (d-C8-alkyl-carbamothioyl)-oxy, substituted or non-substituted substituted or non-substituted (di-d-C8-alkyl-carbamothioyl)-oxy, substituted or non-substituted d-C8-alkylsulphenyl, substituted or non-substituted d-C8-halogenoalkylsulphenyl having 1 to 5 halogen atoms, substituted or non-substituted d-C8-alkylsulphinyl, substituted or non- substituted C-i-Cs-halogenoalkylsulphinyl having 1 to 5 halogen atoms, substituted or non-substituted d-C8-alkylsulphonyl, substituted or non-substituted d-C8-halogenoalkylsulphonyl having 1 to 5 halogen atoms, substituted or non-substituted d-C8-alkylaminosulfannoyl, substituted or non- substituted di-C-i-Cs-alkylaminosulfamoyl, substituted or non-substituted (d-C6-alkoxyinnino)-d-C6- alkyl, substituted or non-substituted (d-C6-alkenyloxyinnino)-d-C6-alkyl, substituted or non- substituted (d-C6-alkynyloxyinnino)-d-C6-alkyl, substituted or non-substituted (benzyloxyimino)-d- C6-alkyl, substituted or non-substituted benzyloxy, substituted or non-substituted benzylsulphenyl, substituted or non-substituted benzylamino, substituted or non-substituted phenoxy, substituted or non-substituted phenylsulphenyl, substituted or non-substituted phenylamino, substituted or non- substituted aryl, substituted or non-substituted aryl-[d-C8]-alkyl, substituted or non-substituted tri(d- C8-alkyl)-silyloxy, substituted or non-substituted d-C8-alkylsulfenylannino, substituted or non- substituted d-Cs-halogenoalkylsulphinylamino having 1 to 5 halogen atoms, substituted or non- substituted C-i-Cs-alkylsulphonylamino, substituted or non-substituted C1-C8- halogenoalkylsulphonylamino having 1 to 5 halogen atoms, substituted or non-substituted C1-C8- alkoxysulphonylamino, substituted or non-substituted Ci-C8-halogenoxysulphonylamino having 1 to 5 halogen atoms, substituted or non-substituted tri(Ci-C8-alkyl)-silyl, substituted or non-substituted (C1- C6-alkylideneamino)oxy, substituted or non-substituted (Ci-C6-alkenylideneamino)oxy, substituted or non-substituted (d-C6-alkynylideneamino)oxy, substituted or non-substituted
(benzylideneamino)oxy, substituted or non-substituted [(arylcarbonyl)amino]-[C-ι-C8]-alkyl, substituted or non-substituted [{C-ι-C8-alkyl(C-ι-C8-alkylcarbonyl)amino}]-[C-ι-C8]-alkyl, substituted or non- substituted [{C-ι-C8-alkyl(arylcarbonyl)amino}]-[C-ι-C8]-alkyl, substituted or non-substituted [(C1-C8- alkylcarbonyl)amino]-[C-ι-C8]-alkyl;
• Z2, Z3, Z4 Z5, Z6 and Z7 independently represent a hydrogen atom, a halogen atom, a nitro group, a hydroxy group, a cyano group, an amino group, a sulphenyl group, a formyl group, a substituted or non-substituted carbaldehyde O-(C-ι-C8-alkyl)oxime, a formyloxy group, a formylamino group, a carbamoyl group, a N-hydroxycarbamoyl group, a pentafluoro-λ6-sulphenyl group, substituted or non-substituted Ci-C8-alkoxyamino group, substituted or non-substituted N-C-ι-C8-alkyl-
(Ci-C8-alkoxy)-amino group, substituted or non-substituted (Ci-C8-alkylamino)-amino group, substituted or non-substituted N-Ci-C8-alkyl-(Ci-C8-alkylamino)-amino group, a substituted or non- substituted (hydroxyimino)-Ci-C6-alkyl group, substituted or non-substituted Ci-C8-alkyl, substituted or non-substituted tri(C-ι-C8-alkyl)silyl-C-ι-C8-alkyl, substituted or non-substituted d-C8-cycloalkyl, substituted or non-substituted tri(C-ι-C8-alkyl)silyl-C-ι-C8-cycloalkyl, substituted or non-substituted C1-
C8-halogenoalkyl having 1 to 5 halogen atoms, substituted or non-substituted C1-C8- halogenocycloalkyl having 1 to 5 halogen atoms, a C2-C8-alkenyl, substituted or non-substituted C2- C8-alkynyl, substituted or non-substituted C-ι-C8-alkylamino, substituted or non-substituted CIi-C1-C8- alkylamino, substituted or non-substituted C-ι-C8-alkoxy, substituted or non-substituted (C1-C8- alkoxycarbonyl)amino,, substituted or non-substituted (C2-C8-alkenyloxycarbonyl)amino, substituted or non-substituted (Cs-Cs-alkynyloxycarbonyOamino, substituted or non-substituted C1-C8- halogenoalkoxy having 1 to 5 halogen atoms, substituted or non-substituted C-ι-C8-alkylsulphenyl, substituted or non-substituted C-ι-C8-halogenoalkylsulphenyl having 1 to 5 halogen atoms, substituted or non-substituted C2-C8-alkenyloxy, substituted or non-substituted C2-C8-halogenoalkenyloxy having 1 to 5 halogen atoms, substituted or non-substituted C3-C8-alkynyloxy, substituted or non-substituted
C3-C8-halogenoalkynyloxy having 1 to 5 halogen atoms, substituted or non-substituted C1-C8- alkylcarbonyl, substituted or non-substituted N-(C1-C8-alkoxy)-C1-C8-alkanimidoyl, substituted or non- substituted N-(C1-C8-alkoxy)-C1-C8-halogenoalkanimidoyl having 1 to 5 halogen atoms, substituted or non-substituted C-ι-C8-halogenoalkylcarbonyl having 1 to 5 halogen atoms, substituted or non- substituted C-ι-C8-alkylcarbamoyl, substituted or non-substituted di-C-ι-C8-alkylcarbamoyl, substituted or non-substituted N-C-ι-C8-alkyloxycarbamoyl, substituted or non-substituted C1-C8- alkoxycarbamoyl, substituted or non-substituted N-C-i-Cs-alkyl-C-i-Cs-alkoxycarbamoyl, substituted or non-substituted C-ι-C8-alkoxycarbonyl, substituted or non-substituted C-ι-C8-halogenoalkoxycarbonyl having 1 to 5 halogen atoms, substituted or non-substituted C-ι-C8-alkylcarbonyloxy, substituted or non-substituted C-i-Cs-halogenoalkylcarbonyloxy having 1 to 5 halogen atoms, substituted or non- substituted C-i-Cs-alkylcarbonylamino, substituted or non-substituted C1-C8- halogenoalkylcarbonylamino having 1 to 5 halogen atoms, substituted or non-substituted C1-C8- alkylcarbamoylamino, substituted or non-substituted Ci-Cs-halogenoalkylcarbamoylamino having 1 to 5 halogen atoms, substituted or non-substituted di-Ci-Cs-alkylcarbamoylamino, substituted or non- substituted di-Ci-Cs-halogenoalkylcarbamoylamino having 1 to 5 halogen atoms , substituted or non- substituted N-C-ι-C8-alkyl-(C-ι-C8-alkylcarbamoyl)amino, substituted or non-substituted N-C-ι-C8-alkyl- (C-ι-C8-halogenoalkylcarbamoyl)amino having 1 to 5 halogen atoms, substituted or non-substituted N- C-ι-C8-alkyl-(di-C-ι-C8-alkylcarbamoyl)amino, substituted or non-substituted N-C-rCs-alkyl^di-C-rCs- halogenoalkylcarbamoyl)amino having 1 to 5 halogen atoms, substituted or non-substituted C1-C8- alkylaminocarbonyloxy, substituted or non-substituted di-C-i-Cs-alkylaminocarbonyloxy, substituted or non-substituted C-i-Cs-alkylcarbamothioyl, substituted or non-substituted di-C-i-Cs-alkylcarbamothioyl, substituted or non-substituted N-C-i-Cs-alkyloxycarbamothioyl, substituted or non-substituted C1-C8- alkoxycarbamothioyl, substituted or non-substituted N-C-rCs-alkyl-C-rCs-alkoxycarbamothioyll, substituted or non-substituted C-i-Cs-alkylthioylamino, substituted or non-substituted C1-C8- halogenoalkylthioylamino having 1 to 5 halogen atoms, substituted or non-substituted (C1-C8- alkoxythiocarbonyl)amino, substituted or non-substituted (C-i-Cs-alkyl-carbamothioyO-oxy, substituted or non-substituted substituted or non-substituted (di-C-i-Cs-alkyl-carbamothioyO-oxy, substituted or non-substituted C-ι-C8-alkylsulphenyl, substituted or non-substituted C-i-Cs-halogenoalkylsulphenyl having 1 to 5 halogen atoms, substituted or non-substituted C-ι-C8-alkylsulphinyl, substituted or non- substituted C-i-Cs-halogenoalkylsulphinyl having 1 to 5 halogen atoms, substituted or non-substituted C-ι-C8-alkylsulphonyl, substituted or non-substituted C-i-Cs-halogenoalkylsulphonyl having 1 to 5 halogen atoms, substituted or non-substituted C-i-Cs-alkylaminosulfamoyl, substituted or non- substituted di-C-i-Cs-alkylaminosulfamoyl, substituted or non-substituted (C1-C6-BIkOXyImInO)-C1-C6- alkyl, substituted or non-substituted (C-i-Ce-alkenyloxyimino^C-i-Ce-alkyl, substituted or non- substituted (C-i-Ce-alkynyloxyimino^C-i-Ce-alkyl, substituted or non-substituted (benzyloxyimino)-C-ι- C6-alkyl, substituted or non-substituted benzyloxy, substituted or non-substituted benzylsulphenyl, substituted or non-substituted benzylamino, substituted or non-substituted phenoxy, substituted or non-substituted phenylsulphenyl, substituted or non-substituted phenylamino, substituted or non- substituted aryl, substituted or non-substituted aryl-[C-ι-C8]-alkyl, substituted or non-substituted tri(d- C8-alkyl)-silyloxy, substituted or non-substituted CrC8-alkylsulfenylamino, substituted or non- substituted C-i-Cs-halogenoalkylsulphinylamino having 1 to 5 halogen atoms, substituted or non- substituted C-i-Cs-alkylsulphonylamino, substituted or non-substituted C1-C8- halogenoalkylsulphonylamino having 1 to 5 halogen atoms, substituted or non-substituted C1-C8- alkoxysulphonylamino, substituted or non-substituted C-ι-C8-halogenoxysulphonylamino having 1 to 5 halogen atoms, substituted or non-substituted tri(C-ι-C8-alkyl)-silyl, substituted or non-substituted (C1- C6-alkylideneamino)oxy, substituted or non-substituted (C-ι-C6-alkenylideneamino)oxy, substituted or non-substituted (C-ι-C6-alkynylideneamino)oxy, substituted or non-substituted (benzylideneamino)oxy, substituted or non-substituted [(arylcarbonyl)amino]-[C-ι-C8]-alkyl, substituted or non-substituted [{C1-C8-alkyl(C1-C8-alkylcarbonyl)amino}]-[C1-C8]-alkyl, substituted or non- substituted [{Ci-C8-alkyl(arylcarbonyl)amino}]-[Ci-C8]-alkyl, or a substituted or non-substituted [(C1- C8-alkylcarbonyl)amino]-[Ci-C8]-alkyl;
Provided that when A represents A2 to A9, A42 to A46, A58, A60, A64, A65 or A66, then Z1, Z2, Z3, Z4 Z5, Z6 and Z7 independently cannot represent a hydrogen atom, a halogen atom, a cyano group, an amino group, a sulphenyl group, a formylamino group, substituted or non-substituted Ci-C8-alkyl, substituted or non-substituted d-C8-halogenoalkyl having 1 to 5 halogen atoms, substituted or non- substituted d-C8-alkoxy, substituted or non-substituted d-C8-halogenoalkoxy having 1 to 5 halogen atoms, substituted or non-substituted d-C8-alkylsulphenyl, substituted or non-substituted C1-C8- halogenoalkylsulphenyl having 1 to 5 halogen atoms, substituted or non-substituted C1-C8- alkylcarbonylamino, substituted or non-substituted d-Cs-halogenoalkylcarbonylamino having 1 to 5 halogen atoms, substituted or non-substituted C-i-Cs-alkylcarbamoylamino, substituted or non- substituted C-i-Cs-halogenoalkylcarbamoylamino having 1 to 5 halogen atoms, substituted or non- substituted di-C-i-Cs-alkylcarbamoylamino, substituted or non-substituted CIi-C1-C8- halogenoalkylcarbamoylamino having 1 to 5 halogen atoms , substituted or non-substituted N-C1-C8- alkyl-(C-ι-C8-alkylcarbamoyl)amino, substituted or non-substituted N-C1-C8-alkyl-(C1-C8- halogenoalkylcarbamoyl)amino having 1 to 5 halogen atoms, substituted or non-substituted N-C1-C8- alkyl-(di-C-ι-C8-alkylcarbamoyl)amino, substituted or non-substituted N-C1-C8-alkyl-(di-C1-C8- halogenoalkylcarbamoyl)amino having 1 to 5 halogen atoms, substituted or non-substituted C1-C8- alkylsulphonyl, or a substituted or non-substituted d-C8-halogenoalkylsulphonyl having 1 to 5 halogen atoms;
Provided that when A represents A10 to A36, A47 to A56, then Z\ Z2, Z3, Z4 , Z5, Z6 and Z7 independently cannot represent a hydrogen atom, a halogen atom, a cyano group, an amino group, a sulphenyl group, a formylamino group, a carbamoyl group, substituted or non-substituted d-C8-alkyl, substituted or non-substituted d-C8-cycloalkyl, substituted or non-substituted d-C8-halogenoalkyl having 1 to 5 halogen atoms, substituted or non-substituted d-C8-halogenocycloalkyl having 1 to 5 halogen atoms, a C2-C8-alkenyl, substituted or non-substituted C2-C8-alkynyl, substituted or non- substituted C-ι-C8-alkylamino, substituted or non-substituted di-C-ι-C8-alkylamino, substituted or non- substituted d-C8-alkoxy, substituted or non-substituted (d-C8-alkoxycarbonyl)amino, substituted or non-substituted d-C8-alkylsulphenyl, substituted or non-substituted d-C8-halogenoalkylsulphenyl having 1 to 5 halogen atoms, substituted or non-substituted d-C8-alkylcarbamoyl, substituted or non-substituted di-d-Cs-alkylcarbamoyl, substituted or non-substituted d-C8-alkoxycarbonyl, substituted or non-substituted d-Cs-alkylcarbonylamino, substituted or non-substituted C1-C8- halogenoalkylcarbonylamino having 1 to 5 halogen atoms, substituted or non-substituted C1-C8- alkylcarbamoylamino, substituted or non-substituted d-C8-halogenoalkylcarbamoylannino having 1 to
5 halogen atoms, substituted or non-substituted di-d-C8-alkylcarbamoylannino, substituted or non- substituted di-C-i-Cs-halogenoalkylcarbamoylamino having 1 to 5 halogen atoms , substituted or non- substituted N-C1-C8-alkyl-(C1-C8-alkylcarbamoyl)amino, substituted or non-substituted N-d-C8-alkyl- (C-ι-C8-halogenoalkylcarbamoyl)amino having 1 to 5 halogen atoms, substituted or non-substituted N- Ci-C8-alkyl-(di-Ci-C8-alkylcarbamoyl)annino, substituted or non-substituted N-Ci-C8-alkyl-(di-Ci-C8- halogenoalkylcarbamoyl)annino having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8- alkylsulphinyl, substituted or non-substituted Ci-C8-alkylsulphonyl, substituted or non-substituted d- C8-alkylaminosulfannoyl, substituted or non-substituted di-C-i-Cs-alkylaminosulfannoyl, substituted or non-substituted benzyloxy, substituted or non-substituted benzylsulphenyl, substituted or non- substituted benzylamino, or a substituted or non-substituted aryl;
• K1 represents a hydrogen atom, a formyl group, a carbamoyl group, a N-hydroxycarbamoyl group, a formylamino group, substituted or non-substituted Ci-C8-alkyl, substituted or non-substituted tri(Ci-C8-alkyl)silyl-Ci-C8-alkyl, substituted or non-substituted Ci-C8-cycloalkyl, substituted or non- substituted tri(Ci-C8-alkyl)silyl-Ci-C8-cycloalkyl, substituted or non-substituted Ci-C8-halogenoalkyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-halogenocycloalkyl having 1 to 5 halogen atoms, a C2-C8-alkenyl, substituted or non-substituted C2-C8-alkynyl, substituted or non- substituted C-i-Cs-alkylcarbonyl, substituted or non-substituted d-Cs-halogenoalkylcarbonyl having 1 to 5 halogen atoms, substituted or non-substituted d-Cs-alkylcarbamoyl, substituted or non- substituted di-C-i-Cs-alkylcarbamoyl, substituted or non-substituted N-C-i-Cs-alkyloxycarbamoyl, substituted or non-substituted C-ι-C8-alkoxycarbamoyl, substituted or non-substituted N-Ci-C8-alkyl- C-ι-C8-alkoxycarbamoyl, substituted or non-substituted C-i-C8-alkoxycarbonyl, substituted or non- substituted C-i-Cs-halogenoalkoxycarbonyl having 1 to 5 halogen atoms, substituted or non- substituted C-i-Cs-alkylcarbamothioyl, substituted or non-substituted di-C-i-Cs-alkylcarbamothioyl, substituted or non-substituted N-Ci-C8-alkyloxycarbamothioyl, substituted or non-substituted Ci-C8- alkoxycarbamothioyl, substituted or non-substituted N-Ci-C8-alkyl-Ci-C8-alkoxycarbamothioyl, substituted or non-substituted Ci-C8-alkylsulphinyl, substituted or non-substituted Ci-C8- halogenoalkylsulphinyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-alkyl- sulphonyl, substituted or non-substituted Ci-C8-halogenoalkylsulphonyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-alkylaminosulfamoyl, substituted or non-substituted di-Ci-C8- alkylaminosulfamoyl, substituted or non-substituted aryl, substituted or non-substituted aryl-[d-C8]- alkyl ;
Q is selected in the list consisting of Q1 to Q 19
wherein
• Y1 to Y5 independently represent a hydrogen atom, a nitro group, a hydroxy group, a cyano group, an amino group, a sulphenyl group, a formyl group, a substituted or non-substituted carbaldehyde O-(C-ι-C8-alkyl)oxime, a formyloxy group, a formylamino group, a carbamoyl group, a N-hydroxycarbamoyl group, a pentafluoro-λ6-sulphenyl group, a formylamino group, substituted or non-substituted C-i-Cs-alkoxyamino group, substituted or non-substituted N-Ci-C8-alkyl-(Ci-C8- alkoxy)-amino group, substituted or non-substituted (d-C8-alkylamino)-amino group, substituted or non-substituted N-Ci-C8-alkyl-(Ci-C8-alkylannino)-annino group, a substituted or non-substituted (hydroxyimino)-Ci-C6-alkyl group, substituted or non-substituted Ci-C8-alkyl, substituted or non- substituted tri(Ci-C8-alkyl)silyl-Ci-C8-alkyl, substituted or non-substituted Ci-C8-cycloalkyl, substituted or non-substituted tri(C1-C8-alkyl)silyl-C1-C8-cycloalkyl, substituted or non-substituted Ci-C8- halogenoalkyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-halogenocycloalkyl having 1 to 5 halogen atoms, a C2-C8-alkenyl, substituted or non-substituted C2-C8-alkynyl, substituted or non-substituted Ci-C8-alkylamino, substituted or non-substituted di-Ci-C8-alkylamino, substituted or non-substituted Ci-C8-alkoxy, substituted or non-substituted Ci-C8-halogenoalkoxy having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-alkylsulphenyl, substituted or non- substituted Ci-C8-halogenoalkylsulphenyl having 1 to 5 halogen atoms, substituted or non-substituted C2-C8-alkenyloxy, substituted or non-substituted C2-C8-halogenoalkenyloxy having 1 to 5 halogen atoms, substituted or non-substituted C3-C8-alkynyloxy, substituted or non-substituted C3-C8- halogenoalkynyloxy having 1 to 5 halogen atoms, substituted or non-substituted Ci-Cs-alkylcarbonyl, substituted or non-substituted N-(Ci-C8-alkoxy)-Ci-C8-alkanimidoyl, substituted or non-substituted N- (Ci-C8-alkoxy)-Ci-C8-halogenoalkanimidoyl having 1 to 5 halogen atoms, substituted or non- substituted Ci-C8-halogenoalkylcarbonyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-alkylcarbamoyl, substituted or non-substituted di-Ci-C8-alkylcarbamoyl, substituted or non- substituted N-Ci-C8-alkyloxycarbamoyl, substituted or non-substituted Ci-C8-alkoxycarbamoyl, substituted or non-substituted N-Ci-C8-alkyl-Ci-C8-alkoxycarbamoyl, substituted or non-substituted Ci-C8-alkoxycarbonyl, substituted or non-substituted Ci-C8-halogenoalkoxycarbonyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-alkylcarbonyloxy, substituted or non-substituted Ci-C8-halogenoalkylcarbonyloxy having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8- alkylcarbonylamino, substituted or non-substituted Ci-C8-halogenoalkylcarbonylamino having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-alkylcarbamoylamino, substituted or non- substituted Ci-C8-halogenoalkylcarbamoylamino having 1 to 5 halogen atoms, substituted or non- substituted di-Ci-C8-alkylcarbamoylamino, substituted or non-substituted di-Ci-C8- halogenoalkylcarbamoylamino having 1 to 5 halogen atoms , substituted or non-substituted N-Ci-C8- alkyl-(Ci-C8-alkylcarbamoyl)amino, substituted or non-substituted N-Ci-C8-alkyl-(Ci-C8- halogenoalkylcarbamoyl)amino having 1 to 5 halogen atoms, substituted or non-substituted N-Ci-C8- alkyl-(di-Ci-C8-alkylcarbamoyl)amino, substituted or non-substituted N-Ci-C8-alkyl-(di-Ci-C8- halogenoalkylcarbamoyl)amino having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8- alkylaminocarbonyloxy, substituted or non-substituted di-Ci-C8-alkylaminocarbonyloxy, substituted or non-substituted Ci-C8-alkylcarbamothioyl, substituted or non-substituted di-Ci-C8-alkylcarbamothioyl, substituted or non-substituted N-Ci-C8-alkyloxycarbamothioyll, substituted or non-substituted Ci-C8- alkoxycarbamothioyl, substituted or non-substituted N-Ci-C8-alkyl-Ci-C8-alkoxycarbamothioyl, substituted or non-substituted Ci-C8-alkylthioylamino, substituted or non-substituted Ci-C8- halogenoalkylthioylamino having 1 to 5 halogen atoms, substituted or non-substituted (Ci-C8-alkyl- carbamothioyl)-oxy, substituted or non-substituted substituted or non-substituted (di-Ci-C8-alkyl- carbamothioyl)-oxy, substituted or non-substituted Ci-C8-alkylsulphenyl, substituted or non- substituted Ci-C8-halogenoalkylsulphenyl having 1 to 5 halogen atoms, substituted or non-substituted C-i-Cs-alkylsulphinyl, substituted or non-substituted Ci-C8-halogenoalkylsulphinyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-alkylsulphonyl, substituted or non-substituted C-i-Cs-halogenoalkylsulphonyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8- alkylaminosulfamoyl, substituted or non-substituted di-Ci-Cs-alkylaminosulfamoyl, substituted or non- substituted (Ci-C6-alkoxyimino)-Ci-C6-alkyl, substituted or non-substituted (d-C6-alkenyloxyimino)- Ci-C6-alkyl, substituted or non-substituted (Ci-C6-alkynyloxyimino)-Ci-C6-alkyl, substituted or non- substituted (benzyloxyimino)-Ci-C6-alkyl, substituted or non-substituted benzyloxy, substituted or non-substituted benzylsulphenyl, substituted or non-substituted benzylamino, substituted or non- substituted phenoxy, substituted or non-substituted phenylsulphenyl, substituted or non-substituted phenylamino, substituted or non-substituted aryl, substituted or non-substituted aryl-[Ci-C8]-alkyl, substituted or non-substituted tri(Ci-C8-alkyl)-silyloxy, substituted or non-substituted Ci-C8- alkylsulfenylamino, substituted or non-substituted Ci-Cs-halogenoalkylsulphinylamino having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-alkylsulphonylamino, substituted or non- substituted Ci-Cs-halogenoalkylsulphonylamino having 1 to 5 halogen atoms, substituted or non- substituted Ci-Cs-alkoxysulphonylamino, substituted or non-substituted Ci-C8- halogenoxysulphonylamino having 1 to 5 halogen atoms, substituted or non-substituted tri(Ci-C8- alkyl)-silyl, substituted or non-substituted (d-C6-alkylideneamino)oxy, substituted or non-substituted (Ci-C6-alkenylideneamino)oxy, substituted or non-substituted (d-C6-alkynylideneamino)oxy, or a substituted or non-substituted (benzylideneamino)oxy ;
• W1 represents a group as defined for T ; as well as salts, N-oxides, metallic complexes and metalloidic complexes thereof or (E) and (Z) isomers and mixtures thereof.
Any of the compounds according to the invention can exist as one or more stereoisomers depending on the number of stereogenic units (as defined by the IUPAC rules) in the compound. The invention thus relates equally to all the stereoisomers, and to the mixtures of all the possible stereoisomers, in all proportions. The stereoisomers can be separated according to the methods which are known per se by the man ordinary skilled in the art.
Notably, the stereostructure of the oxime moiety present in the heterocyclyloxime derivative of formula (I) includes (E) or (Z) isomer, and these stereoisomers form part of the present invention.
According to the invention, the following generic terms are generally used with the following meanings: • halogen means fluorine, chlorine, bromine or iodine ;
• heteroatom can be nitrogen, oxygen or sulphur ;
• unless indicated otherwise, a group or a substituent that is substituted according to the invention can be substituted by one or more of the following groups or atoms: a halogen atom, a nitro group, a hydroxy group, a cyano group, an amino group, a sulphenyl group, a pentafluoro-λ6- sulphenyl group, a formyl group, a substituted or non-substituted carbaldehyde O-(Ci-C8-alkyl)oxime, a formyloxy group, a formylamino group, a carbamoyl group, a N-hydroxycarbamoyl group, a formylamino group, a (hydroxyimino)-Ci-C6-alkyl group, a Ci-C8-alkyl, a tri(C1-C8-alkyl)silyl-C1-C8- alkyl, Ci-C8-cycloalkyl, tri(C1-C8-alkyl)silyl-C1-C8-cycloalkyl, a Ci-C8-halogenoalkyl having 1 to 5 halogen atoms, a Ci-C8-halogenocycloalkyl having 1 to 5 halogen atoms, a C2-C8-alkenyl, a C2-C8- alkynyl, a C2-C8-alkenyloxy, a C2-C8-alkynyloxy, a Ci-C8-alkylamino, a di-Ci-C8-alkylamino, a C1-C8- alkoxy, a d-C8-halogenoalkoxy having 1 to 5 halogen atoms, a d-C8-alkylsulphenyl, a C1-C8- halogenoalkylsulphenyl having 1 to 5 halogen atoms, a C2-C8-alkenyloxy, a C2-C8- halogenoalkenyloxy having 1 to 5 halogen atoms, a C3-C8-alkynyloxy, a C3-C8-halogenoalkynyloxy having 1 to 5 halogen atoms, a d-Cs-alkylcarbonyl, a d-Cs-halogenoalkylcarbonyl having 1 to 5 halogen atoms, a d-C8-alkylcarbamoyl, a di-d-Cs-alkylcarbamoyl, a N-d-Cs-alkyloxycarbamoyl, a d-C8-alkoxycarbamoyl, a N-d-Cs-alkyl-d-Cs-alkoxycarbamoyl, a d-C8-alkoxycarbonyl, a C1-C8- halogenoalkoxycarbonyl having 1 to 5 halogen atoms, a d-Cs-alkylcarbonyloxy, a C1-C8- halogenoalkylcarbonyloxy having 1 to 5 halogen atoms, a d-Cs-alkylcarbonylamino, a C1-C8- halogenoalkylcarbonylamino having 1 to 5 halogen atoms, substituted or non-substituted C1-C8- alkoxycarbonylamino, substituted or non-substituted d-Cs-halogenoalkoxycarbonylamino having 1 to 5 halogen atoms, a d-Cs-alkylaminocarbonyloxy, a di-d-Cs-alkylaminocarbonyloxy, a C1-C8- alkyloxycarbonyloxy, a d-C8-alkylsulphenyl, a C-i-Cs-halogenoalkylsulphenyl having 1 to 5 halogen atoms, a d-C8-alkylsulphinyl, a d-C8-halogenoalkylsulphinyl having 1 to 5 halogen atoms, a C1-C8- alkylsulphonyl, a d-C8-halogenoalkylsulphonyl having 1 to 5 halogen atoms, a C1-C8- alkylaminosulfamoyl, a di-d-Cs-alkylaminosulfannoyl, a (d-C6-alkoxyinnino)-d-C6-alkyl, a (C1-C6- alkenyloxyimino)-C-ι-C6-alkyl, a (d-C6-alkynyloxyinnino)-d-C6-alkyl, (benzyloxyimino)-C-ι-C6-alkyl, C1- C8-alkoxyalkyl, C-ι-C8-halogenoalkoxyalkyl having 1 to 5 halogen atoms, benzyloxy, benzylsulphenyl, benzylamino, phenoxy, phenylsulphenyl, or phenylamino ; • the term "aryl" means phenyl or naphthyl.
• The term "heterocyclyl" means saturated or unsaturated A-, 5-, 6- or 7-membered heterocyclyl comprising up to 4 heteroatoms selected in the list consisting of N, O, S
Preferred compounds of formula (I) according to the invention are those wherein L1 represents a direct bond or a divalent group selected in the list consisting of
-(CR1R2)n- -C(=O)-(CR1R2)p-
-(CR1R2)m-O- -(CR1R2)m-C(=O)-O-
-(CR1R2)m-NH- -(CR1R2)m-C(=O)-NH-
-(CR1R2)m-C(=O)- -(CR1R2)m-NH-C(=O) wherein
• n represents 1 or 2 ;
• m and p independently represent 0 or 1 ; • R1 and R2 independently represent a hydrogen atom, a halogen atom, a cyano group, substituted or non-substituted C-ι-C8-alkyl, substituted or non-substituted C-ι-C8-cycloalkyl, substituted or non-substituted C-ι-C8-halogenoalkyl having 1 to 5 halogen atoms, substituted or non-substituted C-ι-C8-halogenocycloalkyl having 1 to 5 halogen atoms, a C2-C8-alkenyl, substituted or non- substituted C2-C8-alkynyl, substituted or non-substituted d-C8-alkoxy, substituted or non-substituted
Ci-C8-halogenoalkoxy having 1 to 5 halogen atoms, substituted or non-substituted C2-C8-alkenyloxy, substituted or non-substituted C2-C8-halogenoalkenyloxy having 1 to 5 halogen atoms, substituted or non-substituted C3-C8-alkynyloxy, substituted or non-substituted C3-C8-halogenoalkynyloxy having 1 to 5 halogen atoms. More preferred compounds of formula (I) according to the invention are those wherein L1 represents a direct bond or a divalent group selected in the list consisting of -(CR1R2)-, -C(=O)-(CR1R2)- and -C(=O)- ; wherein R1 and R2 are independently selected in the list consisting of hydrogen, halogen, methyl, ethyl, isopropyl, trifluoromethyl, difluoromethyl, allyl, ethynyl, propargyl, cyclopropyl, methoxy, trifluoromethoxy and cyano.
Other preferred compounds of formula (I) according to the invention are those wherein T represents T2 or T3.
Other preferred compounds of formula (I) according to the invention are those wherein X1 represents a hydrogen atom, a halogen atom, a cyano group, an amino group, a sulphenyl group, a pentafluoro-λ6- sulphenyl group, substituted or non-substituted d-C8-alkyl, substituted or non-substituted tri(Ci-C8-alkyl)silyl- d-C8-alkyl, substituted or non-substituted d-C8-cycloalkyl, substituted or non-substituted tri(Ci-C8-alkyl)silyl- C-ι-C8-cycloalkyl, substituted or non-substituted d-C8-halogenoalkyl having 1 to 5 halogen atoms, substituted or non-substituted d-Cs-halogenocycloalkyl having 1 to 5 halogen atoms, a C2-C8-alkenyl, substituted or non-substituted C2-C8-alkynyl, substituted or non-substituted d-C8-alkoxy, substituted or non-substituted C1- C8-halogenoalkoxy having 1 to 5 halogen atoms, substituted or non-substituted d-C8-alkylsulphenyl, substituted or non-substituted d-C8-halogenoalkylsulphenyl having 1 to 5 halogen atoms, substituted or non- substituted C2-C8-alkenyloxy, substituted or non-substituted C2-C8-halogenoalkenyloxy having 1 to 5 halogen atoms, substituted or non-substituted C3-C8-alkynyloxy, substituted or non-substituted C3-C8- halogenoalkynyloxy having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-alkylcarbonyl, substituted or non-substituted N-(d-C8-alkoxy)-Ci-C8-alkanimidoyl, substituted or non-substituted N-(Ci-C8- alkoxy)-Ci-C8-halogenoalkanimidoyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8- halogenoalkylcarbonyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-alkylcarbamoyl, substituted or non-substituted di-Ci-C8-alkylcarbamoyl, substituted or non-substituted N-Ci-C8- alkyloxycarbamoyl, substituted or non-substituted Ci-C8-alkoxycarbamoyl, substituted or non-substituted N- Ci-C8-alkyl-Ci-C8-alkoxycarbamoyl, substituted or non-substituted Ci-C8-alkoxycarbonyl, substituted or non- substituted Ci-C8-halogenoalkoxycarbonyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8- alkylcarbamothioyl, substituted or non-substituted di-Ci-C8-alkylcarbamothioyl, substituted or non-substituted N-Ci-C8-alkyloxycarbamothioyll, substituted or non-substituted Ci-C8-alkoxycarbamothioyl, substituted or non-substituted N-Ci-C8-alkyl-Ci-C8-alkoxycarbamothioyl, substituted or non-substituted Ci-C8- alkylsulphenyl, substituted or non-substituted Ci-C8-halogenoalkylsulphenyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-alkylsulphonyl, substituted or non-substituted Ci-C8-halogenoalkyl- sulphonyl having 1 to 5 halogen atoms, substituted or non-substituted (Ci-C6-alkoxyimino)-Ci-C6-alkyl, substituted or non-substituted (Ci-C6-alkenyloxyimino)-Ci-C6-alkyl, substituted or non-substituted (Ci-C6- alkynyloxyimino)-Ci-C6-alkyl, substituted or non-substituted (benzyloxyimino)-Ci-C6-alkyl, substituted or non- substituted benzyloxy, substituted or non-substituted benzylsulphenyl, substituted or non-substituted phenoxy, substituted or non-substituted phenylsulphenyl, substituted or non-substituted aryl, substituted or non-substituted aryl-[C-ι-C8]-alkyl, substituted or non-substituted tri(C-ι-C8-alkyl)-silyloxy, or a substituted or non-substituted tri(C-ι-C8-alkyl)-silyl.
Other more preferred compounds of formula (I) according to the invention are those wherein X1 represents a hydrogen atom, a halogen atom, methyl, isopropyl, isobutyl, tertbutyl, trifluoromethyl, difluoromethyl, allyl, ethynyl, propargyl, cyclopropyl, benzyl, phenethyl, methoxy, trifluoromethoxy, acetyl, trifluoroacetyl or cyano.
Other preferred compounds of formula (I) according to the invention are those wherein W1 represents a hydrogen atom, a halogen atom, a cyano group, substituted or non-substituted d-C8-alkyl, substituted or non-substituted Ci-C8-cycloalkyl, substituted or non-substituted Ci-C8-halogenoalkyl having 1 to 5 halogen atoms, a C2-C8-alkenyl, substituted or non-substituted C2-C8-alkynyl, substituted or non-substituted Ci-C8- alkoxy, substituted or non-substituted Ci-C8-halogenoalkoxy having 1 to 5 halogen atoms, substituted or non- substituted phenoxy, substituted or non-substituted aryl, or a substituted or non-substituted aryl-[Ci-C8]-alkyl. Other more preferred compounds of formula (I) according to the invention are those wherein W1 represents a hydrogen atom, a halogen atom, methyl, ethyl, isopropyl, isobutyl, terbutyl, trifluoromethyl, difluoromethyl, allyl, ethynyl, propargyl, cyclopropyl, methoxy, trifluoromethoxy or cyano.
Other preferred compounds of formula (I) according to the invention are those wherein A is selected in the list consisting of A2 to A18. Other more preferred compounds of formula (I) according to the invention are those wherein A is selected in the list consisting of A2, A8, A16 and A18.
Other preferred compounds of formula (I) according to the invention are those wherein Z1 represents a halogen atom, an amino group, a formylamino group, substituted or non-substituted Ci-C8-alkoxyamino group, substituted or non-substituted N-Ci-C8-alkyl-(Ci-C8-alkoxy)-amino group, substituted or non- substituted Ci-C8-alkyl, substituted or non-substituted Ci-C8-cycloalkyl, a C2-C8-alkenyl, substituted or non- substituted C2-C8-alkynyl, substituted or non-substituted Ci-C8-alkylamino, substituted or non-substituted di- Ci-C8-alkylamino, substituted or non-substituted Ci-C8-alkoxy, substituted or non-substituted Ci-C8- halogenoalkoxy having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-alkylsulphenyl, substituted or non-substituted Ci-C8-alkylcarbonyl, substituted or non-substituted Ci-C8-alkylcarbamoyl, substituted or non-substituted di-Ci-C8-alkylcarbamoyl, substituted or non-substituted N-Ci-C8-alkyloxycarbamoyl, substituted or non-substituted Ci-C8-alkoxycarbamoyl, substituted or non-substituted N-Ci-C8-alkyl-Ci-C8- alkoxycarbamoyl, substituted or non-substituted Ci-C8-alkoxycarbonyl, substituted or non-substituted Ci-C8- alkylcarbonylamino, substituted or non-substituted Ci-C8-halogenoalkylcarbonylamino having 1 to 5 halogen atoms, substituted or non-substituted (Ci-C8-alkoxycarbonyl)annino,, substituted or non-substituted (C2-C8- alkenyloxycarbonyl)amino, substituted or non-substituted (Cs-Cs-alkynyloxycarbonyOamino, substituted or non-substituted d-Cs-alkylcarbamoylannino, substituted or non-substituted (d-Cs-alkoxythiocarbonyOannino, substituted or non-substituted di-Ci-Cs-alkylcarbannoylannino, substituted or non-substituted Ci-C8- alkylthioylamino, substituted or non-substituted benzylamino, substituted or non-substituted phenylamino, substituted or non-substituted aryl-[d-C8]-alkyl.
More preferred compounds of formula (I) according to the invention are those wherein Z1 represents an amino group, a formylamino group, substituted or non-substituted Ci-C8-alkoxyamino group, substituted or non-substituted Ci-C8-alkyl, substituted or non-substituted Ci-C8-cycloalkyl, a C2-C8-alkenyl, substituted or non-substituted C2-C8-alkynyl, substituted or non-substituted Ci-C8-alkylamino, substituted or non-substituted di-Ci-C8-alkylamino, substituted or non-substituted (Ci-C8-alkoxycarbonyl)amino,, substituted or non- substituted (C2-C8-alkenyloxycarbonyl)amino, substituted or non-substituted (C3-C8- alkynyloxycarbonyl)amino, substituted or non-substituted (Ci-C8-alkoxythiocarbonyl)amino, substituted or non-substituted di-Ci-Cs-alkylcarbamoylamino, substituted or non-substituted Ci-C8-alkylthioylamino, substituted or non-substituted benzylamino, substituted or non-substituted phenylamino, substituted or non- substituted aryl-[Ci-C8]-alkyl.
Other preferred compounds of formula (I) according to the invention are those wherein Z2 to Z9 independently represent a hydrogen atom, a halogen atom, a cyano group, substituted or non-substituted Ci-C8-alkyl, substituted or non-substituted Ci-C8-cycloalkyl, substituted or non-substituted Ci-C8-halogenoalkyl having 1 to 5 halogen atoms, a C2-C8-alkenyl, substituted or non-substituted C2-C8-alkynyl, substituted or non- substituted Ci-C8-alkoxy, substituted or non-substituted Ci-C8-halogenoalkoxy having 1 to 5 halogen atoms, substituted or non-substituted phenoxy, substituted or non-substituted aryl, or a substituted or non-substituted aryl-[Ci-C8]-alkyl. Other more preferred compounds of formula (I) according to the invention are those wherein Z2 to Z9 are independently selected in the list consisting of hydrogen, halogen, methyl, ethyl, isopropyl, isobutyl, terbutyl, trifluoromethyl, difluoromethyl, allyl, ethynyl, propargyl, cyclopropyl, methoxy, trifluoromethoxy, acetyl, and cyano.
Other preferred compounds of formula (I) according to the invention are those wherein K1 is selected in the list consisting of hydrogen, methyl, ethyl, isopropyl, isobutyl, terbutyl, allyl, propargyl, cyclopropyl, acetyl, trifluoroacetyl and mesyl.
Other preferred compounds of formula (I) according to the invention are those wherein Q is selected in the list consisting of Q1, Q3, Q7.
Other more preferred compounds of formula (I) according to the invention are those wherein Q represents Q1. Other preferred compounds of formula (I) according to the invention are those wherein Y1 to Y5 independently represent a hydrogen atom, a halogen atom, a cyano group, an amino group, a sulphenyl group, a pentafluoro-λ6-sulphenyl group, substituted or non-substituted C-ι-C8-alkyl, substituted or non-substituted tri(C-ι-C8-alkyl)silyl-C-ι-C8-alkyl, substituted or non-substituted C-ι-C8-cycloalkyl, substituted or non-substituted tri(Ci-C8-alkyl)silyl-Ci-C8-cycloalkyl, substituted or non-substituted Ci-C8-halogenoalkyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-halogenocycloalkyl having 1 to 5 halogen atoms, a C2-C8-alkenyl, substituted or non-substituted C2-C8-alkynyl, substituted or non-substituted Ci-C8-alkoxy, substituted or non- substituted Ci-C8-halogenoalkoxy having 1 to 5 halogen atoms, substituted or non-substituted C1-C8- alkylsulphenyl, substituted or non-substituted Ci-C8-halogenoalkylsulphenyl having 1 to 5 halogen atoms, substituted or non-substituted C2-C8-alkenyloxy, substituted or non-substituted C2-C8-halogenoalkenyloxy having 1 to 5 halogen atoms, substituted or non-substituted C3-C8-alkynyloxy, substituted or non-substituted C3-C8-halogenoalkynyloxy having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-alkylcarbonyl, substituted or non-substituted N-(C-ι-C8-alkoxy)-C-ι-C8-alkanimidoyl, substituted or non-substituted N-(C1-C8- alkoxy)-C-ι-C8-halogenoalkanimidoyl having 1 to 5 halogen atoms, substituted or non-substituted C1-C8- halogenoalkylcarbonyl having 1 to 5 halogen atoms, substituted or non-substituted C-ι-C8-alkylcarbamoyl, substituted or non-substituted di-C-ι-C8-alkylcarbamoyl, substituted or non-substituted N-C1-C8- alkyloxycarbamoyl, substituted or non-substituted C-ι-C8-alkoxycarbamoyl, substituted or non-substituted N- C-i-Cs-alkyl-C-i-Cs-alkoxycarbamoyl, substituted or non-substituted C-ι-C8-alkoxycarbonyl, substituted or non- substituted C-rCs-halogenoalkoxycarbonyl having 1 to 5 halogen atoms, substituted or non-substituted C1-C8- alkylcarbamothioyl, substituted or non-substituted di-C-ι-C8-alkylcarbamothioyl, substituted or non-substituted N-C-i-Cs-alkyloxycarbamothioyll, substituted or non-substituted C-i-Cs-alkoxycarbamothioyl, substituted or non-substituted N-C-i-Cs-alkyl-C-i-Cs-alkoxycarbamothioyl, substituted or non-substituted C1-C8- alkylsulphenyl, substituted or non-substituted C-i-Cs-halogenoalkylsulphenyl having 1 to 5 halogen atoms, substituted or non-substituted C-ι-C8-alkylsulphonyl, substituted or non-substituted C-ι-C8-halogenoalkyl- sulphonyl having 1 to 5 halogen atoms, substituted or non-substituted (C-i-Ce-alkoxyimino^C-i-Ce-alkyl, substituted or non-substituted (C-i-Ce-alkenyloxyimino^C-i-Ce-alkyl, substituted or non-substituted (C1-C6- alkynyloxyimino)-C-ι-C6-alkyl, substituted or non-substituted (benzyloxyimino)-C-ι-C6-alkyl, substituted or non- substituted benzyloxy, substituted or non-substituted benzylsulphenyl, substituted or non-substituted phenoxy, substituted or non-substituted phenylsulphenyl, substituted or non-substituted aryl, substituted or non-substituted aryl-[C-ι-C8]-alkyl, substituted or non-substituted tri(C-ι-C8-alkyl)-silyloxy, substituted or non- substituted tri(C1-C8-alkyl)-silyl.
Other more preferred compounds of formula (I) according to the invention are those wherein Y1 to Y5 independently represent a hydrogen atom, a halogen atom, methyl, isopropyl, isobutyl, tertbutyl, trifluoromethyl, difluoromethyl, allyl, ethynyl, propargyl, cyclopropyl, methoxy, trifluoromethoxy or cyano.
The above mentioned preferences with regard to the substituents of the compounds of formula (I) according to the invention can be combined in various manners. These combinations of preferred features thus provide sub-classes of compounds according to the invention. Examples of such sub-classes of preferred compounds according to the invention can combine: preferred features of A with preferred features of one or more of L1 , T and Q ; preferred features of L1 with preferred features of one or more of A, T and Q ; preferred features T with preferred features of one or more of A, L1 and Q ; preferred features of Q with preferred features of one or more of A, L1 and T. In these combinations of preferred features of the substituents of the compounds according to the invention, the said preferred features can also be selected among the more preferred features of each of A, L1, T and Q, so as to form most preferred subclasses of compounds according to the invention.
The preferred features of the other substituents of the compounds according to the invention can also be part of such sub-classes of preferred compounds according to the invention, notably the groups of substituents X1 to X6, n, m, R1, R2, Z1 to Z7, K1, Y1 to Y5 and W1.
The present invention also relates to a process for the preparation of compounds of formula (I), Thus, according to a further aspect of the present invention, there is provided a process P1 for the preparation of compounds of formula (I) as herein-defined, as illustrated by the following reaction schemes.
(H) (ill) (i)
Process P1 wherein T, A, Q and L1 are as herein-defined and LG represents a leaving group. Suitable leaving groups can be selected in the list consisting of a halogen atom or other customary nucleofugal groups such as triflate, mesylate, or tosylate.
For the compounds of formula (Ia) according to the invention when Z1, Z2, Z3, Z4 Z5, Z6 or Z7 represents a hydroxyl group, a sulphenyl group, an amino group, substituted or non-substituted C-i-Cs-alkylamino, substituted or non-substituted Ci-C8-halogenoalkylannino having 1 to 5 halogen atoms, a formylamino group, substituted or non-substituted C-ι-C8-alkoxyamino group, substituted or non-substituted N-C-rCs-alkyl^C-rCs- alkoxy)-amino group, substituted or non-substituted (C-ι-C8-alkylamino)-amino group, substituted or non- substituted N-C-ι-C8-alkyl-(C-ι-C8-alkylamino)-amino group, substituted or non-substituted C1-C8- alkylcarbonylamino, substituted or non-substituted C-ι-C8-halogenoalkylcarbonylamino having 1 to 5 halogen atoms, substituted or non-substituted C-ι-C8-alkoxycarbonylamino, substituted or non-substituted C1-C8- halogenoalkoxycarbonylamino having 1 to 5 halogen atoms, substituted or non-substituted C1-C8- alkylcarbamoylamino, substituted or non-substituted C-i-Cs-halogenoalkylcarbamoylamino having 1 to 5 halogen atoms, substituted or non-substituted di-C-ι-C8-alkylcarbamoylamino, substituted or non-substituted C-i-Cs-alkylthioylamino, substituted or non-substituted C-i-Cs-halogenoalkylthioylamino having 1 to 5 halogen atoms, substituted or non-substituted (C-ι-C8-alkyl-carbamothioyl)-amino, substituted or non-substituted (di- C-ι-C8-alkyl-carbamothioyl)-amino, process P1 according to the invention can be completed by a further step comprising the additional modification of this group, notably by a reaction of alkylation, acylation, alkoxycarbonylation, alkylaminocarbonylation and alkylaminothiocarbonylation, to yield to a compound of formula (Ib), according to known methods. In such a case there is provided a process P2 according to the invention and such a process P2 can be illustrated by the following reaction schemes :
(Ia) (III) (Ib)
(Ia) ... .
(IV) (lb)
zVLlo' T + G / - 2 I (Ia) (V) (lb)
Process P2 wherein
• T, A, Q and L1 are as herein-defined, LG' represents a leaving group, J1 optionally represents a hydrogen atom, a formyl group, substituted or non-substituted Ci-C8-alkyl, substituted or non- substituted Ci-C8-halogenoalkyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8- alkylamino, substituted or non-substituted di-Ci-C8-alkylamino, substituted or non-substituted Ci-C8- alkoxy, substituted or non-substituted Ci-C8-halogenoalkoxy having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-alkylcarbonyl, substituted or non-substituted Ci-C8-halogenoalkylcarbonyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-alkylcarbamoyl, substituted or non- substituted di-Ci-C8-alkylcarbamoyl, substituted or non-substituted N-Ci-C8-alkyloxycarbamoyl, substituted or non-substituted Ci-C8-alkoxycarbamoyl, substituted or non-substituted N-Ci-C8-alkyl- Ci-C8-alkoxycarbamoyl, substituted or non-substituted Ci-C8-alkoxycarbonyl, substituted or non- substituted Ci-C8-halogenoalkoxycarbonyl having 1 to 5 halogen atoms ; • Za represents a hydroxyl group, a sulphenyl group, an amino group, substituted or non- substituted C-i-Cs-alkylannino, substituted or non-substituted d-Cs-halogenoalkylannino having 1 to 5 halogen atoms, a formylamino group, substituted or non-substituted C-ι-C8-alkoxyamino group, substituted or non-substituted N-C-ι-C8-alkyl-(C-ι-C8-alkoxy)-amino group, substituted or non- substituted (C-ι-C8-alkylamino)-amino group, substituted or non-substituted N-Ci-C8-alkyl-(Ci-C8- alkylamino)-amino group, substituted or non-substituted C-i-Cs-alkylcarbonylamino, substituted or non-substituted d-Cs-halogenoalkylcarbonylannino having 1 to 5 halogen atoms, substituted or non- substituted C-i-Cs-alkoxycarbonylamino, substituted or non-substituted Ci-C8- halogenoalkoxycarbonylamino having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8- alkylcarbamoylamino, substituted or non-substituted Ci-Cs-halogenoalkylcarbamoylamino having 1 to
5 halogen atoms, substituted or non-substituted di-Ci-Cs-alkylcarbamoylamino, substituted or non- substituted Ci-Cs-alkylthioylamino, substituted or non-substituted Ci-Cs-halogenoalkylthioylamino having 1 to 5 halogen atoms, substituted or non-substituted (Ci-Cs-alkyl-carbamothioy^-amino, substituted or non-substituted (di-Ci-Cs-alkyl-carbamothioy^-amino, • G represents an oxygen atom or a sulphur atom ;
• Zb represents a formyloxy group, a formylamino group, a formylamino group, substituted or non-substituted N-Ci-C8-alkyl-(Ci-C8-alkoxy)-amino group, substituted or non-substituted (Ci-C8- alkylamino)-amino group, substituted or non-substituted N-Ci-C8-alkyl-(Ci-C8-alkylamino)-amino group, substituted or non-substituted Ci-C8-alkylamino, substituted or non-substituted di-Ci-C8- alkylamino, substituted or non-substituted Ci-C8-alkoxy, substituted or non-substituted Ci-C8- halogenoalkoxy having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-alkylsulphenyl, substituted or non-substituted Ci-C8-halogenoalkylsulphenyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-Cs-alkylcarbonyloxy, substituted or non-substituted Ci-C8- halogenoalkylcarbonyloxy having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8- alkylcarbonylamino, substituted or non-substituted Ci-Cs-halogenoalkylcarbonylamino having 1 to 5 halogen atoms, substituted or non-substituted Ci-Cs-alkoxycarbonylamino, substituted or non- substituted Ci-Cs-halogenoalkoxycarbonylamino having 1 to 5 halogen atoms, substituted or non- substituted Ci-C8-alkylcarbamoylamino, substituted or non-substituted Ci-C8- halogenoalkylcarbamoylamino having 1 to 5 halogen atoms, substituted or non-substituted di-Ci-C8- alkylcarbamoylamino, substituted or non-substituted di-Ci-C8-halogenoalkylcarbamoylamino having 1 to 5 halogen atoms , substituted or non-substituted N-Ci-C8-alkyl-(Ci-C8-alkylcarbamoyl)amino, substituted or non-substituted N-Ci-C8-alkyl-(Ci-C8-halogenoalkylcarbamoyl)amino having 1 to 5 halogen atoms, substituted or non-substituted N-Ci-C8-alkyl-(di-Ci-C8-alkylcarbamoyl)amino, substituted or non-substituted N-Ci-C8-alkyl-(di-Ci-C8-halogenoalkylcarbamoyl)amino having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-alkylaminocarbonyloxy, substituted or non- substituted di-Ci-C8-alkylaminocarbonyloxy, substituted or non-substituted Ci-C8-alkylcarbamothioyl, substituted or non-substituted di-Ci-C8-alkylcarbamothioyl, substituted or non-substituted N-Ci-C8- alkyloxycarbamothioyll, substituted or non-substituted Ci-C8-alkoxycarbamothioyl, substituted or non- substituted N-Ci-C8-alkyl-Ci-C8-alkoxycarbamothioyl, substituted or non-substituted (Ci-C8-alkyl- carbamothioyl)-annino, substituted or non-substituted substituted or non-substituted (di-d-C8-alkyl- carbamothioyl)-annino, substituted or non-substituted Ci-C8-alkylsulphenyl, substituted or non- substituted d-Cs-halogenoalkylsulphenyl having 1 to 5 halogen atoms, substituted or non-substituted benzyloxy, substituted or non-substituted benzylsulphenyl, substituted or non-substituted benzylamino, substituted or non-substituted tri(d-C8-alkyl)-silyloxy.
• Suitable leaving groups can be selected in the list consisting of a halogen atom or other customary nucleofugal groups such as alcoolate, hydroxide or cyanide.
For the compounds of formula (Ic) according to the invention when Z\ Z2, Z3, Z4 Z5, Z6 or Z7 represent a substituted or non-substituted d-Cs-alkylcarbamothioyl, substituted or non-substituted di-d-C8- alkylcarbamothioyl, substituted or non-substituted N-d-Cs-alkyloxycarbamothioyl, substituted or non- substituted C-i-Cs-alkoxycarbamothioyl, substituted or non-substituted N-Ci-C8-alkyl-Ci-C8- alkoxycarbamothioyl, substituted or non-substituted C-ι-C8-alkylthioylamino, substituted or non-substituted C-i-Cs-halogenoalkylthioylamino having 1 to 5 halogen atoms, substituted or non-substituted (d-C8-alkyl- carbamothioyl)-oxy, substituted or non-substituted substituted or non-substituted (di-d-C8-alkyl- carbamothioyl)-oxy, substituted or non-substituted (d-C8-alkyl-carbamothioyl)-annino, substituted or non- substituted substituted or non-substituted (di-d-Cs-alkyl-carbamothioy^-annino, process P1 according to the invention can be completed by a further step comprising the additional modification of this group, notably by a reaction of thiocarbonylation in the presence of a thiocarbonylating agent such as 2,4-bis(4-methoxyphenyl)- 1 ,3,2,4-dithiadiphosphetane 2,4-disulfide, phosphorus pentasulfide, sulphur to yield to a compound of formula (Id), according to known methods. In such a case there is provided a process P3 according to the invention and such a process P3 can be illustrated by the following reaction scheme : zVLVNγQ - ZVLVVQ
T T
(Ic) (Id)
Process P3 wherein
• T, A, Q and L1 are as herein-defined, Zc represents a substituted or non-substituted CrC8- alkylcarbamoyl, substituted or non-substituted di-d-Cs-alkylcarbamoyl, substituted or non-substituted N-d-Cs-alkyloxycarbamoyl, substituted or non-substituted d-Cs-alkoxycarbamoyl, substituted or non-substituted N-d-Cs-alkyl-d-Cs-alkoxycarbamoyl, substituted or non-substituted CrC8- alkylcarbonylamino, substituted or non-substituted d-Cs-halogenoalkylcarbonylamino having 1 to 5 halogen atoms, substituted or non-substituted (d-C8-alkyl-carbannoyl)-oxy, substituted or non- substituted substituted or non-substituted (di-d-C8-alkyl-carbamoyl)-oxy, substituted or non- substituted (d-C8-alkyl-carbamoyl)-amino, substituted or non-substituted substituted or non- substituted (di-d-Cs-alkyl-carbamoy^-amino, • And Zd represents a substituted or non-substituted d-Cs-alkylcarbamothioyl, substituted or non-substituted di-d-Cs-alkylcarbamothioyl, substituted or non-substituted N-CrC8- alkyloxycarbamothioyl, substituted or non-substituted C-i-Cs-alkoxycarbamothioyl, substituted or non- substituted N-Ci-C8-alkyl-Ci-C8-alkoxycarbannothioyl, substituted or non-substituted C1-C8- alkylthioylamino, substituted or non-substituted C-rC8-halogenoalkylthioylannino having 1 to 5 halogen atoms, substituted or non-substituted (C-i-Cs-alkyl-carbamothioyO-oxy, substituted or non- substituted substituted or non-substituted (di-C-i-Cs-alkyl-carbamothioyO-oxy, substituted or non- substituted (C-i-Cs-alkyl-carbannothioyO-annino, substituted or non-substituted substituted or non- substituted (di-C-i-Cs-alkyl-carbannothioy^-annino.
For the compounds of formula (Ie) according to the invention when Z\ Z2, Z3, Z4 Z5, Z6 or Z7 represent a hydroxy group, a cyano group, an amino group, a sulphenyl group, a formyloxy group, a formylamino group, a carbamoyl group, a N-hydroxycarbamoyl group, a formylamino group, substituted or non-substituted C1-C8- alkoxyamino group, substituted or non-substituted N-C-ι-C8-alkyl-(C-ι-C8-alkoxy)-amino group, substituted or non-substituted (C-ι-C8-alkylamino)-amino group, substituted or non-substituted N-C-rCs-alkyl^C-rCs- alkylamino)-amino group, substituted or non-substituted C-ι-C8-alkyl, substituted or non-substituted tri(C-ι-C8- alkyl)silyl-Ci-C8-alkyl, substituted or non-substituted Ci-C8-cycloalkyl, substituted or non-substituted tri(C-ι-C8- alkyl)silyl-Ci-C8-cycloalkyl, substituted or non-substituted Ci-C8-halogenoalkyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-halogenocycloalkyl having 1 to 5 halogen atoms, a C2-C8-alkenyl, substituted or non-substituted C2-C8-alkynyl, substituted or non-substituted Ci-C8-alkylamino, substituted or non-substituted di-Ci-C8-alkylamino, substituted or non-substituted Ci-C8-alkoxy, substituted or non- substituted Ci-C8-halogenoalkoxy having 1 to 5 halogen atoms, substituted or non-substituted C1-C8- alkylsulphenyl, substituted or non-substituted Ci-C8-halogenoalkylsulphenyl having 1 to 5 halogen atoms, substituted or non-substituted C2-C8-alkenyloxy, substituted or non-substituted C2-C8-halogenoalkenyloxy having 1 to 5 halogen atoms, substituted or non-substituted C3-C8-alkynyloxy, substituted or non-substituted C3-C8-halogenoalkynyloxy having 1 to 5 halogen atoms, substituted or non-substituted C-ι-C8-alkylcarbamoyl, substituted or non-substituted di-C-ι-C8-alkylcarbamoyl, substituted or non-substituted N-C1-C8- alkyloxycarbamoyl, substituted or non-substituted d-C8-alkoxycarbamoyl, substituted or non-substituted N- C-ι-C8-alkyl-C-ι-C8-alkoxycarbamoyl, substituted or non-substituted d-C8-alkoxycarbonyl, substituted or non- substituted C-i-Cs-halogenoalkoxycarbonyl having 1 to 5 halogen atoms, substituted or non-substituted C1-C8- alkylcarbonyloxy, substituted or non-substituted C-i-Cs-halogenoalkylcarbonyloxy having 1 to 5 halogen atoms, substituted or non-substituted C-i-Cs-alkylcarbonylamino, substituted or non-substituted C1-C8- halogenoalkylcarbonylamino having 1 to 5 halogen atoms, substituted or non-substituted C1-C8- alkoxycarbonylamino, substituted or non-substituted C-i-C8-halogenoalkoxycarbonylamino having 1 to 5 halogen atoms, substituted or non-substituted C-ι-C8-alkylcarbamoylamino, substituted or non-substituted C-i-Cs-halogenoalkylcarbamoylamino having 1 to 5 halogen atoms, substituted or non-substituted CIi-C1-C8- alkylcarbamoylamino, substituted or non-substituted C-ι-C8-alkylsulphenyl, substituted or non-substituted C1- C8-halogenoalkylsulphenyl having 1 to 5 halogen atoms, substituted or non-substituted benzyloxy, substituted or non-substituted benzylsulphenyl, substituted or non-substituted benzylamino, substituted or non- substituted phenoxy, substituted or non-substituted phenylsulphenyl, substituted or non-substituted phenylamino, substituted or non-substituted aryl, substituted or non-substituted aryl-[C-ι-C8]-alkyl, process P1 according to the invention can be completed by a further step comprising the additional modification of this group, notably by a reaction of nucleophilic substitution to yield to a compound of formula (If), according to known methods, optionnally in the presence of carbon monoxide or a carbon monoxide generating agent such as Mo(CO)6 or W(CO)6, optionally in the presence of a catalyst notably a transition metal catalyst, such as palladium salts or complexes for example palladium (II) chloride, palladium (II) acetate, tetrakis- (triphenylphosphine) palladium(O), bis-(triphenylphosphine) palladium dichloride (II), tris(dibenzylideneacetone) dipalladium(O), bis(dibenzylideneacetone) palladium(O), or 1 ,1'- bis(diphenylphosphino)ferrocene-palladium (II) chloride. As an alternative the palladium complex is directly generated in the reaction mixture by separately adding to the reaction mixture a palladium salt and a complex ligand such as a phosphine, for example triethylphosphine, tri-tert-butylphosphine, tricyclohexylphosphine, 2- (dicyclohexylphosphine)biphenyl, 2-(di-tert-butylphosphin)biphenyl, 2-(dicyclohexylphosphine)-2'-(N,N- dimethylamino)-biphenyl, triphenylphosphine, tris-(o-tolyl)phosphine, sodium 3-
(diphenylphosphino)benzolsulfonate, tris-2-(methoxyphenyl)phosphine, 2,2'-bis-(diphenylphosphine)-1 ,1'- binaphthyl, 1 ,4-bis-(diphenylphosphine)butane, 1 ,2-bis-(diphenylphosphine)ethane, 1 ,4-bis- (dicyclohexylphosphine)butane, 1 ,2-bis-(dicyclohexylphosphine)ethane, 2-(dicyclohexylphosphine)-2'-(N,N- dimethylamino)-biphenyl, bis(diphenylphosphino)ferrocene, tris-(2,4-tert-butylphenyl)-phosphite, (R)-(-)-1- [(S)-2-(diphenylphosphino)ferrocenyl]ethyldi-tert-butylphosphine, (S)-(+)-1-[(R)-2-
(diphenylphosphino)ferrocenyl]ethyldicyclohexylphosphine, (R)-(-)-1-[(S)-2-
(diphenylphosphino)ferrocenyl]ethyldicyclohexylphosphine, (S)-(+)-1-[(R)-2- (diphenylphosphino)ferrocenyl]ethyldi-t-butylphosphine, optionally in the presence of a base such as an inorganic or an organic base; preferably an alkaline earth metal or alkali metal hydride, hydroxide, amide, alcoholate, acetate, carbonate or hydrogen carbonate, such as sodium hydride, sodium amide, lithiium diisopropylamide, sodium methanolate, sodium ethanolate, potassium tert-butanolate, sodium acetate, potassium acetate, calcium acetate, sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, potassium bicarbonate, sodium bicarbonate, cesium carbonate or ammonium carbonate; and also tertiary amine, such as trimethylamine, triethylamine (TEA), tributylamine, N,N-dimethylaniline, N,N-dimethyl- benzylamine, N,N-diisopropyl-ethylamine (DIPEA), pyridine, N-methylpiperidine, N-methylmorpholine, N, N- dimethylaminopyridine, diazabicyclooctane (DABCO), diazabicyclononene (DBN) or diazabicycloundecene (DBU), to yield a compound of formula (I).. In such a case there is provided a process P4 according to the invention and such a process P4 can be illustrated by the following reaction scheme :
<le> (If)
Process P4 wherein
• T, A, Q and L1 are as herein-defined as herein-defined, Ze represents a halogen atom., and Zf represents a hydroxy group, a cyano group, an amino group, a sulphenyl group, a formyloxy group, a formylamino group, a carbamoyl group, a N-hydroxycarbamoyl group, a formylamino group, substituted or non-substituted Ci-C8-alkoxyannino group, substituted or non-substituted N-Ci-C8-alkyl- (Ci-C8-alkoxy)-amino group, substituted or non-substituted (Ci-C8-alkylamino)-annino group, substituted or non-substituted N-Ci-C8-alkyl-(Ci-C8-alkylamino)-annino group, substituted or non- substituted Ci-C8-alkyl, substituted or non-substituted tri(C1-C8-alkyl)silyl-C1-C8-alkyl, substituted or non-substituted Ci-C8-cycloalkyl, substituted or non-substituted tri(C1-C8-alkyl)silyl-C1-C8-cycloalkyl, substituted or non-substituted Ci-C8-halogenoalkyl having 1 to 5 halogen atoms, substituted or non- substituted C-rCs-halogenocycloalkyl having 1 to 5 halogen atoms, a C2-C8-alkenyl, substituted or non-substituted C2-C8-alkynyl, substituted or non-substituted d-C8-alkylamino, substituted or non- substituted di-d-C8-alkylamino, substituted or non-substituted d-C8-alkoxy, substituted or non- substituted d-C8-halogenoalkoxy having 1 to 5 halogen atoms, substituted or non-substituted C1-C8- alkylsulphenyl, substituted or non-substituted C-ι-C8-halogenoalkylsulphenyl having 1 to 5 halogen atoms, substituted or non-substituted C2-C8-alkenyloxy, substituted or non-substituted C2-C8- halogenoalkenyloxy having 1 to 5 halogen atoms, substituted or non-substituted C3-C8-alkynyloxy, substituted or non-substituted C3-C8-halogenoalkynyloxy having 1 to 5 halogen atoms, substituted or non-substituted d-Cs-alkylcarbamoyl, substituted or non-substituted di-d-Cs-alkylcarbamoyl, substituted or non-substituted N-d-Cs-alkyloxycarbamoyl, substituted or non-substituted C1-C8- alkoxycarbamoyl, substituted or non-substituted N-d-Cs-alkyl-d-Cs-alkoxycarbamoyl, substituted or non-substituted Ci-C8-alkoxycarbonyl, substituted or non-substituted d-Cs-halogenoalkoxycarbonyl having 1 to 5 halogen atoms, substituted or non-substituted d-Cs-alkylcarbonyloxy, substituted or non-substituted d-Cs-halogenoalkylcarbonyloxy having 1 to 5 halogen atoms, substituted or non- substituted d-Cs-alkylcarbonylamino, substituted or non-substituted C1-C8- halogenoalkylcarbonylamino having 1 to 5 halogen atoms, substituted or non-substituted C1-C8- alkoxycarbonylamino, substituted or non-substituted d-Cs-halogenoalkoxycarbonylamino having 1 to 5 halogen atoms, substituted or non-substituted d-Cs-alkylcarbamoylamino, substituted or non- substituted d-Cs-halogenoalkylcarbamoylamino having 1 to 5 halogen atoms, substituted or non- substituted di-d-Cs-alkylcarbamoylamino, substituted or non-substituted d-C8-alkylsulphenyl, substituted or non-substituted d-C8-halogenoalkylsulphenyl having 1 to 5 halogen atoms, substituted or non-substituted benzyloxy, substituted or non-substituted benzylsulphenyl, substituted or non- substituted benzylamino, substituted or non-substituted phenoxy, substituted or non-substituted phenylsulphenyl, substituted or non-substituted phenylamino, substituted or non-substituted aryl, substituted or non-substituted aryl-[d-C8]-alkyl,
If Z1, Z2, Z3, Z4 Z5, Z6 or Z7 represent a protected amino group, carrying out process P2 would previously require a deprotection step in order to yield the amino group. Amino-protecting groups and related methods of cleavage thereof are known and can be found in T. W. Greene and P. G. M. Wuts, Protective Group in Organic Chemistry, 3rd ed., John Wiley & Sons.
According to the invention, processes P1 and P2 may be performed if appropriate in the presence of a solvent and if appropriate in the presence of a base. According to the invention, processes P1 and P2 may be performed if appropriate in the presence of a catalyst. Suitable catalyst may be chosen as being 4-dimethyl-aminopyridine, 1-hydroxy-benzotriazole or dimethylformamide. In case LG' represents a hydroxy group, the process P2 according to the present invention may be performed in the presence of condensing agent. Suitable condensing agent may be chosen as being acid halide former, such as phosgene, phosphorous tribromide, phosphorous trichloride, phosphorous pentachloride, phosphorous trichloride oxide or thionyl chloride; anhydride former, such as ethyl chloroformate, methyl chloroformate, isopropyl chloroformate, isobutyl chloroformate or methanesulfonyl chloride; carbodiimides, such as N.N'-dicyclohexylcarbodiimide (DCC) or other customary condensing agents, such as phosphorous pentoxide, polyphosphoric acid, N,N'-carbonyl-diimidazole, 2-ethoxy-N-ethoxycarbonyl-1 ,2-dihydroquinoline (EEDQ), triphenylphosphine/tetrachloromethane, 4-(4,6-dimethoxy[1.3.5]triazin-2-yl)-4-methylmorpholinium chloride hydrate or bromo-tripyrrolidino-phosphonium-hexafluorophosphate.
Suitable solvents for carrying out processes P1 to P4 according to the invention are customary inert organic solvents. Preference is given to using optionally halogenated aliphatic, alicyclic or aromatic hydrocarbons, such as petroleum ether, hexane, heptane, cyclohexane, methylcyclohexane, benzene, toluene, xylene or decalin ; chlorobenzene, dichlorobenzene, dichloromethane, chloroform, carbon tetrachloride, dichlorethane or trichlorethane ; ethers, such as diethyl ether, diisopropyl ether, methyl tert-butyl ether, methyl tert-amyl ether, dioxane, tetrahydrofuran, 1 ,2-dimethoxyethane, 1 ,2-diethoxyethane or anisole ; nitriles, such as acetonitrile, propionitrile, n- or iso-butyronitrile or benzonitrile ; amides, such as Λ/,Λ/-dimethylformamide, N, N- dimethylacetamide, Λ/-methylformanilide, Λ/-methylpyrrolidone or hexamethylphosphoric triamide ; esters, such as methyl acetate or ethyl acetate, sulphoxides, such as dimethyl sulphoxide, or sulphones, such as sulpholane.
Suitable bases for carrying out processes P1 and P2 according to the invention are inorganic and organic bases which are customary for such reactions. Preference is given to using alkaline earth metal, alkali metal hydride, alkali metal hydroxides or alkali metal alkoxides, such as sodium hydroxide, sodium hydride, calcium hydroxide, potassium hydroxide, potassium tert-butoxide or other ammonium hydroxide, alkali metal carbonates, such as sodium carbonate, potassium carbonate, potassium bicarbonate, sodium bicarbonate, cesium carbonate, alkali metal or alkaline earth metal acetates, such as sodium acetate, potassium acetate, calcium acetate, and also tertiary amines, such as trimethylamine, triethylamine, diisopropylethylamine, tributylamine, Λ/,Λ/-dimethylaniline, pyridine, Λ/-methylpiperidine, Λ/,Λ/-dimethylaminopyridine, 1 ,4- diazabicyclo[2.2.2]octane (DABCO), 1 ,5-diazabicyclo[4.3.0]non-5-ene (DBN) or 1 ,8-diazabicyclo[5.4.0]undec- 7-ene (DBU).
When carrying out processes P1 and P4 according to the invention, the reaction temperature can independently be varied within a relatively wide range. Generally, process P1 according to the invention is carried out at temperatures between -8O0C and 16O0C. Processes P1 to P4 according to the invention are generally independently carried out under atmospheric pressure. However, it is also possible to operate under elevated or reduced pressure.
Work-up is carried out by customary methods. Generally, the reaction mixture is treated with water and the organic phase is separated off and, after drying, concentrated under reduced pressure. If appropriate, the remaining residue can be freed by customary methods, such as chromatography or recrystallization, from any impurities that may still be present.
Compounds according to the invention can be prepared according to the above described processes. It will nevertheless be understood that, on the basis of his general knowledge and of available publications, the skilled worker will be able to adapt these processes according to the specifics of each of the compounds according to the invention that is desired to be synthesised.
When T represents a compound of formula T2 to T9 as described previously, the compounds of formula (II), useful as a starting material, can be prepared, for example, by reacting hydroxylamine with the corresponding ketones that can be prepared, for example, according to the method described in WO99/02689.
In a further aspect, the present invention relates to compounds of formula (II) useful as intermediate compounds or materials for the process of preparation according to the invention. The present invention thus provides compounds of formula (II) wherein T and Q are as herein-defined:
O- H
-Q
(II)
In a further aspect, the present invention also relates to a fungicide composition comprising an effective and non-phytotoxic amount of an active compound of formula (I).
The expression "effective and non-phytotoxic amount" means an amount of composition according to the invention which is sufficient to control or destroy the fungi present or liable to appear on the crops and which does not entail any appreciable symptom of phytotoxicity for the said crops. Such an amount can vary within a wide range depending on the fungus to be controlled, the type of crop, the climatic conditions and the compounds included in the fungicide composition according to the invention. This amount can be determined by systematic field trials, which are within the capabilities of a person skilled in the art. Thus, according to the invention, there is provided a fungicide composition comprising, as an active ingredient, an effective amount of a compound of formula (I) as herein defined and an agriculturally acceptable support, carrier or filler.
According to the invention, the term "support" denotes a natural or synthetic organic or inorganic compound with which the active compound of formula (I) is combined or associated to make it easier to apply, notably to the parts of the plant. This support is thus generally inert and should be agriculturally acceptable. The support can be a solid or a liquid. Examples of suitable supports include clays, natural or synthetic silicates, silica, resins, waxes, solid fertilisers, water, alcohols, in particular butanol organic solvents, mineral and plant oils and derivatives thereof. Mixtures of such supports can also be used.
The composition according to the invention can also comprise additional components. In particular, the composition can further comprise a surfactant. The surfactant can be an emulsifier, a dispersing agent or a wetting agent of ionic or non-ionic type or a mixture of such surfactants. Mention can be made, for example, of polyacrylic acid salts, lignosulphonic acid salts, phenolsulphonic or naphthalenesulphonic acid salts, polycondensates of ethylene oxide with fatty alcohols or with fatty acids or with fatty amines, substituted phenols (in particular alkylphenols or arylphenols), salts of sulphosuccinic acid esters, taurine derivatives (in particular alkyl taurates), phosphoric esters of polyoxyethylated alcohols or phenols, fatty acid esters of polyols and derivatives of the above compounds containing sulphate, sulphonate and phosphate functions. The presence of at least one surfactant is generally essential if the active compound and/or the inert support are water-insoluble and if the vector agent for the application is water. Preferably, surfactant content can be comprised from 5% to 40% by weight of the composition.
Optionally, additional components can also be included, e.g. protective colloids, adhesives, thickeners, thixotropic agents, penetration agents, stabilisers, sequestering agents. More generally, the active compounds can be combined with any solid or liquid additive, which complies with the usual formulation techniques.
In general, the composition according to the invention can contain from 0.05 to 99% by weight of active compound, preferably 10 to 70% by weight.
Compositions according to the invention can be used in various forms such as aerosol dispenser, capsule suspension, cold fogging concentrate, dustable powder, emulsifiable concentrate, emulsion oil in water, emulsion water in oil, encapsulated granule, fine granule, flowable concentrate for seed treatment, gas (under pressure), gas generating product, granule, hot fogging concentrate, macrogranule, microgranule, oil dispersible powder, oil miscible flowable concentrate, oil miscible liquid, paste, plant rodlet, powder for dry seed treatment, seed coated with a pesticide, soluble concentrate, soluble powder, solution for seed treatment, suspension concentrate (flowable concentrate), ultra low volume (ULV) liquid, ultra low volume (ULV) suspension, water dispersible granules or tablets, water dispersible powder for slurry treatment, water soluble granules or tablets, water soluble powder for seed treatment and wettable powder. These compositions include not only compositions which are ready to be applied to the plant or seed to be treated by means of a suitable device, such as a spraying or dusting device, but also concentrated commercial compositions which must be diluted before application to the crop.
The compounds according to the invention can also be mixed with one or more insecticide, fungicide, bactericide, attractant, acaricide or pheromone active substance or other compounds with biological activity. The mixtures thus obtained have a broadened spectrum of activity. The mixtures with other fungicide compounds are particularly advantageous. The composition according to the invention comprising a mixture of a compound of formula (I) with a bactericide compound can also be particularly advantageous
Examples of suitable fungicide mixing partners can be selected in the following lists:
(1 ) Inhibitors of the nucleic acid synthesis, for example benalaxyl, benalaxyl-M, bupirimate, clozylacon, dimethirimol, ethirimol, furalaxyl, hymexazol, metalaxyl, metalaxyl-M, ofurace, oxadixyl and oxolinic acid. (2) Inhibitors of the mitosis and cell division, for example benomyl, carbendazim, chlorfenazole, diethofencarb, ethaboxam, fluopicolide, fuberidazole, pencycuron, thiabendazole, thiophanate-methyl, thiophanate, zoxamide and 5-chloro-7-(4-methylpiperidin-1-yl)-6-(2,4,6-trifluorophenyl)[1 ,2,4]triazolo[1 ,5- a]pyrimidine..
(3) inhibitors of the respiratory chain at complex I or II, for example diflumetorim as Cl-respiration inhibitor; bixafen, boscalid, carboxin, diflumetorim, fenfuram, fluopyram, flutolanil, furametpyr, furmecyclox, isopyrazam (mixture of syn-epimeric racemate 1 RS,4SR,9RS and anti-epimeric racemate 1 RS, 4SR, 9SR), isopyrazam (anti-epimeric racemate 1 RS, 4SR, 9SR), isopyrazam (anti-epimeric enantiomer 1 R,4S,9S), isopyrazam (anti- epimeric enantiomer 1S,4R,9R), isopyrazam (syn epimeric racemate 1 RS, 4SR, 9RS), isopyrazam (syn- epimeric enantiomer 1 R,4S,9R), isopyrazam (syn-epimeric enantiomer 1S,4R,9S), mepronil, oxycarboxin, penflufen, penthiopyrad, sedaxane, thifluzamide, 1-methyl-N-[2-(1 ,1 ,2,2-tetrafluoroethoxy)phenyl]-3- (trifluoromethyl)-1 H-pyrazole-4-carboxamide, 3-(difluoromethyl)-1-methyl-N-(3',4',5'-trifluorobiphenyl-2-yl)-1 H- pyrazole-4-carboxamide, 3-(difluoromethyl)-1-methyl-N-[2-(1 ,1 ,2,2-tetrafluoroethoxy)phenyl]-1 H-pyrazole-4- carboxamide and 3-(difluoromethyl)-N-[4-fluoro-2-(1 ,1 ,2,3,3,3-hexafluoropropoxy)phenyl]-1-methyl-1 H- pyrazole-4-carboxamide Cll-respiration inhibitor; amisulbrom, azoxystrobin, cyazofamid, dimoxystrobin, enestroburin, famoxadone, fenamidone, fluoxastrobin, kresoxim-methyl, metominostrobin, orysastrobin, picoxystrobin, pyraclostrobin, pyrametostrobin, pyraoxystrobin, pyribencarb, trifloxystrobin, (2E)-2-(2-{[6-(3-chloro-2-methylphenoxy)-5-fluoropyrimidin-4- yl]oxy}phenyl)-2-(methoxyimino)-N-methylethanamide, (2E)-2-(methoxyimino)-N-methyl-2-(2-{[({(1 E)-1-[3- (trifluoromethyl)phenyl]ethylidene}amino)oxy]methyl}phenyl)ethanamide, (2E)-2-(methoxyimino)-N-methyl-2- {2-[(E)-({1-[3-(trifluoromethyl)phenyl]ethoxy}imino)methyl]phenyl}ethanamide, (2E)-2-{2-[({[(1 E)-1-(3-{[(E)-1- fluoro-2-phenylethenyl]oxy}phenyl)ethylidene]amino}oxy)methyl]phenyl}-2-(methoxyimino)-N- methylethanamide, (2E)-2-{2-[({[(2E,3E)-4-(2,6-dichlorophenyl)but-3-en-2-ylidene]amino}oxy)methyl]phenyl}- 2-(methoxyimino)-N-methylethanamide, 2-chloro-N-(1 ,1 ,3-trinnethyl-2,3-dihydro-1 H-inden-4-yl)pyridine-3- carboxamide, 5-methoxy-2-methyl-4-(2-{[({(1 E)-1-[3-
(trifluoromethyl)phenyl]ethylidene}amino)oxy]methyl}phenyl)-2,4-dihydro-3H-1 ,2,4-triazol-3-one, methyl 2-{2- [({cyclopropyl[(4-methoxyphenyl)innino]nnethyl}sulfanyl)nnethyl]phenyl}-3-nnethoxyacrylate and N-(3-ethyl- S.S.S-trimethylcyclohexyO-S-^ormylamino^-hydroxybenzamide as Clll-respiration inhibitor.
(4) Compounds capable to act as an uncoupler, like for example binapacryl, dinocap, ferimzone, fluazinam and meptyldinocap.
(5) Inhibitors of the ATP production, for example fentin acetate, fentin chloride, fentin hydroxide and silthiofam.
(6) Inhibitors of the amino acid and/or protein biosynthesis, for example andoprim, blasticidin-S, cyprodinil, kasugamycin, kasugamycin hydrochloride hydrate, mepanipyrim and pyrimethanil .
(7) Inhibitors of the signal transduction, for example chlozolinate, fenpiclonil, fludioxonil, iprodione, procymidone, quinoxyfen and vinclozolin.
(8) Inhibitors of the lipid and membrane synthesis, for example biphenyl, chloroneb, dicloran, edifenphos, etridiazole, iodocarb, iprobenfos, isoprothiolane, propamocarb, propamocarb hydrochloride, prothiocarb, pyrazophos, quintozene, tecnazene and tolclofos-methyl.
(9) Inhibitors of the ergosterol biosynthesis, for example aldimorph, azaconazole, bitertanol, bromuconazole, cyproconazole, diclobutrazole, difenoconazole, diniconazole, diniconazole-M, dodemorph, dodemorph acetate, epoxiconazole, etaconazole, fenarimol, fenbuconazole, fenhexamid, fenpropidin, fenpropimorph, fluquinconazole, flurprimidol, flusilazole, flutriafol, furconazole, furconazole-cis, hexaconazole, imazalil, imazalil sulfate, imibenconazole, ipconazole, metconazole, myclobutanil, naftifine, nuarimol, oxpoconazole, paclobutrazol, pefurazoate, penconazole, piperalin, prochloraz, propiconazole, prothioconazole, pyributicarb, pyrifenox, quinconazole, simeconazole, spiroxamine, tebuconazole, terbinafine, tetraconazole, triadimefon, triadimenol, tridemorph, triflumizole, triforine, triticonazole, uniconazole, uniconazole-p, viniconazole, voriconazole, 1-(4-chlorophenyl)-2-(1 H-1 ,2,4-triazol-1-yl)cycloheptanol, methyl 1-(2,2-dimethyl-2,3-dihydro- 1 H-inden-1-yl)-1 H-imidazole-5-carboxylate, N'-{5-(difluoromethyl)-2-methyl-4-[3-
(trimethylsilyl)propoxy]phenyl}-N-ethyl-N-methylimidoformamide, N-ethyl-N-methyl-N'-{2-methyl-5-
(trifluoromethyl)-4-[3-(trimethylsilyl)propoxy]phenyl}imidoformamide and O-{1-[(4-methoxyphenoxy)methyl]- 2,2-dimethylpropyl} I H-imidazole-1-carbothioate,
(10) Inhibitors of the cell wall synthesis, for example benthiavalicarb, dimethomorph, flumorph, iprovalicarb, mandipropamid, polyoxins, polyoxorim, validamycin A and valifenalate. (11 ) Inhibitors of the melanine biosynthesis, for example carpropamid, diclocymet, fenoxanil, phthalide, pyroquilon and tricyclazole,
(12) Compounds capable to induce a host defence, like for example acibenzolar-S-methyl, isotianil, probenazole and tiadinil.
(13) Compounds capable to have a multisite action, like for example bordeaux mixture, captafol, captan, chlorothalonil, copper hydroxide, copper naphthenate, copper oxide, copper oxychloride, copper(2+) sulfate, dichlofluanid, dithianon, dodine, dodine free base, ferbam, fluorofolpet, folpet, guazatine, guazatine acetate, iminoctadine, iminoctadine albesilate, iminoctadine triacetate, mancopper, mancozeb, maneb, metiram, metiram zinc, oxine-copper, propamidine, propineb, sulphur and sulphur preparations including calcium polysulphide, thiram, tolylfluanid, zineb and ziram.
(14) Further compounds like for example 1-(4-{4-[(5R)-5-(2,6-difluorophenyl)-4,5-dihydro-1 ,2-oxazol-3-yl]- 1 ,3-thiazol-2-yl}piperidin-1-yl)-2-[5-methyl-3-(trifluoromethyl)-1 H-pyrazol-1-yl]ethanone, 1-[(4- methoxyphenoxy)methyl]-2,2-dimethylpropyl 1 H-imidazole-1-carboxylate, 2,3,5,6-tetrachloro-4-
(methylsulfonyl)pyridine, 2,3-dibutyl-6-chlorothieno[2,3-d]pyrimidin-4(3H)-one, 2-[5-methyl-3-(trifluoromethyl)- 1 H-pyrazol-1-yl]-1-(4-{4-[(5R)-5-phenyl-4,5-dihydro-1 ,2-oxazol-3-yl]-1 ,3-thiazol-2-yl}piperidin-1-yl)ethanone, 2-butoxy-6-iodo-3-propyl-4H-chromen-4-one, 2-phenylphenol and salts, 3,4,5-trichloropyridine-2,6- dicarbonitrile, 3-[5-(4-chlorophenyl)-2,3-dimethylisoxazolidin-3-yl]pyridine, 3-chloro-5-(4-chlorophenyl)-4-(2,6- difluorophenyl)-6-methylpyridazine, 4-(4-chlorophenyl)-5-(2,6-difluorophenyl)-3,6-dimethylpyridazine, 5- amino-1 ,3,4-thiadiazole-2-thiol, 5-chloro-N'-phenyl-N'-prop-2-yn-1-ylthiophene-2-sulfonohydrazide, 5-methyl- 6-octyl-3,7-dihydro[1 ,2,4]triazolo[1 ,5-a]pyrimidin-7-amine, ametoctradin, benthiazole, bethoxazin, capsimycin, carvone, chinomethionat, chlazafenone, cufraneb, cyflufenamid, cymoxanil, cyprosulfamide, dazomet, debacarb, dichlorophen, diclomezine, difenzoquat, difenzoquat methylsulphate, diphenylamine, ecomate, ethyl (2Z)-3-amino-2-cyano-3-phenylprop-2-enoate, flumetover, fluoroimide, flusulfamide, flutianil, fosetyl- aluminium, fosetyl-calcium, fosetyl-sodium, hexachlorobenzene, irumamycin, methasulfocarb, methyl isothiocyanate, metrafenone, mildiomycin, N-(4-chlorobenzyl)-3-[3-methoxy-4-(prop-2-yn-1- yloxy)phenyl]propanamide, N-[(4-chlorophenyl)(cyano)methyl]-3-[3-methoxy-4-(prop-2-yn-1- yloxy)phenyl]propanamide, N-[(5-bromo-3-chloropyridin-2-yl)methyl]-2,4-dichloropyridine-3-carboxamide, N- [i^δ-bromo-S-chloropyridin^-yOethyll^^-dichloropyridine-S-carboxamide, N-[1-(5-bromo-3-chloropyridin-2- yl)ethyl]-2-fluoro-4-iodopyridine-3-carboxamide, N-{(E)-[(cyclopropylmethoxy)imino][6-(difluoromethoxy)-2,3- difluorophenyl]methyl}-2-phenylacetamide, N-{(Z)-[(cyclopropylmethoxy)imino][6-(difluoromethoxy)-2,3- difluorophenyl]methyl}-2-phenylacetamide, natamycin, nickel dimethyldithiocarbamate, nitrothal-isopropyl, N- methyl-2-(1-{[5-methyl-3-(trifluoromethyl)-1 H-pyrazol-1-yl]acetyl}piperidin-4-yl)-N-(1 ,2,3,4- tetrahydronaphthalen-1-yl)-1 ,3-thiazole-4-carboxamide, N-methyl-2-(1-{[5-methyl-3-(trifluoromethyl)-1 H- pyrazol-i-yljacetylJpiperidin^-yO-N-^I R^I ^.S^-tetrahydronaphthalen-i-yll-I .S-thiazole^-carboxamide, octhilinone, oxamocarb, oxyfenthiin, pentachlorophenol and salts, pentyl {6-[({[( 1-m ethyl- 1 H-tetrazol-5- yl)(phenyl)methylidene]amino}oxy)methyl]pyridin-2-yl}carbamate, phenazine-1-carboxylic acid, phenothrin, phosphorous acid and its salts, propamocarb-fosetylate, propanosine-sodium, proquinazid, pyrrolnitrine, quinolin-8-ol, quinolin-8-ol sulfate (2:1 ) (salt), fenpyrazamine, tebufloquin, tecloftalam, tolnifanide, triazoxide, trichlamide and zarilamid.
According to another object of the present invention, there is provided a method for controlling the phytopathogenic fungi of plants, crops or seeds, characterized in that an agronomically effective and substantially non-phytotoxic quantity of a pesticide composition according to the invention is applied as seed treatment, foliar application, stem application, drench or drip application (chemigation) to the seed, the plant or to the fruit of the plant or to soil or to inert substrate (e.g. inorganic substrates like sand, rockwool, glasswool; expanded minerals like perlite, vermiculite, zeolite or expanded clay), Pumice, Pyroclastic materials or stuff, synthetic organic substrates (e.g. polyurethane) organic substrates (e.g. peat, composts, tree waste products like coir, wood fibre or chips, tree bark) or to a liquid substrate (e.g. floating hydroponic systems, Nutrient Film Technique, Aeroponics) wherein the plant is growing or wherein it is desired to grow. The expression "are applied to the plants to be treated" is understood to mean, for the purposes of the present invention, that the pesticide composition which is the subject of the invention can be applied by means of various methods of treatment such as:
• spraying onto the aerial parts of the said plants a liquid comprising one of the said compositions,
• dusting, the incorporation into the soil of granules or powders, spraying, around the said plants and in the case of trees injection or daubing, • coating or film-coating the seeds of the said plants with the aid of a plant-protection mixture comprising one of the said compositions.
The method according to the invention can either be a curing, preventing or eradicating method.
In this method, a composition used can be prepared beforehand by mixing the two or more active compounds according to the invention. According to an alternative of such a method, it is also possible to apply simultaneously, successively or separately compounds (A) and (B) so as to have the conjugated (A)/(B) effects, of distinct compositions each containing one of the two or three active ingredients (A) or (B).
The dose of active compound usually applied in the method of treatment according to the invention is generally and advantageously
• for foliar treatments: from 0.1 to 10,000 g/ha, preferably from 10 to 1 ,000 g/ha, more preferably from 50 to 300g/ha; in case of drench or drip application, the dose can even be reduced, especially while using inert substrates like rockwool or perlite;
• for seed treatment: from 2 to 200 g per 100 kilogram of seed, preferably from 3 to 15O g per 100 kilogram of seed;
• for soil treatment: from 0.1 to 10,000 g/ha, preferably from 1 to 5,000 g/ha.
The doses herein indicated are given as illustrative Examples of method according to the invention. A person skilled in the art will know how to adapt the application doses, notably according to the nature of the plant or crop to be treated. Under specific conditions, for example according to the nature of the phytopathogenic fungus to be treated or controlled, a lower dose can offer adequate protection. Certain climatic conditions, resistance or other factors like the nature of the phytopathogenic fungi or the degree of infestation, for example, of the plants with these fungi, can require higher doses of combined active ingredients. The optimum dose usually depends on several factors, for example on the type of phytopathogenic fungus to be treated, on the type or level of development of the infested plant, on the density of vegetation or alternatively on the method of application. Without it being limiting, the crop treated with the pesticide composition or combination according to the invention is, for example, grapevine, but this could be cereals, vegetables, lucerne, soybean, market garden crops, turf, wood, tree or horticultural plants. The method of treatment according to the invention can also be useful to treat propagation material such as tubers or rhizomes, but also seeds, seedlings or seedlings pricking out and plants or plants pricking out. This method of treatment can also be useful to treat roots. The method of treatment according to the invention can also be useful to treat the over-ground parts of the plant such as trunks, stems or stalks, leaves, flowers and fruit of the concerned plant. Among the plants that can be protected by the method according to the invention, mention can be made of cotton; flax; vine; fruit or vegetable crops such as Rosaceae sp. (for instance pip fruit such as apples and pears, but also stone fruit such as apricots, almonds and peaches), Ribesioidae sp., Juglandaceae sp., Betulaceae sp. , Anacardiaceae sp. , Fagaceae sp. , Moraceae sp. , Oleaceae sp. , Actinidaceae sp. , Lauraceae sp., Musaceae sp. (for instance banana trees and plantins), Rubiaceae sp., Theaceae sp., Sterculiceae sp., Rutaceae sp. (for instance lemons oranges and grapefruit); Solanaceae sp. (for instance tomatoes), ϋliaceae sp., Asteraceae sp. (for instance lettuces), Umbelliferae sp., Cruciferae sp., Chenopodiaceae sp., Cucurbitaceae sp., Papilionaceae sp. (for instance peas), Rosaceae sp. (for instance strawberries); major crops such as Graminae sp. (for instance maize, lawn or cereals such as wheat, rice, barley and triticale), Asteraceae sp. (for instance sunflower), Cruciferae sp. (for instance colza), Fabacae sp. (for instance peanuts), Papilionaceae sp. (for instance soybean), Solanaceae sp. (for instance potatoes), Chenopodiaceae sp. (for instance beetroots); horticultural and forest crops; as well as genetically modified homologues of these crops.
The composition according to the invention can also be used in the treatment of genetically modified organisms with the compounds according to the invention or the agrochemical compositions according to the invention. Genetically modified plants are plants into genome of which a heterologous gene encoding a protein of interest has been stably integrated. The expression "heterologous gene encoding a protein of interest" essentially means genes which give the transformed plant new agronomic properties or genes for improving the agronomic quality of the modified plant.
The composition according to the invention can also be used against fungal diseases liable to grow on or inside timber. The term "timber" means all types of species of wood and all types of working of this wood intended for construction, for example solid wood, high-density wood, laminated wood and plywood. The method for treating timber according to the invention mainly consists in contacting one or more compounds according to the invention or a composition according to the invention; this includes for example direct application, spraying, dipping, injection or any other suitable means.
Among the diseases of plants or crops that can be controlled by the method according to the invention, mention can be made of :
Powdery mildew diseases such as :
Blumeria diseases, caused for example by Blumeha graminis ; Podosphaera diseases, caused for example by Podosphaera leucothcha ; Sphaerotheca diseases, caused for example by Sphaerotheca fuliginea ; Uncinula diseases, caused for example by Uncinula necator ;
Rust diseases such as :
Gymnosporangium diseases, caused for example by Gymnosporangium sabinae ; Hemileia diseases, caused for example by Hemileia vastathx ;
Phakopsora diseases, caused for example by Phakopsora pachyrhizi or Phakopsora meibomiae ;
Puccinia diseases, caused for example by Puccinia recondite, Pucciniα graminis or
Puccinia striiformis]
Uromyces diseases, caused for example by Uromyces appendiculatus ; Oomycete diseases such as : Albugo diseases caused for example by Albugo cαndidα;
Bremia diseases, caused for example by Bremia lactucae ; Peronospora diseases, caused for example by Peronospora pisior P. brassicae ; Phytophthora diseases, caused for example by Phytophthora infestans ; Plasmopara diseases, caused for example by Plasmopara viticola ; Pseudoperonospora diseases, caused for example by Pseudoperonospora humuli or
Pseudoperonospora cubensis ;
Pythium diseases, caused for example by Pythium ultimum ; Leafspot, leaf blotch and leaf blight diseases such as :
Alternaria diseases, caused for example by Alternaria solani ; Cercospora diseases, caused for example by Cercospora beticola ;
Cladiosporum diseases, caused for example by Cladiosporium cucumerinum ;
Cochliobolus diseases, caused for example by Cochliobolus sativus (Conidiaform:
Drechslera, Syn: Helminthosporium) or Cochliobolus miyαbeαnus ; Colletotrichum diseases, caused for example by Colletotrichum lindemuthanium ; Cycloconium diseases, caused for example by Cycloconium oleaginum ;
Diaporthe diseases, caused for example by Diaporthe citri ; Elsinoe diseases, caused for example by Elsinoe fawcettii ; Gloeosporium diseases, caused for example by Gloeospohum laeticolor ; Glomerella diseases, caused for example by Glomerella cingulata ; Guignardia diseases, caused for example by Guignardia bidwelli ;
Leptosphaeria diseases, caused for example by Leptosphaeria maculans ; Leptosphaeria nodorum ;
Magnaporthe diseases, caused for example by Magnaporthe grisea ;
Mycosphaerella diseases, caused for example by Mycosphaerella graminicola ; Mycosphaerella arachidicola ; Mycosphaerella fijiensis ;
Phaeosphaeria diseases, caused for example by Phaeosphaeria nodorum ;
Pyrenophora diseases, caused for example by Pyrenophora teres, or Pyrenophorα tritici repentis;
Ramularia diseases, caused for example by Ramularia collo-cygni , or Rαmulαriα areola; Rhynchosporium diseases, caused for example by Rhynchosporium secalis ;
Septoria diseases, caused for example by Septoria apii or Septoria lycopercisi ;
Typhula diseases, caused for example by Typhula incarnata ;
Venturia diseases, caused for example by Venturia inaequalis ; Root, Sheath and stem diseases such as : Corticium diseases, caused for example by Corticium graminearum ;
Fusarium diseases, caused for example by Fusarium oxysporum ;
Gaeumannomyces diseases, caused for example by Gaeumannomyces graminis ;
Rhizoctonia diseases, caused for example by Rhizoctonia solani ;
Sarocladium diseases caused for example by Sαroclαdium oryzαe; Sclerotium diseases caused for example by Sclerotium oryzαe;
Tapesia diseases, caused for example by Tapesia acuformis ;
Thielaviopsis diseases, caused for example by Thielaviopsis basicola ; Ear and panicle diseases such as :
Alternaria diseases, caused for example by Alternaria spp. ; Aspergillus diseases, caused for example by Aspergillus flavus ;
Cladosporium diseases, caused for example by Cladosporium spp. ;
Claviceps diseases, caused for example by Claviceps purpurea ;
Fusarium diseases, caused for example by Fusarium culmorum ;
Gibberella diseases, caused for example by Gibberella zeae ; Monographella diseases, caused for example by Monographella nivalis ;
Smut and bunt diseases such as :
Sphacelotheca diseases, caused for example by Sphacelotheca reiliana ;
Tilletia diseases, caused for example by Tilletia caries ;
Urocystis diseases, caused for example by Urocystis occulta ; Ustilago diseases, caused for example by Ustilago nuda ;
Fruit rot and mould diseases such as :
Aspergillus diseases, caused for example by Aspergillus flavus ;
Botrytis diseases, caused for example by Botrytis cinerea ; Penicillium diseases, caused for example by Penicillium expansum ;
Rhizopus diseases caused by example by Rhizopus stolonifer
Sclerotinia diseases, caused for example by Sclerotinia sclerotiorum ; Verticilium diseases, caused for example by Verticilium alboatrum ;
Seed and soilborne decay, mould, wilt, rot and dam ping-off diseases :
Alternaria diseases, caused for example by Alternaria brassicicola
Aphanomyces diseases, caused for example by Aphanomyces euteiches
Ascochyta diseases, caused for example by Ascochyta lentis Aspergillus diseases, caused for example by Aspergillus flavus
Cladosporium diseases, caused for example by Cladosporium herbarum
Cochliobolus diseases, caused for example by Cochliobolus sativus
(Conidiaform: Drechslera, Bipolaris Syn: Helminthosporium);
Colletotrichum diseases, caused for example by Colletotrichum coccodes; Fusarium diseases, caused for example by Fusarium culmorum;
Gibberella diseases, caused for example by Gibberella zeae;
Macrophomina diseases, caused for example by Macrophomina phaseolina
Monographella diseases, caused for example by Monographella nivalis;
Penicillium diseases, caused for example by Penicillium expansum Phoma diseases, caused for example by Phoma lingam
Phomopsis diseases, caused for example by Phomopsis sojae;
Phytophthora diseases, caused for example by Phytophthora cactorum;
Pyrenophora diseases, caused for example by Pyrenophora graminea
Pyricularia diseases, caused for example by Pyricularia oryzae; Pythium diseases, caused for example by Pythium ultimum;
Rhizoctonia diseases, caused for example by Rhizoctonia solani;
Rhizopus diseases, caused for example by Rhizopus oryzae
Sclerotium diseases, caused for example by Sclerotium rolfsii;
Septoria diseases, caused for example by Septoria nodorum; Typhula diseases, caused for example by Typhula incarnata;
Verticillium diseases, caused for example by Verticillium dahliae ; Canker, broom and dieback diseases such as :
Nectria diseases, caused for example by Nectria galligena ; Blight diseases such as : Monilinia diseases, caused for example by Monilinia laxa ;
Leaf blister or leaf curl diseases such as :
Exobasidium diseases caused for example by Exobαsidium vexαns
Taphrina diseases, caused for example by Taphrina deformans ; Decline diseases of wooden plants such as : Esca diseases, caused for example by Phaemoniella clamydospora ; Eutypa dyeback, caused for example by Eutypa lata ; Ganoderma diseases caused for example by Gαnodermα boninense; Rigidoporus diseases caused for example by Rigidoporus lignosus
Diseases of Flowers and Seeds such as
Botrytis diseases caused for example by Botrytis cinereα;
Diseases of Tubers such as Rhizoctonia diseases caused for example by Rhizoctoniα solαni;
Helminthosporium diseases caused for example by Helminthosporium solαni;
Club root diseases such as
Plasmodiophora diseases, cause for example by Plαmodiophorα brαssicαe.
Diseases caused by Bacterial Organisms such as
Xanthomonas species for example Xαnthomonαs cαmpestris pv. oryzae; Pseudomonas species for example Pseudomonαs syringαe pv. lachrymans; Erwinia species for example Erwiniα αmylovorα.
The compounds according to the invention can also be used for the preparation of composition useful to curatively or preventively treat human or animal fungal diseases such as, for example, mycoses, dermatoses, trichophyton diseases and candidiases or diseases caused by Aspergillus spp., for example Aspergillus fumigatus.
The various aspects of the invention will now be illustrated with reference to the following table I of compound examples and the following preparation or efficacy examples.
The following table illustrates in a non-limiting manner examples of compounds according to the invention. In the following table, M+H (or M-H) means the molecular ion peak, plus or minus 1 a.m.u. (atomic mass unit) respectively, as observed in mass spectroscopy and M (Apcl+) means the molecular ion peak as it was found via positive atmospheric pressure chemical ionisation in mass spectroscopy. Table I
(I)
In Table I we use the following abbreviations for specified moieties A and T in formula (I):
Measurement of logP values was performed according EEC directive 79/831 Annex V.A8 by HPLC (High Performance Liquid Chromatography) on reversed phase columns with the following methods:
M Measurement was done at pH 2.3 with 0,1% phosphoric acid and acetonitrile as eluent.
M Measurement of LC-MS was done at pH 2,7 with 0,1 % formic acid in water and with acetonitrile (contains 0,1% formic acid) as eluent with a linear gradient from 10 % acetonitrle to 95 % acetonitrile.
[c] Measurement with LC-MS was done at pH 7.8 with 0,001 molar ammonium hydrogen carbonate solution in water as eluent with a linear gradient from 10 % acetonitrile to 95 % acetonitrile.
Calibration was done with not branched alkan2-ones (with 3 to 16 carbon atoms) with known logP-values (measurement of logP values using retention times with linear interpolation between successive alkanones).. lambda-maX-values were determined using UV-spectra from 200 nm to 400 nm and the peak values of the chromatographic signals.
Double bond geometry: In the IUP AC -Names of the Examples 20, 21, 22, 23, 24, 25, 26, 27, 28 double bond geometry is labeled as Z. Double bond geometry of all other examples is not specified, but all potential mixtures of E, Z and the pure E- and Z-isomers are claimed.
Preparation of 6-[({[(3-fluorophenyl)(5-methyl-1,2,3-thiadiazol-4-yl)methylene]amino}oxy)methyl]- N-hexylpyridin-2-amine (Example 1)
Step 1 : Preparation of tert-butyl hexyl[6-(hydroxymethyl)pyridin-2-yl]carbamate
To a stirred solution of tert-butyl [6-(hydroxymethyl)pyridin-2-yl]carbamate (3.79 g, 16.9 mmol) in DMF, cooled to O0C with a brine/ice bath, was added potassium tert-butoxide (126 mg, 1.07 mmol). The mixture was stirred 5 minutes at O0C then 1-bromo-2cyclohexylethane (205 mg, 1.07 mmol) was added. After stirring at room temperature for 4h, the reaction mixture was diluted with water (200 ml_), extracted with ethyl acetate (150 ml_). The organic layer was washed with water, dried (MgSO4) and concentrated in vacuo. Purification on silica gel afforded tert-butyl hexyl[6-(hydroxymethyl)pyridin-2-yl]carbamate as a yellow oil [3.60 g, yield 69%; HPLC/MS: m/z = 309 (M+H) ; logP(HCooH) = 3.94].
Step 2 : Preparation of tert-butyl (6-{[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)oxy]methyl}pyridin-2- yl)hexylcarbamate
To a solution of tert-butyl hexyl[6-(hydroxymethyl)pyridin-2-yl]carbamate (2.52 g, 8.18 mmol) in acetonitrile (50 ml_) was added Λ/,Λ/-diisopropylethylamine (1.59g, 12.2 mmol). The solution was cooled to O0C, then methanesulfonyl chloride (1.12 g, 9.81 mmol) was slowly added. After stirring at room temperature for 6h, N-hydroxyphthalimide (1.46 g, 8.96 mmol), cesium carbonate (5.58 g, 17.1 mmol) and potassium iodide (135 mg, 0.81 mmol) were sequentially added, followed by acetonitrile (10 ml_). The heterogenous mixture was stirred at room temperature for 2Oh, then N-hydroxyphthalimide (0.33 g, 2.0 mmol) was added and the mixture was stirred at 5O0C for 7h. The cooled reaction mixture was filtered and the filtrate was concentrated in vacuo. The oily residue was dissolved in ethyl acetate (200 ml_), washed with water (100 ml_), the organic layer was dried (MgSO4) and concentrated in vacuo. Purification on silica gel afforded tert-butyl (6-{[(1 ,3-dioxo-1 ,3-dihydro-2H-isoindol-2-yl)oxy]methyl}pyridin-2- yl)hexylcarbamate as a yellow oil [2.107 g, yield 57%; HPLC/MS: m/z = 454 (M+H) ; logP(HcooH) = 5.48].
Step 3 : Preparation of tert-butyl {6-[(aminooxy)methyl]pyridin-2-yl}hexylcarbamate
To a solution of tert-butyl (6-{[(1 ,3-dioxo-1 ,3-dihydro-2H-isoindol-2-yl)oxy]methyl}pyridin-2- yl)hexylcarbamate (2.10 g, 4.63 mmol) in tetrahydrofuran (50 ml_) was added hydrazine hydrate (464 mg, 9.28 mmol) dropwise. After stirring 7h at room temperature, the reaction mixture was filtered, diluted with ethyl acetate, washed with water and the organic layer drid (MgSO4) and concentrated in vacuo. Purification on silica gel afforded tert-butyl {6-[(aminooxy)methyl]pyridin-2-yl}hexylcarbamate as a colourless oil [1.29 g, yield 86% ; HPLC/MS : m/z = 324 (M+H) ; logP(HCooH) = 3.42].
Step 4 : Preparation of 6-[({[(3-fluorophenyl)(5-methyl-1,2,3-thiadiazol-4-yl)methylene]amino}oxy) methyl]-N-hexylpyridin-2 -amine
A solution of (3-fluorophenyl)(5-methyl-1 ,2,3-thiadiazol-4-yl)methanone (61.8 mg, 0.27 mmol), tert-butyl {6-[(aminooxy)methyl]pyridin-2-yl}hexylcarbamate (98.9 mg, 0.30 mmol) and para-toluenesulfonic acid monohydrate (52.9 mg, 0.27 mmol) in 2-propanol was heated up to 16O0C by microwave irradiation for 2h in a sealed tube. The cooled reaction mixture was diluted with dichloromethane (70 mL), washed with aq. sat. NaHCO3 (50 mL), dried (MgSO4) and concentrated in vacuo. Chromatography of the residue afforded the title compound as an orange oil [57 mg, yield 43% ; HPLC/MS : m/z = 428 (M+H) ; logP(HcooH) = 3.06]. Example 1 : Preparation of 1-(3-chlorophenyl)-N-{[2-(hex-1-yn-1-yl)-1,3-thiazol-4-yl]methoxy}-1-(5- methyl-1,2,3-thiadiazol-4-yl)methanimine (Example 6)
Step 1 : Preparation of 2-[(2-amino-1,3-thiazol-4-yl)methoxy]-1H-isoindole-1,3(2H)-dione
To a solution of 2-hydroxy-1 H-isoindole-1 ,3(2H)-dione (4.13 g, 15.0 mmol) in acetonitrile (150 ml_) were added 4-(chloromethyl)-1 ,3-thiazol-2-annine hydrochloride (50.1 g, 337 mmol), cesium carbonate (210 g, 643 mmol) and potassium iodide (2.54 g, 15.3 mmol). The heterogenous mixture was stirred at room temperature for 16h. The reaction mixture was diluted with water, the insolubles were filtered off, rinsed with water and dried over night to afford 2-[(2-amino-1 ,3-thiazol-4-yl)methoxy]-1 H-isoindole-1 ,3(2H)-dione as a colourless solid [36.0 g, yield 43%; HPLC/MS: m/z = 276 (M+H) ; logP(HCooH) = 0.74].
Step 2 : Preparation of 2-[(2-bromo-1,3-thiazol-4-yl)methoxy]-1H-isoindole-1,3(2H)-dione
To a suspension of 2-[(2-amino-1 ,3-thiazol-4-yl)methoxy]-1 H-isoindole-1 ,3(2H)-dione (4.13 g, 15 mmol), NaBr (3.10 g, 30 mmol) and CuBr (2.15 g, 15 mmol) in acetonitrile (150 mL) at 4O0C under nitrogen atmosphere was added tert-butyl nitrite (2.32 mL, 19.5 mmol) dropwise over 30-40 min. After the addition was complete, heating was maintained towards an internal temp of 60-700C, and the suspension was stirred at this temperature for 2h. After cooling down, the mixture was diluted with water, and extracted with ethyl acetate. The combined organic layers (200 mL) were washed with aq HCI (1 M, 50 mL), then with brine (50 mL) and dried (MgSO4). After concentration on the rotary evaporator, the residue was purified on silica gel to afford 2-[(2-bromo-1 ,3-thiazol-4-yl)methoxy]-1 H-isoindole-1 ,3(2H)-dione [1.50 g, yield 28% ; HPLC/MS : m/z = 339 (M+H) ; logP(HCooH) = 2.39].
Step 3 : Preparation of 2-{[2-(hex-1-yn-1-yl)-1,3-thiazol-4-yl]methoxy}-1H-isoindole-1,3(2H)-dione
To a solution of 2-[(2-bromo-1 ,3-thiazol-4-yl)methoxy]-1 H-isoindole-1 ,3(2H)-dione (23.1 g, 68.1 mmol) in dry tetrahydrofuran (300 mL) were added 1-hexyne (11.2g, 136 mmol) , triethylamine (13.8 g, 136 mmol). The reaction mixture was degassed by blowing a flow of Argon through it, then palladium tetrakis(triphenylphosphine) (3.94 g, 3.41 mmol) and copper iodide (1.30 g, 6.81 mmol) were added. After stirring at room temperature for 21 h under argon, the mixture was concentrated in vacuo, diluted with water (800 mL) and ethyl acetate (900 mL), the organic layer was washed with water, dried (MgSO4) and concentrated in vacuo. Purification on silica gel afforded 2-{[2-(hex-1-yn-1-yl)-1 ,3-thiazol-4-yl]methoxy}- 1 H-isoindole-1 ,3(2H)-dione [13.6 g, yield 59% ; HPLC/MS : m/z = 341 (M+H) ; logP(HCooH) = 3.78].
Step 4 : Preparation of 4-[(aminooxy)methyl]-2-(hex-1-yn-1-yl)-1,3-thiazole
To a solution of 2-{[2-(hex-1-yn-1-yl)-1 ,3-thiazol-4-yl]methoxy}-1 H-isoindole-1 ,3(2H)-dione (13.6 g, 40.1 mmol) in tetrahydrofuran (250 mL) was added methylhydrazine (3.69 g, 80.1 mmol) dropwise. After stirring 2Oh at room temperature, the reaction mixture was concentrated in vacuo, diluted with ethyl acetate, washed with water and the organic layer drid (MgSO4) and concentrated in vacuo. Purification on silica gel afforded 4-[(aminooxy)methyl]-2-(hex-1-yn-1-yl)-1 ,3-thiazole as a colourless oil [8.15 g, yield 94% ; HPLC/MS : m/z = 211 (M+H) ; logP(HCooH) = 1.76]. Step 5 : Preparation of 1-(3-chlorophenyl)-N-{[2-(hex-1-yn-1-yl)-1,3-thiazol-4-yl]methoxy}-1-(5- methyl-1,2,3-thiadiazol-4-yl)methanimine
A solution of (3-chlorophenyl)(5-methyl-1 ,2,3-thiadiazol-4-yl)nnethanone (190 mg, 0.80 mmol), 4- [(aminooxy)nnethyl]-2-(hex-1-yn-1-yl)-1 ,3-thiazole (184 mg, 0.88 mmol) and para-toluenesulfonic acid monohydrate (151 mg, 0.80 mmol) in 2-propanol was stirred 4h at 5O0C then 2 days at room temperature. The cooled reaction mixture was diluted with dichloromethane (70 ml_), washed with aq. sat. NaHCO3 (50 ml_), dried (MgSO4) and concentrated in vacuo. Chromatography of the residue afforded the title compound as an orange oil [175 mg, yield 51 % ; HPLC/MS : m/z = 431 (M+H) ; logP(HcooH) = 5.68].
Example 2: Preparation of But-2-yn-1-yl {6-[({[(4-methyl-1,2,5-thiadiazol-3-yl)(phenyl)methylidene] amino}oxy)-methyl]pyridin-2-yl}carbamate (Example 25)
Step 1 : Preparation of Λ/-hydroxy-1-(4-methyl-1,2,5-thiadiazol-3-yl)-1-phenylmethanimine
To a stirred solution of (4-Methyl-[1 ,2,5]thiadiazol-3-yl)-phenyl-methanone (20 g, 98 mmol) in dry pyridine (70 ml_) was added hydroxylamine hydrochloride (17 g, 245 mmol). The reaction mixture was stirred at 7O0C for 3h, then concentrated in vacuo and diluted with ethyl acetate (100 ml_) and water (100 ml_). The organic layer was washed with water (2 x 100 ml_) and dried over MgSO4. Evaporation of the solvent in vacuo afforded Λ/-hydroxy-1-(4-methyl-1 ,2,5-thiadiazol-3-yl)-1-phenylmethanimine as an orange oil [24.3 g, yield 99.6% ; HPLC/MS : m/z = 220 (M+H) ; logP(HCooH) = 2.26].
Step 2: Preparation of 2-{6-[({[(Z)-(4-methyl-1,2,5-thiadiazol-3-yl)(phenyl)methylene]amino}- oxy)methyl]pyridin-2-yl}-1H-isoindole-1,3(2H)-dione
To a stirred solution of Λ/-hydroxy-1-(4-methyl-1 ,2,5-thiadiazol-3-yl)-1-phenylmethanimine (24.3 g, 111 mmol) in dry acetonitrile (600 ml_) were added 2-[6-(bromomethyl)pyridin-2-yl]-1 H-isoindole-1 ,3(2H)-dione (36.9 g, 116 mmol), cesium carbonate (37.9 g, 116 mmol) and potassium iodide (1.84 g, 1 1 mmol). The reaction mixture was stirred at room temperature for 14h, then diluted with water (200 ml_) and concentrated in vacuo. The residue was extracted with ethyl acetate (2 x 300 ml_). The combined organic layers were combined and concentrated in vacuo to afford 2-{6-[({[(Z)-(4-methyl-1 ,2,5-thiadiazol-3- yl)(phenyl)methylene]amino}-oxy)methyl]pyridin-2-yl}-1H-isoindole-1 ,3(2H)-dione as a red oil [49 g, yield 82% ; HPLC/MS : m/z = 456 (M+H) ; logP(HCooH) = 3.99].
Step 3: Preparation of 6-[({[(Z)-(4-methyl-1,2,5-thiadiazol-3-yl)(phenyl)methylene]amino}oxy)- methyl]pyridin-2 -amine
To a stirred solution of 2-{6-[({[(Z)-(4-methyl-1 ,2,5-thiadiazol-3-yl)(phenyl)methylene]amino}- oxy)methyl]pyridin-2-yl}-1 H-isoindole-1 ,3(2H)-dione (49 g, 91 mmol) in dry THF (800 mL) was added hydrazine hydrate (22.2 mL, 457 mmol). The reaction mixture was stirred at room temperature for 14h, then insolubles were removed by filtration and washed with THF. The filtrates were combined and concentrated in vacuo. Purification of the residual oil on silica gel afforded 6-[({[(Z)-(4-methyl-1 ,2,5- thiadiazol-3-yl)(phenyl)nnethylene]annino}oxy)-nnethyl]pyridin-2-annine as a yellow oil [22.2 g, yield 75% ; HPLC/MS : m/z = 326 (M+H) ; logP(HCooH) = 1.54].
Step 4: Preparation of but-2-yn-1-yl {6-[({[(4-methyl-1,2,5-thiadiazol-3-yl)(phenyl)methylidene]- amino}oxy)methyl]pyridin-2-yl}carbamate
To a stirred solution of 6-[({[(Z)-(4-methyl-1 ,2,5-thiadiazol-3-yl)(phenyl)nnethylene]annino}oxy) methyl]pyridin-2-annine (100 mg, 0.31 mmol) in dry 1 ,4-dioxane (5 ml_) were added pyridine (37 μl_, 0.46 mmol) and but-2-yn-1-yl carbonochloridate (82 mg, 0.62 mmol). The reaction mixture was stirred at room temperature for 18h, then diluted with DCM (10 ml_) and water (10 ml_), the organic layer was dried (MgSO4) and concentrated in vacuo. Purification on silica gel afforded but-2-yn-1-yl {6-[({[(4-methyl-1 ,2,5- thiadiazol-3-yl)(phenyl)methylidene]-amino}oxy)methyl]pyridin-2-yl}carbamate as a colourless oil [120 mg, yield 93% ; HPLC/MS : m/z = 422 (M+H) ; logP(HCooH) = 4.28].
Example 3: Preparation of Λ/-hexyl-6-[({[(4-methyl-1,2,5-thiadiazol-3-yl)(phenyl)methylidene]amino} oxy)methyl]-pyridin-2-amine (Example 31)
Step 1 : Preparation of tert-butyl {6-[({[(4-methyl-1,2,5-thiadiazol-3-yl)(phenyl)methylene]- amino}oxy)methyl]pyridin-2-yl}carbamate
To a stirred solution of 6-[({[(Z)-(4-methyl-1 ,2,5-thiadiazol-3-yl)(phenyl)methylene]amino}oxy) methyl]pyridin-2-amine (10 g, 31 mmol) in dry THF (150 ml_) were added 4-dimethylaminopyridine (38 mg, 0.31 mmol) and di-tert-butyl dicarbonate (6.71 g, 31 mmol). The reaction mixture was stirred at room temperature for 2 days, then concentrated in vacuo. The residue was dissolved in ethyl acetate, washed with water, the organic layer was dried (MgSO4) and concentrated in vacuo. Purification on silica gel afforded tert-butyl {6-[({[(4-methyl-1 ,2,5-thiadiazol-3-yl)(phenyl)methylene]-amino}oxy)methyl]pyridin-2- yl}carbamate as a yellow oil [2.72 g, yield 20% ; HPLC/MS : m/z = 426 (M+H) ; logP(HCooH) = 4.97].
Step 2: Preparation of Λ/-hexyl-6-[({[(4-methyl-1,2,5-thiadiazol-3-yl)(phenyl)methylene]amino}- oxy)methyl]pyridin-2 -amine
To a stirred solution of tert-butyl {6-[({[(4-methyl-1 ,2,5-thiadiazol-3-yl)(phenyl)methylene]- amino}oxy)methyl]pyridin-2-yl}carbamate (104 mg, 0.24 mmol) in dry DMF (5 mL) was added sodium hydride (60 wt.-% in mineral oil, 11 mg, 0.27 mmol). After stirring at room temperature for 15 min, 1- iodohexane (62 mg, 0.29 mmol) was added, and the mixture stirred at room temperature for 16h. After dropwise addition of trifluoroacetic anhydride (1 mL, 13 mmol), the mixture was stirred at 5O0C for 8h. The cooled reaction mixture was poured into sat. aq. NaHCO3 (40 mL), extracted with ethyl acetate (2 x 30 mL), the organic layer was washed with water, dried (MgSO4) and concentrated in vacuo. Purification on silica gel afforded N-hexyl-6-[({[(4-methyl-1 ,2,5-thiadiazol-3-yl)(phenyl)methylene]amino}- oxy)methyl]pyridin-2-amine as an orange oil [79 mg, yield 75% ; HPLC/MS : m/z = 410 (M+H) ; logP(HcooH) = 3.11]. Biological Examples
Example A : Phytophthora test (tomato) / preventive
Solvent: 49 parts by weight of N, N - Dimethylformannicle
Emulsifier: 1 part by weight of Alkylarylpolyglycolether
To produce a suitable preparation of active compound, 1 part by weight of active compound is mixed with the stated amounts of solvent and emulsifier, and the concentrate is diluted with water to the desired concentration.
To test for preventive activity, young plants are sprayed with the preparation of active compound at the stated rate of application. One day after this treatment, the plants are inoculated with an aqueous spore suspension of Phytophthora infestans. The plants remain for one day in an incubation cabinet at approximately 220C and a relative atmospheric humidity of 100%. Then the plants are placed in an incubation cabinet at approximately 2O0C and a relative atmospheric humidity of 96%.
The test is evaluated 7 days after the inoculation. 0% means an efficacy which corresponds to that of the control, while an efficacy of 100% means that no disease is observed.
In this test the following examples of table I according to the invention showed efficacy of 70% or even higher at a concentration of IOOppm of active ingredient:
Example No. 20, 21 , 22, 23, 24, 28, 26, 27, 30, 31 , 32, 33, 34, 35, 36, 36, 37, 38, 50, 61 , 62, 42, 43, 44 and 46.

Claims

1. A compound of formula (I)
(I)
wherein
T represents a substituted or non-substituted heterocyclyl group that is selected in the list consisting of T1 to T9
wherein
• X1 represents a hydrogen atom, a halogen atom, a nitro group, a hydroxy group, a cyano group, an amino group, a sulphenyl group, a formyl group, a substituted or non-substituted carbaldehyde O-(C-ι-C8-alkyl)oxime, a formyloxy group, a formylamino group, a carbamoyl group, a N-hydroxycarbamoyl group, a pentafluoro-λ6-sulphenyl group, a formylamino group, substituted or non-substituted Ci-Cs-alkoxyamino group, substituted or non-substituted N-Ci-C8-alkyl-(Ci-C8- alkoxy)-amino group, substituted or non-substituted (d-C8-alkylamino)-amino group, substituted or non-substituted N-Ci-C8-alkyl-(Ci-C8-alkylamino)-amino group, a substituted or non-substituted (hydroxyimino)-C-ι-C6-alkyl group, substituted or non-substituted d-C8-alkyl, substituted or non- substituted tri(C-ι-C8-alkyl)silyl-C-ι-C8-alkyl, substituted or non-substituted d-C8-cycloalkyl, substituted or non-substituted tri(C-ι-C8-alkyl)silyl-C-ι-C8-cycloalkyl, substituted or non-substituted C-ι-C8-halogenoalkyl having 1 to 5 halogen atoms, substituted or non-substituted C1-C8- halogenocycloalkyl having 1 to 5 halogen atoms, a C2-C8-alkenyl, substituted or non-substituted C2-C8-alkynyl, substituted or non-substituted d-C8-alkylamino, substituted or non-substituted di- d-C8-alkylamino, substituted or non-substituted d-C8-alkoxy, substituted or non-substituted C1- C8-halogenoalkoxy having 1 to 5 halogen atoms, substituted or non-substituted C1-C8- alkylsulphenyl, substituted or non-substituted d-C8-halogenoalkylsulphenyl having 1 to 5 halogen atoms, substituted or non-substituted C2-C8-alkenyloxy, substituted or non-substituted
C2-C8-halogenoalkenyloxy having 1 to 5 halogen atoms, substituted or non-substituted C3-C8- alkynyloxy, substituted or non-substituted C3-C8-halogenoalkynyloxy having 1 to 5 halogen atoms, substituted or non-substituted d-Cs-alkylcarbonyl, substituted or non-substituted N-(d- C8-alkoxy)-Ci-C8-alkanimidoyl, substituted or non-substituted N-(Ci -C8-alkoxy)-Ci -C8- halogenoalkanimidoyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8- halogenoalkylcarbonyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8- alkylcarbamoyl, substituted or non-substituted di-Ci-C8-alkylcarbamoyl, substituted or non- substituted N-Ci-C8-alkyloxycarbamoyl, substituted or non-substituted Ci-C8-alkoxycarbamoyl, substituted or non-substituted N-Ci-C8-alkyl-Ci-C8-alkoxycarbamoyl, substituted or non- substituted Ci-C8-alkoxycarbonyl, substituted or non-substituted Ci-C8-halogenoalkoxycarbonyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-alkylcarbonyloxy, substituted or non-substituted Ci-C8-halogenoalkylcarbonyloxy having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-alkylcarbonylamino, substituted or non-substituted Ci-C8- halogenoalkylcarbonylamino having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8- alkylcarbamoylamino, substituted or non-substituted Ci-C8-halogenoalkylcarbamoylamino having 1 to 5 halogen atoms, substituted or non-substituted di-Ci-C8-alkylcarbamoylamino, substituted or non-substituted di-Ci-C8-halogenoalkylcarbamoylamino having 1 to 5 halogen atoms , substituted or non-substituted N-Ci-C8-alkyl-(Ci-C8-alkylcarbamoyl)amino, substituted or non-substituted N- Ci-C8-alkyl-(Ci-C8-halogenoalkylcarbamoyl)amino having 1 to 5 halogen atoms, substituted or non-substituted N-Ci-C8-alkyl-(di-Ci-C8-alkylcarbamoyl)amino, substituted or non-substituted N- Ci-C8-alkyl-(di-Ci-C8-halogenoalkylcarbamoyl)amino having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-alkylaminocarbonyloxy, substituted or non-substituted di-Ci-C8- alkylaminocarbonyloxy, substituted or non-substituted Ci-C8-alkylcarbamothioyl, substituted or non-substituted di-Ci-Cs-alkylcarbamothioyl, substituted or non-substituted N-Ci-C8- alkyloxycarbamothioyl, substituted or non-substituted Ci-C8-alkoxycarbamothioyl, substituted or non-substituted N-Ci-C8-alkyl-Ci-C8-alkoxycarbamothioyl, substituted or non-substituted Ci-C8- alkylthioylamino, substituted or non-substituted Ci-C8-halogenoalkylthioylamino having 1 to 5 halogen atoms, substituted or non-substituted (Ci-C8-alkyl-carbamothioyl)-oxy, substituted or non-substituted substituted or non-substituted (di-Ci-C8-alkyl-carbamothioyl)-oxy, substituted or non-substituted Ci-C8-alkylsulphenyl, substituted or non-substituted Ci-C8- halogenoalkylsulphenyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8- alkylsulphinyl, substituted or non-substituted Ci-C8-halogenoalkylsulphinyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-alkylsulphonyl, substituted or non-substituted Ci-C8- halogenoalkylsulphonyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8- alkylaminosulfamoyl, substituted or non-substituted di-Ci-C8-alkylaminosulfamoyl, substituted or non-substituted (Ci-C6-alkoxyimino)-Ci-C6-alkyl, substituted or non-substituted (Ci-C6- alkenyloxyimino)-Ci-C6-alkyl, substituted or non-substituted (Ci-C6-alkynyloxyimino)-Ci-C6-alkyl, substituted or non-substituted (benzyloxyimino)-Ci-C6-alkyl, substituted or non-substituted benzyloxy, substituted or non-substituted benzylsulphenyl, substituted or non-substituted benzylamino, substituted or non-substituted phenoxy, substituted or non-substituted phenylsulphenyl, substituted or non-substituted phenylamino, substituted or non-substituted aryl, substituted or non-substituted aryl-[d-C8]-alkyl, substituted or non-substituted tri(d-C8-alkyl)- silyloxy, substituted or non-substituted d-C8-alkylsulfenylamino, substituted or non-substituted C-i-Cs-halogenoalkylsulphinylamino having 1 to 5 halogen atoms, substituted or non-substituted d-Cs-alkylsulphonylannino, substituted or non-substituted d-Cs-halogenoalkylsulphonylamino having 1 to 5 halogen atoms, substituted or non-substituted d-C8-alkoxysulphonylamino, substituted or non-substituted d-C8-halogenoxysulphonylamino having 1 to 5 halogen atoms, substituted or non-substituted tri(d-C8-alkyl)-silyl, substituted or non-substituted (C1-C6- alkylideneamino)oxy, substituted or non-substituted (d-C6-alkenylideneamino)oxy, substituted or non-substituted (d-C6-alkynylideneamino)oxy, substituted or non-substituted
(benzylideneamino)oxy ;
• W1 represents a hydrogen atom, a formyl group, substituted or non-substituted CrC8- alkyl, substituted or non-substituted tri(d-C8-alkyl)silyl-d-C8-alkyl, substituted or non-substituted d-C8-cycloalkyl, substituted or non-substituted tri(d-C8-alkyl)silyl-d-C8-cycloalkyl, substituted or non-substituted d-C8-halogenoalkyl having 1 to 5 halogen atoms, substituted or non-substituted d-Cs-halogenocycloalkyl having 1 to 5 halogen atoms, a C2-C8-alkenyl, substituted or non- substituted C2-C8-alkynyl, substituted or non-substituted d-C8-alkylamino, substituted or non- substituted d-Cs-alkylcarbonyl, substituted or non-substituted d-Cs-halogenoalkylcarbonyl having 1 to 5 halogen atoms, substituted or non-substituted d-C8-alkylcarbamoyl, substituted or non-substituted di-d-Cs-alkylcarbamoyl, substituted or non-substituted N-CrC8- alkyloxycarbamoyl, substituted or non-substituted Ci-C8-alkoxycarbamoyl, substituted or non- substituted N-d-Cs-alkyl-d-Cs-alkoxycarbamoyl, substituted or non-substituted CrC8- alkoxycarbonyl, substituted or non-substituted d-Cs-halogenoalkoxycarbonyl having 1 to 5 halogen atoms, substituted or non-substituted aryl, substituted or non-substituted aryl-[d-C8]- alkyl ;
• L1 represents a direct bond or a divalent group selected in the list consisting of
-(CR1 R2)n- -(CR1 R2)m-C(=O)-(CR1 R2)p-
-(CR1 R2)m-(CR1 =CR2)-(CR1 R2)p- -(CR1 R2)m-C(=O)-O-(CR1 R2)p -(CR1 R2)m-C≡C-(CR1 R2)p- -(CR1 R2)m-O-C(=O)-(CR1 R2)p- -(CR1 R2)m-O-(CR1 R2)p- -(CR1 R2)m-C(=O)-NH-(CR1 R2)p-
-(CR1 R2)m-NH-(CR1 R2)p- -(CR1 R2)m-NH-C(=O)-(CR1 R2)p- wherein
• n represents 1 , 2, 3 or 4 ;
• m and p independently represent 0, 1 , 2 or 3;
• R1 and R2 independently represent a hydrogen atom, a halogen atom, a cyano group, substituted or non-substituted d-C8-alkyl, substituted or non-substituted C3-C8-cycloalkyl, substituted or non-substituted d-C8-halogenoalkyl having 1 to 5 halogen atoms, substituted or non-substituted C-ι-C8-halogenocycloalkyl having 1 to 5 halogen atoms, a C2-C8-alkenyl, substituted or non-substituted C2-C8-alkynyl, substituted or non-substituted Ci-C8-alkoxy, substituted or non-substituted Ci-C8-halogenoalkoxy having 1 to 5 halogen atoms, substituted or non-substituted C2-C8-alkenyloxy, substituted or non-substituted C2-C8-halogenoalkenyloxy having 1 to 5 halogen atoms, substituted or non-substituted C3-C8-alkynyloxy, substituted or non- substituted C3-C8-halogenoalkynyloxy having 1 to 5 halogen atoms.
A is selected in the list consisting of A1 to A6
wherein
• Z1 represents a halogen atom, a nitro group, a hydroxy group, a cyano group, a sulphenyl group, a formyl group, a substituted or non-substituted carbaldehyde O-(Ci-C8-alkyl)oxime, a formyloxy group, a carbamoyl group, a N-hydroxycarbamoyl group, a pentafluoro-λ6-sulphenyl group, substituted or non-substituted Ci-C8-alkoxyamino group, substituted or non-substituted N- Ci-C8-alkyl-(Ci-C8-alkoxy)-amino group, substituted or non-substituted (d-C8-alkylamino)-amino group, substituted or non-substituted N-Ci-C8-alkyl-(Ci-C8-alkylamino)-amino group, a substituted or non-substituted (hydroxyimino)-Ci-C6-alkyl group, substituted or non-substituted Ci-C8-alkyl, substituted or non-substituted tri(C1-C8-alkyl)silyl-Ci-C8-alkyl, substituted or non-substituted d- C8-cycloalkyl, substituted or non-substituted tri(C-ι-C8-alkyl)silyl-C-ι-C8-cycloalkyl, substituted or non-substituted d-C8-halogenoalkyl having 1 to 5 halogen atoms, substituted or non-substituted C-rCs-halogenocycloalkyl having 1 to 5 halogen atoms, a C2-C8-alkenyl, substituted or non- substituted C2-C8-alkynyl, substituted or non-substituted d-C8-alkylamino, substituted or non- substituted di-d-C8-alkylamino, substituted or non-substituted d-C8-alkoxy, substituted or non- substituted (d-C8-alkoxycarbonyl)amino,, substituted or non-substituted (C2-C8- alkenyloxycarbonyl)amino, substituted or non-substituted (C3-C8-alkynyloxycarbonyl)annino, substituted or non-substituted d-Cs-alkylcarbonylamino, substituted or non-substituted Ci-C8- halogenoalkylcarbonylamino having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8- halogenoalkoxy having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-alkylsulphenyl, substituted or non-substituted Ci-C8-halogenoalkylsulphenyl having 1 to 5 halogen atoms, substituted or non-substituted C2-C8-alkenyloxy, substituted or non-substituted C2-C8- halogenoalkenyloxy having 1 to 5 halogen atoms, substituted or non-substituted C3-C8- alkynyloxy, substituted or non-substituted C3-C8-halogenoalkynyloxy having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-alkylcarbonyl, substituted or non-substituted N-(Ci- C8-alkoxy)-Ci-C8-alkaninnicloyl, substituted or non-substituted N-(Ci -C8-alkoxy)-Ci -C8- halogenoalkanimidoyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8- halogenoalkylcarbonyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8- alkylcarbamoyl, substituted or non-substituted di-Ci-Cs-alkylcarbamoyl, substituted or non- substituted N-Ci-Cs-alkyloxycarbamoyl, substituted or non-substituted Ci-C8-alkoxycarbamoyl, substituted or non-substituted N-Ci-C8-alkyl-Ci-C8-alkoxycarbamoyl, substituted or non- substituted Ci-C8-alkoxycarbonyl, substituted or non-substituted Ci-C8-halogenoalkoxycarbonyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-alkylcarbonyloxy, substituted or non-substituted Ci-C8-halogenoalkylcarbonyloxy having 1 to 5 halogen atoms, substituted or non-substituted Ci-Cs-alkylcarbamoylamino, substituted or non-substituted Ci-C8- halogenoalkylcarbamoylamino having 1 to 5 halogen atoms, substituted or non-substituted di- Ci-C8-alkylcarbamoylamino, substituted or non-substituted di-Ci-C8- halogenoalkylcarbamoylamino having 1 to 5 halogen atoms , substituted or non-substituted N- Ci-C8-alkyl-(Ci-C8-alkylcarbamoyl)amino, substituted or non-substituted N-Ci-C8-alkyl-(Ci-C8- halogenoalkylcarbamoyl)amino having 1 to 5 halogen atoms, substituted or non-substituted N-
Ci-C8-alkyl-(di-Ci-C8-alkylcarbamoyl)amino, substituted or non-substituted N-Ci-C8-alkyl-(di- Ci-C8-halogenoalkylcarbamoyl)amino having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-alkylaminocarbonyloxy, substituted or non-substituted di-Ci-C8-alkylaminocarbonyloxy, substituted or non-substituted Ci-C8-alkylcarbamothioyl, substituted or non-substituted di-Ci-C8- alkylcarbamothioyl, substituted or non-substituted N-Ci-C8-alkyloxycarbamothioyl, substituted or non-substituted Ci-C8-alkoxycarbamothioyl, substituted or non-substituted N-Ci-C8-alkyl-Ci-C8- alkoxycarbamothioyll, substituted or non-substituted Ci-C8-alkylthioylamino, substituted or non- substituted Ci-C8-halogenoalkylthioylamino having 1 to 5 halogen atoms, substituted or non- substituted (Ci-C8-alkoxythiocarbonyl)amino, substituted or non-substituted (Ci-C8-alkyl- carbamothioyl)-oxy, substituted or non-substituted substituted or non-substituted (di-Ci-C8-alkyl- carbamothioyl)-oxy, substituted or non-substituted Ci-C8-alkylsulphenyl, substituted or non- substituted Ci-C8-halogenoalkylsulphenyl having 1 to 5 halogen atoms, substituted or non- substituted Ci-C8-alkylsulphinyl, substituted or non-substituted Ci-C8-halogenoalkylsulphinyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-alkylsulphonyl, substituted or non-substituted Ci-C8-halogenoalkylsulphonyl having 1 to 5 halogen atoms, substituted or non- substituted Ci-C8-alkylaminosulfamoyl, substituted or non-substituted di-Ci-C8- alkylaminosulfamoyl, substituted or non-substituted (Ci-C6-alkoxyimino)-Ci-C6-alkyl, substituted or non-substituted (Ci-C6-alkenyloxyimino)-Ci-C6-alkyl, substituted or non-substituted (Ci-C6- alkynyloxyimino)-Ci-C6-alkyl, substituted or non-substituted (benzyloxyimino)-Ci-C6-alkyl, substituted or non-substituted benzyloxy, substituted or non-substituted benzylsulphenyl, substituted or non-substituted benzylamino, substituted or non-substituted phenoxy, substituted or non-substituted phenylsulphenyl, substituted or non-substituted phenylamino, substituted or non-substituted aryl, substituted or non-substituted aryl-[Ci-C8]-alkyl, substituted or non- substituted tri(Ci-C8-alkyl)-silyloxy, substituted or non-substituted Ci-C8-alkylsulfenylamino, substituted or non-substituted Ci-C8-halogenoalkylsulphinylamino having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-alkylsulphonylamino, substituted or non-substituted Ci-C8- halogenoalkylsulphonylamino having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8- alkoxysulphonylamino, substituted or non-substituted Ci-C8-halogenoxysulphonylannino having 1 to 5 halogen atoms, substituted or non-substituted tri(d-C8-alkyl)-silyl, substituted or non- substituted (Ci-C6-alkylideneamino)oxy, substituted or non-substituted (Ci-C6- alkenylideneamino)oxy, substituted or non-substituted (d-C6-alkynylideneamino)oxy, substituted or non-substituted (benzylideneamino)oxy, substituted or non-substituted [(arylcarbonyl)amino]- [Ci-C8]-alkyl, substituted or non-substituted [{Ci-C8-alkyl(Ci-C8-alkylcarbonyl)amino}]-[Ci-C8]- alkyl, substituted or non-substituted [{Ci-C8-alkyl(arylcarbonyl)amino}]-[Ci-C8]-alkyl, substituted or non-substituted [(Ci-C8-alkylcarbonyl)amino]-[Ci-C8]-alkyl; • Z2, Z3, Z4 Z5, Z6 and Z7 independently represent a hydrogen atom, a halogen atom, a nitro group, a hydroxy group, a cyano group, an amino group, a sulphenyl group, a formyl group, a substituted or non-substituted carbaldehyde O-(Ci-C8-alkyl)oxime, a formyloxy group, a formylamino group, a carbamoyl group, a N-hydroxycarbamoyl group, a pentafluoro-λ6-sulphenyl group, substituted or non-substituted Ci-C8-alkoxyamino group, substituted or non-substituted N- Ci-C8-alkyl-(Ci-C8-alkoxy)-amino group, substituted or non-substituted (Ci-C8-alkylamino)-amino group, substituted or non-substituted N-Ci-C8-alkyl-(Ci-C8-alkylamino)-amino group, a substituted or non-substituted (hydroxyimino)-Ci-C6-alkyl group, substituted or non-substituted Ci-C8-alkyl, substituted or non-substituted tri(Ci-C8-alkyl)silyl-Ci-C8-alkyl, substituted or non-substituted Ci- C8-cycloalkyl, substituted or non-substituted tri(Ci-C8-alkyl)silyl-Ci-C8-cycloalkyl, substituted or non-substituted Ci-C8-halogenoalkyl having 1 to 5 halogen atoms, substituted or non-substituted
Ci-C8-halogenocycloalkyl having 1 to 5 halogen atoms, a C2-C8-alkenyl, substituted or non- substituted C2-C8-alkynyl, substituted or non-substituted Ci-C8-alkylamino, substituted or non- substituted di-Ci-C8-alkylamino, substituted or non-substituted Ci-C8-alkoxy, substituted or non- substituted (Ci-C8-alkoxycarbonyl)amino,, substituted or non-substituted (C2-C8- alkenyloxycarbonyl)amino, substituted or non-substituted (C3-C8-alkynyloxycarbonyl)amino, substituted or non-substituted Ci-C8-halogenoalkoxy having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-alkylsulphenyl, substituted or non-substituted Ci-C8- halogenoalkylsulphenyl having 1 to 5 halogen atoms, substituted or non-substituted C2-C8- alkenyloxy, substituted or non-substituted C2-C8-halogenoalkenyloxy having 1 to 5 halogen atoms, substituted or non-substituted C3-C8-alkynyloxy, substituted or non-substituted C3-C8- halogenoalkynyloxy having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8- alkylcarbonyl, substituted or non-substituted N-(Ci-C8-alkoxy)-Ci-C8-alkanimidoyl, substituted or non-substituted N-(Ci-C8-alkoxy)-Ci-C8-halogenoalkanimidoyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-halogenoalkylcarbonyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-alkylcarbamoyl, substituted or non-substituted di-Ci-C8- alkylcarbamoyl, substituted or non-substituted N-Ci-C8-alkyloxycarbamoyl, substituted or non- substituted Ci-C8-alkoxycarbamoyl, substituted or non-substituted N-Ci-C8-alkyl-Ci-C8- alkoxycarbamoyl, substituted or non-substituted Ci-C8-alkoxycarbonyl, substituted or non- substituted Ci-C8-halogenoalkoxycarbonyl having 1 to 5 halogen atoms, substituted or non- substituted Ci-C8-alkylcarbonyloxy, substituted or non-substituted Ci-C8- halogenoalkylcarbonyloxy having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8- alkylcarbonylamino, substituted or non-substituted d-Cs-halogenoalkylcarbonylannino having 1 to
5 halogen atoms, substituted or non-substituted C-i-Cs-alkylcarbamoylannino, substituted or non- substituted d-Cs-halogenoalkylcarbannoylannino having 1 to 5 halogen atoms, substituted or non- substituted di-Ci-Cs-alkylcarbamoylamino, substituted or non-substituted di-Ci-C8- halogenoalkylcarbamoylamino having 1 to 5 halogen atoms , substituted or non-substituted N-
Ci-C8-alkyl-(Ci-C8-alkylcarbamoyl)amino, substituted or non-substituted N-Ci-C8-alkyl-(Ci-C8- halogenoalkylcarbamoyl)amino having 1 to 5 halogen atoms, substituted or non-substituted N- C-ι-C8-alkyl-(di-C-ι-C8-alkylcarbamoyl)amino, substituted or non-substituted N-Ci-C8-alkyl-(di- C-ι-C8-halogenoalkylcarbamoyl)amino having 1 to 5 halogen atoms, substituted or non-substituted C-i-Cs-alkylaminocarbonyloxy, substituted or non-substituted di-C-i-Cs-alkylaminocarbonyloxy, substituted or non-substituted d-Cs-alkylcarbamothioyl, substituted or non-substituted CIi-C1-C8- alkylcarbamothioyl, substituted or non-substituted N-C-i-Cs-alkyloxycarbamothioyl, substituted or non-substituted d-Cs-alkoxycarbamothioyl, substituted or non-substituted N-Ci-C8-alkyl-Ci-C8- alkoxycarbamothioyll, substituted or non-substituted d-C8-alkylthioylamino, substituted or non- substituted d-Cs-halogenoalkylthioylamino having 1 to 5 halogen atoms, substituted or non- substituted (Ci-C8-alkoxythiocarbonyl)amino, substituted or non-substituted (d-C8-alkyl- carbamothioyl)-oxy, substituted or non-substituted substituted or non-substituted (di-d-C8-alkyl- carbamothioyl)-oxy, substituted or non-substituted d-C8-alkylsulphenyl, substituted or non- substituted Ci-C8-halogenoalkylsulphenyl having 1 to 5 halogen atoms, substituted or non- substituted Ci-C8-alkylsulphinyl, substituted or non-substituted d-drhalogenoalkylsulphinyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-alkylsulphonyl, substituted or non-substituted d-C8-halogenoalkylsulphonyl having 1 to 5 halogen atoms, substituted or non- substituted d-C8-alkylaminosulfamoyl, substituted or non-substituted di-d-C8- alkylaminosulfamoyl, substituted or non-substituted (d-C6-alkoxyimino)-d-C6-alkyl, substituted or non-substituted (d-C6-alkenyloxyimino)-d-C6-alkyl, substituted or non-substituted (C1-C6- alkynyloxyimino)-d-C6-alkyl, substituted or non-substituted (benzyloxyimino)-d-C6-alkyl, substituted or non-substituted benzyloxy, substituted or non-substituted benzylsulphenyl, substituted or non-substituted benzylamino, substituted or non-substituted phenoxy, substituted or non-substituted phenylsulphenyl, substituted or non-substituted phenylamino, substituted or non-substituted aryl, substituted or non-substituted aryl-[Ci-C8]-alkyl, substituted or non- substituted tri(Ci-C8-alkyl)-silyloxy, substituted or non-substituted Ci-C8-alkylsulfenylamino, substituted or non-substituted d-Cs-halogenoalkylsulphinylamino having 1 to 5 halogen atoms, substituted or non-substituted d-C8-alkylsulphonylamino, substituted or non-substituted Ci-C8- halogenoalkylsulphonylamino having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8- alkoxysulphonylamino, substituted or non-substituted Ci-C8-halogenoxysulphonylamino having 1 to 5 halogen atoms, substituted or non-substituted tri(Ci-C8-alkyl)-silyl, substituted or non- substituted (Ci-C6-alkylideneamino)oxy, substituted or non-substituted (Ci-C6- alkenylideneamino)oxy, substituted or non-substituted (Ci-C6-alkynylideneamino)oxy, substituted or non-substituted (benzylideneamino)oxy, substituted or non-substituted [(arylcarbonyl)amino]- [Ci-C8]-alkyl, substituted or non-substituted [{Ci-C8-alkyl(Ci-C8-alkylcarbonyl)amino}]-[Ci-C8]- alkyl, substituted or non-substituted [{Ci-C8-alkyl(arylcarbonyl)amino}]-[Ci-C8]-alkyl, substituted or non-substituted [(Ci-C8-alkylcarbonyl)amino]-[Ci-C8]-alkyl;
Provided that when A represents A2 to A9, A42 to A46, A58, A60, A64, A65 or A66, then Z1, Z2, Z3, Z4 Z5, Z6 and Z7 independently cannot represent a hydrogen atom, a halogen atom, a cyano group, an amino group, a sulphenyl group, a formylamino group, substituted or non-substituted Ci-C8-alkyl, substituted or non-substituted Ci-C8-halogenoalkyl having 1 to 5 halogen atoms, substituted or non-substituted C1-C8- alkoxy, substituted or non-substituted d-C8-halogenoalkoxy having 1 to 5 halogen atoms, substituted or non-substituted d-C8-alkylsulphenyl, substituted or non-substituted C-ι-C8-halogenoalkylsulphenyl having 1 to 5 halogen atoms, substituted or non-substituted d-Cs-alkylcarbonylamino, substituted or non- substituted d-Cs-halogenoalkylcarbonylamino having 1 to 5 halogen atoms, substituted or non- substituted d-Cs-alkylcarbamoylamino, substituted or non-substituted C1-C8- halogenoalkylcarbamoylamino having 1 to 5 halogen atoms, substituted or non-substituted di-d-C8- alkylcarbamoylamino, substituted or non-substituted di-d-Cs-halogenoalkylcarbamoylamino having 1 to 5 halogen atoms , substituted or non-substituted N-Ci-C8-alkyl-(d-C8-alkylcarbamoyl)amino, substituted or non-substituted N-d-C8-alkyl-(d-C8-halogenoalkylcarbamoyl)amino having 1 to 5 halogen atoms, substituted or non-substituted N-Ci-C8-alkyl-(di-d-C8-alkylcarbamoyl)amino, substituted or non- substituted N-Ci-C8-alkyl-(di-d-C8-halogenoalkylcarbamoyl)amino having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-alkylsulphonyl, substituted or non-substituted d-C8-halogenoalkyl- sulphonyl having 1 to 5 halogen atoms; Provided that when A represents A10 to A36, A47 to A56, then Z1, Z2, Z3, Z4 , Z5, Z6 and Z7 independently cannot represented that when A represents A10 to A36, A47 to A56, then Z\ Z2, Z3, Z4 Z5, Z6 and Z7 independently cannot represent a hydrogen atom, a halogen atom, a cyano group, an amino group, a sulphenyl group, a formylamino group, a carbamoyl group, substituted or non-substituted d-C8-alkyl, substituted or non-substituted d-C8-cycloalkyl, substituted or non-substituted d-C8-halogenoalkyl having 1 to 5 halogen atoms, substituted or non-substituted d-C8-halogenocycloalkyl having 1 to 5 halogen atoms, a C2-C8-alkenyl, substituted or non-substituted C2-C8-alkynyl, substituted or non-substituted C1-C8- alkylamino, substituted or non-substituted di-C-ι-C8-alkylamino, substituted or non-substituted C1-C8- alkoxy, substituted or non-substituted (C-ι-C8-alkoxycarbonyl)amino, substituted or non-substituted C1-C8- alkylsulphenyl, substituted or non-substituted d-C8-halogenoalkylsulphenyl having 1 to 5 halogen atoms, substituted or non-substituted d-C8-alkylcarbamoyl, substituted or non-substituted CIi-C1-C8- alkylcarbamoyl, substituted or non-substituted d-C8-alkoxycarbonyl, substituted or non-substituted d-C8-alkylcarbonylannino, substituted or non-substituted d-Cs-halogenoalkylcarbonylamino having 1 to 5 halogen atoms, substituted or non-substituted C-ι-C8-alkylcarbamoylamino, substituted or non-substituted C-i-Cs-halogenoalkylcarbamoylamino having 1 to 5 halogen atoms, substituted or non-substituted di- C-ι-C8-alkylcarbamoylamino, substituted or non-substituted di-d-Cs-halogenoalkylcarbamoylannino having 1 to 5 halogen atoms , substituted or non-substituted N-C1-C8-alkyl-(C1-C8-alkylcarbamoyl)amino, substituted or non-substituted N-C1-C8-alkyl-(C1-C8-halogenoalkylcarbamoyl)amino having 1 to 5 halogen atoms, substituted or non-substituted N-C1-C8-alkyl-(di-C1-C8-alkylcarbamoyl)amino, substituted or non- substituted N-d-Cs-alkyl^di-d-Cs-halogenoalkylcarbamoy^amino having 1 to 5 halogen atoms, substituted or non-substituted d-C8-alkylsulphinyl, substituted or non-substituted d-C8-alkylsulphonyl, substituted or non-substituted C-ι-C8-alkylaminosulfamoyl, substituted or non-substituted CIi-C1-C8- alkylaminosulfamoyl, substituted or non-substituted benzyloxy, substituted or non-substituted benzylsulphenyl, substituted or non-substituted benzylamino, substituted or non-substituted aryl;
• K1 represents a hydrogen atom, a formyl group, a carbamoyl group, a N- hydroxycarbamoyl group, a formylamino group, substituted or non-substituted Ci-C8-alkyl, substituted or non-substituted tri(C1-C8-alkyl)silyl-Ci-C8-alkyl, substituted or non-substituted C1- C8-cycloalkyl, substituted or non-substituted tri(C1-C8-alkyl)silyl-C1-C8-cycloalkyl, substituted or non-substituted Ci-C8-halogenoalkyl having 1 to 5 halogen atoms, substituted or non-substituted C-i-Cs-halogenocycloalkyl having 1 to 5 halogen atoms, a C2-C8-alkenyl, substituted or non- substituted C2-C8-alkynyl, substituted or non-substituted d-Cs-alkylcarbonyl, substituted or non- substituted d-Cs-halogenoalkylcarbonyl having 1 to 5 halogen atoms, substituted or non- substituted Ci-Cs-alkylcarbamoyl, substituted or non-substituted di-d-Cs-alkylcarbamoyl, substituted or non-substituted N-d-Cs-alkyloxycarbamoyl, substituted or non-substituted C1-C8- alkoxycarbamoyl, substituted or non-substituted N-d-Cs-alkyl-d-Cs-alkoxycarbamoyl, substituted or non-substituted d-C8-alkoxycarbonyl, substituted or non-substituted C1-C8- halogenoalkoxycarbonyl having 1 to 5 halogen atoms, substituted or non-substituted C1-C8- alkylcarbamothioyl, substituted or non-substituted di-d-Cs-alkylcarbamothioyl, substituted or non-substituted N-d-Cs-alkyloxycarbamothioyl, substituted or non-substituted C1-C8- alkoxycarbamothioyl, substituted or non-substituted N-d-Cs-alkyl-d-Cs-alkoxycarbamothioyl, substituted or non-substituted d-C8-alkylsulphinyl, substituted or non-substituted C1-C8- halogenoalkylsulphinyl having 1 to 5 halogen atoms, substituted or non-substituted d-C8-alkyl- sulphonyl, substituted or non-substituted d-C8-halogenoalkylsulphonyl having 1 to 5 halogen atoms, substituted or non-substituted d-C8-alkylaminosulfannoyl, substituted or non-substituted di-C-i-Cs-alkylaminosulfamoyl, substituted or non-substituted aryl, substituted or non-substituted aryl-[d-C8]-alkyl ;
Q is selected in the list consisting of Q1 to Q19 :
wherein
• Y1 to Y5 independently represent a hydrogen atom, a nitro group, a hydroxy group, a cyano group, an amino group, a sulphenyl group, a formyl group, a substituted or non-substituted carbaldehyde O-(C-ι-C8-alkyl)oxime, a formyloxy group, a formylamino group, a carbamoyl group, a N-hydroxycarbamoyl group, a pentafluoro-λ6-sulphenyl group, a formylamino group, substituted or non-substituted C-ι-C8-alkoxyamino group, substituted or non-substituted alkoxy)-amino group, substituted or non-substituted (C-ι-C8-alkylamino)-amino group, substituted or non-substituted N-Ci-C8-alkyl-(Ci-C8-alkylannino)-annino group, a substituted or non-substituted
(hydroxyimino)-Ci-C6-alkyl group, substituted or non-substituted Ci-C8-alkyl, substituted or non- substituted tri(Ci-C8-alkyl)silyl-Ci-C8-alkyl, substituted or non-substituted Ci-C8-cycloalkyl, substituted or non-substituted tri(C1-C8-alkyl)silyl-C1-C8-cycloalkyl, substituted or non-substituted Ci-C8-halogenoalkyl having 1 to 5 halogen atoms, substituted or non-substituted C1-C8- halogenocycloalkyl having 1 to 5 halogen atoms, a C2-C8-alkenyl, substituted or non-substituted C2-C8-alkynyl, substituted or non-substituted d-C8-alkylamino, substituted or non-substituted di- d-C8-alkylamino, substituted or non-substituted d-C8-alkoxy, substituted or non-substituted C1- C8-halogenoalkoxy having 1 to 5 halogen atoms, substituted or non-substituted C1-C8- alkylsulphenyl, substituted or non-substituted C-i-Cs-halogenoalkylsulphenyl having 1 to 5 halogen atoms, substituted or non-substituted C2-C8-alkenyloxy, substituted or non-substituted C2-C8-halogenoalkenyloxy having 1 to 5 halogen atoms, substituted or non-substituted C3-C8- alkynyloxy, substituted or non-substituted C3-C8-halogenoalkynyloxy having 1 to 5 halogen atoms, substituted or non-substituted C-i-Cs-alkylcarbonyl, substituted or non-substituted N-(C1- C8-alkoxy)-C-ι-C8-alkanimidoyl, substituted or non-substituted N-(C1 -C8-alkoxy)-C-ι -C8- halogenoalkanimidoyl having 1 to 5 halogen atoms, substituted or non-substituted C1-C8- halogenoalkylcarbonyl having 1 to 5 halogen atoms, substituted or non-substituted C1-C8- alkylcarbamoyl, substituted or non-substituted di-C-ι-C8-alkylcarbamoyl, substituted or non- substituted N-C-i-Cs-alkyloxycarbamoyl, substituted or non-substituted C-i-Cs-alkoxycarbamoyl, substituted or non-substituted N-C-i-Cs-alkyl-C-i-Cs-alkoxycarbamoyl, substituted or non- substituted C-ι-C8-alkoxycarbonyl, substituted or non-substituted C-ι-C8-halogenoalkoxycarbonyl having 1 to 5 halogen atoms, substituted or non-substituted C-ι-C8-alkylcarbonyloxy, substituted or non-substituted C-ι-C8-halogenoalkylcarbonyloxy having 1 to 5 halogen atoms, substituted or non-substituted C-ι-C8-alkylcarbonylamino, substituted or non-substituted C1-C8- halogenoalkylcarbonylamino having 1 to 5 halogen atoms, substituted or non-substituted C1-C8- alkylcarbamoylamino, substituted or non-substituted C-i-C8-halogenoalkylcarbamoylamino having 1 to 5 halogen atoms, substituted or non-substituted di-C-i-Cs-alkylcarbamoylamino, substituted or non-substituted di-C-i-Cs-halogenoalkylcarbamoylamino having 1 to 5 halogen atoms , substituted or non-substituted N-C1-C8-alkyl-(C1-C8-alkylcarbamoyl)amino, substituted or non-substituted N- C1-C8-alkyl-(C1-C8-halogenoalkylcarbamoyl)amino having 1 to 5 halogen atoms, substituted or non-substituted N-C1-C8-alkyl-(di-C1-C8-alkylcarbamoyl)amino, substituted or non-substituted N- C1-C8-alkyl-(di-C1-C8-halogenoalkylcarbamoyl)amino having 1 to 5 halogen atoms, substituted or non-substituted C-ι-C8-alkylaminocarbonyloxy, substituted or non-substituted CIi-C1-C8- alkylaminocarbonyloxy, substituted or non-substituted C-ι-C8-alkylcarbamothioyl, substituted or non-substituted di-C-i-Cs-alkylcarbamothioyl, substituted or non-substituted N-C1-C8- alkyloxycarbamothioyll, substituted or non-substituted C-i-Cs-alkoxycarbamothioyl, substituted or non-substituted N-C-i-Cs-alkyl-C-i-Cs-alkoxycarbamothioyl, substituted or non-substituted C1-C8- alkylthioylamino, substituted or non-substituted C-i-Cs-halogenoalkylthioylamino having 1 to 5 halogen atoms, substituted or non-substituted (C-i-Cs-alkyl-carbamothioy^-oxy, substituted or non-substituted substituted or non-substituted (di-C-i-Cs-alkyl-carbamothioy^-oxy, substituted or non-substituted C-ι-C8-alkylsulphenyl, substituted or non-substituted C1-C8- halogenoalkylsulphenyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8- alkylsulphinyl, substituted or non-substituted Ci-C8-halogenoalkylsulphinyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-alkylsulphonyl, substituted or non-substituted Ci-C8- halogenoalkylsulphonyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8- alkylaminosulfamoyl, substituted or non-substituted di-Ci-C8-alkylaminosulfamoyl, substituted or non-substituted (Ci-C6-alkoxyimino)-Ci-C6-alkyl, substituted or non-substituted (Ci-C6- alkenyloxyimino)-Ci-C6-alkyl, substituted or non-substituted (Ci-C6-alkynyloxyimino)-Ci-C6-alkyl, substituted or non-substituted (benzyloxyimino)-Ci-C6-alkyl, substituted or non-substituted benzyloxy, substituted or non-substituted benzylsulphenyl, substituted or non-substituted benzylamino, substituted or non-substituted phenoxy, substituted or non-substituted phenylsulphenyl, substituted or non-substituted phenylamino, substituted or non-substituted aryl, substituted or non-substituted aryl-[Ci-C8]-alkyl, substituted or non-substituted tri(Ci-C8-alkyl)- silyloxy, substituted or non-substituted Ci-C8-alkylsulfenylamino, substituted or non-substituted Ci-C8-halogenoalkylsulphinylamino having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-alkylsulphonylamino, substituted or non-substituted Ci-C8-halogenoalkylsulphonylamino having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-alkoxysulphonylamino, substituted or non-substituted Ci-C8-halogenoxysulphonylamino having 1 to 5 halogen atoms, substituted or non-substituted tri(Ci-C8-alkyl)-silyl, substituted or non-substituted (Ci-C6- alkylideneamino)oxy, substituted or non-substituted (Ci-C6-alkenylideneamino)oxy, substituted or non-substituted (Ci-C6-alkynylideneamino)oxy, substituted or non-substituted
(benzylideneamino)oxy ;
• W1 represents a group as defined for T
• unless indicated otherwise, a group or a substituent that is substituted is substituted by one or more of the following groups or atoms: a halogen atom, a nitro group, a hydroxy group, a cyano group, an amino group, a sulphenyl group, a pentafluoro-λ6-sulphenyl group, a formyl group, a substituted or non-substituted carbaldehyde O-(Ci-C8-alkyl)oxime, a formyloxy group, a formylamino group, a carbamoyl group, a N-hydroxycarbamoyl group, a formylamino group, a (hydroxyimino)-Ci-C6-alkyl group, a Ci-C8-alkyl, a tri(Ci-C8-alkyl)silyl-Ci-C8-alkyl, Ci-C8- cycloalkyl, tri(Ci-C8-alkyl)silyl-Ci-C8-cycloalkyl, a Ci-C8-halogenoalkyl having 1 to 5 halogen atoms, a Ci-C8-halogenocycloalkyl having 1 to 5 halogen atoms, a C2-C8-alkenyl, a C2-C8-alkynyl, a C2-C8-alkenyloxy, a C2-C8-alkynyloxy, a Ci-C8-alkylamino, a di-Ci-C8-alkylamino, a Ci-C8- alkoxy, a Ci-C8-halogenoalkoxy having 1 to 5 halogen atoms, a Ci-C8-alkylsulphenyl, a Ci-C8- halogenoalkylsulphenyl having 1 to 5 halogen atoms, a C2-C8-alkenyloxy, a C2-C8- halogenoalkenyloxy having 1 to 5 halogen atoms, a C3-C8-alkynyloxy, a C3-C8- halogenoalkynyloxy having 1 to 5 halogen atoms, a Ci-Cs-alkylcarbonyl, a Ci-C8- halogenoalkylcarbonyl having 1 to 5 halogen atoms, a Ci-Cs-alkylcarbamoyl, a di-Ci-C8- alkylcarbamoyl, a N-Ci-C8-alkyloxycarbamoyl, a Ci-C8-alkoxycarbamoyl, a N-Ci-C8-alkyl-Ci-C8- alkoxycarbamoyl, a Ci-C8-alkoxycarbonyl, a Ci-C8-halogenoalkoxycarbonyl having 1 to 5 halogen atoms, a Ci-Cs-alkylcarbonyloxy, a Ci-C8-halogenoalkylcarbonyloxy having 1 to 5 halogen atoms, a Ci-C8-alkylcarbonylamino, a Ci-C8-halogenoalkylcarbonylamino having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-alkoxycarbonylamino, substituted or non-substituted Ci-C8- halogenoalkoxycarbonylamino having 1 to 5 halogen atoms, a d-Cs-alkylaminocarbonyloxy, a di- d-Cs-alkylanninocarbonyloxy, a d-Cs-alkyloxycarbonyloxy, a d-C8-alkylsulphenyl, a Ci-C8- halogenoalkylsulphenyl having 1 to 5 halogen atoms, a Ci-C8-alkylsulphinyl, a Ci-C8- halogenoalkylsulphinyl having 1 to 5 halogen atoms, a Ci-C8-alkylsulphonyl, a Ci-C8-halogeno- alkylsulphonyl having 1 to 5 halogen atoms, a Ci-C8-alkylaminosulfamoyl, a di-Ci-C8- alkylaminosulfamoyl, a (Ci-C6-alkoxyimino)-Ci-C6-alkyl, a (C-rC6-alkenyloxyinnino)-Ci-C6-alkyl, a (C-ι-C6-alkynyloxyimino)-C-ι-C6-alkyl, (benzyloxyimino)-C-ι-C6-alkyl, d-C8-alkoxyalkyl, C1-C8- halogenoalkoxyalkyl having 1 to 5 halogen atoms, benzyloxy, benzylsulphenyl, benzylamino, phenoxy, phenylsulphenyl, or phenylamino ; as well as salts, N-oxides, metallic complexes and metalloidic complexes thereof or (E) and (Z) isomers and mixtures thereof.
2. A compound according to claim 1 wherein L1 represents a direct bond or a divalent group selected in the list consisting of
-(CR1R2)n- -C(=O)-(CR1R2)p-
-(CR1R2)m-O- -(CR1R2)m-C(=O)-O-
-(CR1R2)m-NH- -(CR1R2)m-C(=O)-NH-
-(CR1R2)m-C(=O)- -(CR1R2)m-NH-C(=O) wherein
• n represents 1 or 2 ;
• m and p independently represent 0 or 1 ;
• R1 and R2 independently represent a hydrogen atom, a halogen atom, a cyano group, substituted or non-substituted d-C8-alkyl, substituted or non-substituted d-C8-cycloalkyl, substituted or non-substituted d-C8-halogenoalkyl having 1 to 5 halogen atoms, substituted or non-substituted d-Cs-halogenocycloalkyl having 1 to 5 halogen atoms, a C2-C8-alkenyl, substituted or non-substituted C2-C8-alkynyl, substituted or non-substituted Ci-C8-alkoxy, substituted or non-substituted Ci-C8-halogenoalkoxy having 1 to 5 halogen atoms, substituted or non-substituted C2-C8-alkenyloxy, substituted or non-substituted C2-C8-halogenoalkenyloxy having 1 to 5 halogen atoms, substituted or non-substituted C3-C8-alkynyloxy, substituted or non- substituted drCs-halogenoalkynyloxy having 1 to 5 halogen atoms.
3. A compound according to claim 2 wherein L1 represents a direct bond or a divalent group selected in the list consisting of -(CR1R2)-, -C(=O)-(CR1R2)- and -C(=O)- , wherein R1 and R2 are independently selected in the list consisting of hydrogen, halogen, methyl, ethyl, isopropyl, trifluoromethyl, difluoromethyl, allyl, ethynyl, propargyl, cyclopropyl, methoxy, trifluoromethoxy and cyano.
4. A compound according to claim 1 wherein T represents T2 orT3
5. A compound according to claim 1 wherein X1 represents a hydrogen atom, a halogen atom, a cyano group, an amino group, a sulphenyl group, a pentafluoro-λ6-sulphenyl group, substituted or non- substituted C-ι-C8-alkyl, substituted or non-substituted tri(C-ι-C8-alkyl)silyl-C-ι-C8-alkyl, substituted or non- substituted d-Cs-cycloalkyl, substituted or non-substituted tri(C1-C8-alkyl)silyl-C1-C8-cycloalkyl, substituted or non-substituted Ci-C8-halogenoalkyl having 1 to 5 halogen atoms, substituted or non- substituted d-Cs-halogenocycloalkyl having 1 to 5 halogen atoms, a C2-C8-alkenyl, substituted or non- substituted C2-C8-alkynyl, substituted or non-substituted Ci-C8-alkoxy, substituted or non-substituted C1- C8-halogenoalkoxy having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-alkylsulphenyl, substituted or non-substituted Ci-C8-halogenoalkylsulphenyl having 1 to 5 halogen atoms, substituted or non-substituted C2-C8-alkenyloxy, substituted or non-substituted C2-C8-halogenoalkenyloxy having 1 to 5 halogen atoms, substituted or non-substituted C3-C8-alkynyloxy, substituted or non-substituted C3-C8- halogenoalkynyloxy having 1 to 5 halogen atoms, substituted or non-substituted d-C8-alkylcarbonyl, substituted or non-substituted N-(d-C8-alkoxy)-d-C8-alkanimidoyl, substituted or non-substituted N-(C1- C8-alkoxy)-d-C8-halogenoalkanimidoyl having 1 to 5 halogen atoms, substituted or non-substituted C1- Cs-halogenoalkylcarbonyl having 1 to 5 halogen atoms, substituted or non-substituted C1-C8- alkylcarbamoyl, substituted or non-substituted di-d-C8-alkylcarbamoyl, substituted or non-substituted N- d-C8-alkyloxycarbamoyl, substituted or non-substituted d-C8-alkoxycarbamoyl, substituted or non- substituted N-C-i-Cs-alkyl-C-i-Cs-alkoxycarbamoyl, substituted or non-substituted d-C8-alkoxycarbonyl, substituted or non-substituted d-Cs-halogenoalkoxycarbonyl having 1 to 5 halogen atoms, substituted or non-substituted d-Cs-alkylcarbamothioyl, substituted or non-substituted di-d-Cs-alkylcarbamothioyl, substituted or non-substituted N-d-Cs-alkyloxycarbamothioyll, substituted or non-substituted C1-C8- alkoxycarbamothioyl, substituted or non-substituted N-d-Cs-alkyl-d-Cs-alkoxycarbamothioyl, substituted or non-substituted d-C8-alkylsulphenyl, substituted or non-substituted d-C8-halogenoalkylsulphenyl having 1 to 5 halogen atoms, substituted or non-substituted d-C8-alkylsulphonyl, substituted or non- substituted d-C8-halogenoalkylsulphonyl having 1 to 5 halogen atoms, substituted or non-substituted (d-C6-alkoxyinnino)-d-C6-alkyl, substituted or non-substituted (d-C6-alkenyloxyinnino)-d-C6-alkyl, substituted or non-substituted (d-C6-alkynyloxyinnino)-d-C6-alkyl, substituted or non-substituted (benzyloxyimino)-d-C6-alkyl, substituted or non-substituted benzyloxy, substituted or non-substituted benzylsulphenyl, substituted or non-substituted phenoxy, substituted or non-substituted phenylsulphenyl, substituted or non-substituted aryl, substituted or non-substituted aryl-[d-C8]-alkyl, substituted or non- substituted tri(d-C8-alkyl)-silyloxy, substituted or non-substituted tri(d-C8-alkyl)-silyl.
6. A compound according to claim 5 wherein X1 represents a hydrogen atom, a halogen atom, methyl, isopropyl, isobutyl, tertbutyl, trifluoromethyl, difluoromethyl, allyl, ethynyl, propargyl, cyclopropyl, benzyl, phenethyl, methoxy, trifluoromethoxy, acetyl, trifluoroacetyl or cyano.
7. A compound according to claim 1 wherein W1 represents a hydrogen atom, a halogen atom, a cyano group, substituted or non-substituted d-C8-alkyl, substituted or non-substituted d-C8-cycloalkyl, substituted or non-substituted d-C8-halogenoalkyl having 1 to 5 halogen atoms, a C2-C8-alkenyl, substituted or non-substituted C2-C8-alkynyl, substituted or non-substituted d-C8-alkoxy, substituted or non-substituted d-C8-halogenoalkoxy having 1 to 5 halogen atoms, substituted or non-substituted phenoxy, substituted or non-substituted aryl, or a substituted or non-substituted aryl-[d-C8]-alkyl.
8. A compound according to claim 7 wherein W1 represents a hydrogen atom, a halogen atom, methyl, ethyl, isopropyl, isobutyl, terbutyl, trifluoromethyl, difluoromethyl, allyl, ethynyl, propargyl, cyclopropyl, methoxy, trifluoromethoxy or cyano.
9. A compound according to claim 1 wherein A is selected in the list consisting of A2 to A18.
10. A compound according to claim 9 wherein A is selected in the list consisting of A2, A8, A16 and A18.
11. A compound according to claim 1 wherein Z1 represents a halogen atom, an amino group, a formylamino group, substituted or non-substituted C-ι-C8-alkoxyamino group, substituted or non- substituted N-Ci-C8-alkyl-(Ci-C8-alkoxy)-amino group, substituted or non-substituted Ci-C8-alkyl, substituted or non-substituted Ci-C8-cycloalkyl, a C2-C8-alkenyl, substituted or non-substituted C2-C8- alkynyl, substituted or non-substituted Ci-C8-alkylamino, substituted or non-substituted di-Ci-C8- alkylamino, substituted or non-substituted Ci-C8-alkoxy, substituted or non-substituted Ci-C8- halogenoalkoxy having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-alkylsulphenyl, substituted or non-substituted Ci-C8-alkylcarbonyl, substituted or non-substituted Ci-C8-alkylcarbamoyl, substituted or non-substituted di-Ci-C8-alkylcarbamoyl, substituted or non-substituted N-Ci-C8- alkyloxycarbamoyl, substituted or non-substituted Ci-C8-alkoxycarbamoyl, substituted or non-substituted N-Ci-C8-alkyl-Ci-C8-alkoxycarbamoyl, substituted or non-substituted Ci-C8-alkoxycarbonyl, substituted or non-substituted Ci-C8-alkylcarbonylamino, substituted or non-substituted Ci-C8- halogenoalkylcarbonylamino having 1 to 5 halogen atoms, substituted or non-substituted (Ci-C8- alkoxycarbonyl)amino,, substituted or non-substituted (C2-C8-alkenyloxycarbonyl)amino, substituted or non-substituted (C3-C8-alkynyloxycarbonyl)amino, substituted or non-substituted Ci-C8- alkylcarbamoylamino, substituted or non-substituted (Ci-C8-alkoxythiocarbonyl)amino, substituted or non- substituted di-Ci-C8-alkylcarbamoylamino, substituted or non-substituted Ci-C8-alkylthioylamino, substituted or non-substituted benzylamino, substituted or non-substituted phenylamino, substituted or non-substituted aryl-[Ci-C8]-alkyl.
12. A compound according to claim 11 wherein Z1 represents an amino group, a formylamino group, substituted or non-substituted Ci-C8-alkoxyamino group, substituted or non-substituted Ci-C8-alkyl, substituted or non-substituted Ci-C8-cycloalkyl, a C2-C8-alkenyl, substituted or non-substituted C2-C8- alkynyl, substituted or non-substituted Ci-C8-alkylamino, substituted or non-substituted di-Ci-C8- alkylamino, substituted or non-substituted (Ci-C8-alkoxycarbonyl)amino,, substituted or non-substituted (C2-C8-alkenyloxycarbonyl)amino, substituted or non-substituted (C3-C8-alkynyloxycarbonyl)amino, substituted or non-substituted (Ci-C8-alkoxythiocarbonyl)amino, substituted or non-substituted di-Ci-C8- alkylcarbamoylamino, substituted or non-substituted Ci-C8-alkylthioylamino, substituted or non- substituted benzylamino, substituted or non-substituted phenylamino, substituted or non-substituted aryl- [d-Cβl-alkyl.
13. A compound according to claim 1 wherein Z2 to Z9 independently represent a hydrogen atom, a halogen atom, a cyano group, substituted or non-substituted Ci-C8-alkyl, substituted or non-substituted d-Cs-cycloalkyl, substituted or non-substituted Ci-C8-halogenoalkyl having 1 to 5 halogen atoms, a C2- C8-alkenyl, substituted or non-substituted C2-C8-alkynyl, substituted or non-substituted Ci-C8-alkoxy, substituted or non-substituted Ci-C8-halogenoalkoxy having 1 to 5 halogen atoms, substituted or non- substituted phenoxy, substituted or non-substituted aryl, or a substituted or non-substituted aryl-[d-C8]- alkyl.
14. A compound according to claim 13 wherein Z2 to Z9 are independently selected in the list consisting of hydrogen, halogen, methyl, ethyl, isopropyl, isobutyl, terbutyl, trifluoromethyl, difluoromethyl, allyl, ethynyl, propargyl, cyclopropyl, methoxy, trifluoromethoxy, acetyl, and cyano.
15. A compound according to claim 1 wherein K1 is selected in the list consisting of hydrogen, methyl, ethyl, isopropyl, isobutyl, terbutyl, allyl, propargyl, cyclopropyl, acetyl, trifluoroacetyl and mesyl.
16. A compound according to claim 1 wherein Q is selected in the list consisting of Q1, Q3, Q7.
17. A compound according to claim 16 wherein Q represents Q1.
18. A compound according to claim 1 wherein Y1 to Y5 independently represent a hydrogen atom, a halogen atom, a cyano group, an amino group, a sulphenyl group, a pentafluoro- 6-sulphenyl group, substituted or non-substituted d-C8-alkyl, substituted or non-substituted tri(C-ι-C8-alkyl)silyl-C-ι-C8-alkyl, substituted or non-substituted d-C8-cycloalkyl, substituted or non-substituted tri(d-C8-alkyl)silyl-d-C8- cycloalkyl, substituted or non-substituted d-C8-halogenoalkyl having 1 to 5 halogen atoms, substituted or non-substituted d-C8-halogenocycloalkyl having 1 to 5 halogen atoms, a C2-C8-alkenyl, substituted or non-substituted C2-C8-alkynyl, substituted or non-substituted d-C8-alkoxy, substituted or non-substituted C-ι-C8-halogenoalkoxy having 1 to 5 halogen atoms, substituted or non-substituted d-C8-alkylsulphenyl, substituted or non-substituted d-drhalogenoalkylsulphenyl having 1 to 5 halogen atoms, substituted or non-substituted C2-C8-alkenyloxy, substituted or non-substituted C2-C8-halogenoalkenyloxy having 1 to 5 halogen atoms, substituted or non-substituted C3-C8-alkynyloxy, substituted or non-substituted C3-C8- halogenoalkynyloxy having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-alkylcarbonyl, substituted or non-substituted N-(d-C8-alkoxy)-Ci-C8-alkanimidoyl, substituted or non-substituted N-(d- C8-alkoxy)-d-C8-halogenoalkanimidoyl having 1 to 5 halogen atoms, substituted or non-substituted d- C8-halogenoalkylcarbonyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8- alkylcarbamoyl, substituted or non-substituted di-Ci-C8-alkylcarbamoyl, substituted or non-substituted N- d-C8-alkyloxycarbamoyl, substituted or non-substituted d-C8-alkoxycarbamoyl, substituted or non- substituted N-d-C8-alkyl-d-C8-alkoxycarbamoyl, substituted or non-substituted d-C8-alkoxycarbonyl, substituted or non-substituted d-C8-halogenoalkoxycarbonyl having 1 to 5 halogen atoms, substituted or non-substituted d-C8-alkylcarbamothioyl, substituted or non-substituted di-d-C8-alkylcarbamothioyl, substituted or non-substituted N-d-C8-alkyloxycarbamothioyll, substituted or non-substituted C1-C8- alkoxycarbamothioyl, substituted or non-substituted N-Ci-C8-alkyl-Ci-C8-alkoxycarbannothioyl, substituted or non-substituted Ci-C8-alkylsulphenyl, substituted or non-substituted Ci-C8-halogenoalkylsulphenyl having 1 to 5 halogen atoms, substituted or non-substituted Ci-C8-alkylsulphonyl, substituted or non- substituted Ci-C8-halogenoalkylsulphonyl having 1 to 5 halogen atoms, substituted or non-substituted (Ci-C6-alkoxyimino)-Ci-C6-alkyl, substituted or non-substituted (C-rC6-alkenyloxyinnino)-Ci-C6-alkyl, substituted or non-substituted (Ci-C6-alkynyloxyimino)-Ci-C6-alkyl, substituted or non-substituted (benzyloxyimino)-C-ι-C6-alkyl, substituted or non-substituted benzyloxy, substituted or non-substituted benzylsulphenyl, substituted or non-substituted phenoxy, substituted or non-substituted phenylsulphenyl, substituted or non-substituted aryl, substituted or non-substituted aryl-[d-C8]-alkyl, substituted or non- substituted tri(C-ι-C8-alkyl)-silyloxy, substituted or non-substituted tri(C-ι-C8-alkyl)-silyl.
19. A compound according to claim 18 wherein Y1 to Y5 independently represent a hydrogen atom, a halogen atom, methyl, isopropyl, isobutyl, tertbutyl, trifluoromethyl, difluoromethyl, allyl, ethynyl, propargyl, cyclopropyl, methoxy, trifluoromethoxy or cyano.
20. A method for controlling the phytopathogenic fungi or damaging insects of plants, crops or seeds comprising the application of an agronomically effective and substantially non-phytotoxic quantity of a pesticide composition according to claims 1 to 19 as seed treatment, foliar application, stem application, drench or drip application or chemigation to the seed, the plant or to the fruit of the plant or to soil or to inert substrate, Pumice, Pyroclastic materials or stuff, synthetic organic substrates organic substrates or to a liquid substrate wherein the plant is growing or wherein it is desired to grow.
EP09784075A 2008-12-09 2009-12-08 Fungicide hydroximoyl-heterocycles derivatives Withdrawn EP2376464A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP09784075A EP2376464A1 (en) 2008-12-09 2009-12-08 Fungicide hydroximoyl-heterocycles derivatives

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08356149 2008-12-09
PCT/EP2009/066560 WO2010066697A1 (en) 2008-12-09 2009-12-08 Fungicide hydroximoyl-heterocycles derivatives
EP09784075A EP2376464A1 (en) 2008-12-09 2009-12-08 Fungicide hydroximoyl-heterocycles derivatives

Publications (1)

Publication Number Publication Date
EP2376464A1 true EP2376464A1 (en) 2011-10-19

Family

ID=40589971

Family Applications (1)

Application Number Title Priority Date Filing Date
EP09784075A Withdrawn EP2376464A1 (en) 2008-12-09 2009-12-08 Fungicide hydroximoyl-heterocycles derivatives

Country Status (5)

Country Link
US (1) US8580799B2 (en)
EP (1) EP2376464A1 (en)
JP (1) JP2012511537A (en)
CN (1) CN102227412A (en)
WO (1) WO2010066697A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112012027558A2 (en) * 2010-04-28 2015-09-15 Bayer Cropscience Ag '' Compound of formula (I), fungicidal composition and method for the control of crop phytogenic fungi ''
CN102985419A (en) * 2010-04-28 2013-03-20 拜尔农科股份公司 Fungicide hydroximoyl-heterocycles derivatives
KR102028893B1 (en) * 2011-12-29 2019-10-07 바이엘 인텔렉쳐 프로퍼티 게엠베하 Fungicidal 3-[(1,3-thiazol-4-ylmethoxyimino)(phenyl)methyl]-2-substituted-1,2,4-oxadiazol-5(2h)-one derivatives

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU725138B2 (en) 1996-09-30 2000-10-05 Nihon Nohyaku Co., Ltd. 1,2,3-thiadiazole derivatives and salts thereof, disease controlling agents for agricultural and horticultural use, and method for the use thereof
CN1188411C (en) * 1997-12-10 2005-02-09 大日本油墨化学工业株式会社 Oxime derivatives and agricultural chemicals containing same
EP1184382A4 (en) 1999-06-09 2005-01-05 Dainippon Ink & Chemicals Oxime derivatives, process for the preparation thereof and pesticides
JP2000351772A (en) 1999-06-09 2000-12-19 Sagami Chem Res Center Production of new oxide derivative
JP2002193713A (en) * 2000-12-27 2002-07-10 Dainippon Ink & Chem Inc Fungicidal composition for agriculture and horticulture
CN1259318C (en) 2001-08-20 2006-06-14 日本曹达株式会社 Tetrazoyl oxime derivative and agrochemical containing the same as active ingredient

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2010066697A1 *

Also Published As

Publication number Publication date
WO2010066697A1 (en) 2010-06-17
US8580799B2 (en) 2013-11-12
US20110294829A1 (en) 2011-12-01
CN102227412A (en) 2011-10-26
JP2012511537A (en) 2012-05-24

Similar Documents

Publication Publication Date Title
US9233929B2 (en) Fungicide N-cycloalkyl-N-bicyclimethylene-carboxamide derivatives
US9102588B2 (en) Fungicide N-cycloalkyl-N-bicyclic-carboxamide derivatives
EP2182800A1 (en) Fungicidal n-cycloalkyl-benzyl-thiocarboxamides or n-cycloalkyl-benzyl-n&#39; -substituted-amidine derivatives
EP2310361B1 (en) Fungicidal n-(2-phenoxyethyl)carboxamide derivatives and their aza, thia and sila analogues
CA2692696A1 (en) Fungicide n-6-membered fused (hetero)aryl-methylene-n-cycloalkyl carboxamide derivatives
WO2010012794A1 (en) Fungicide n-cycloalkyl-n-biphenylmethyl-carboxamide derivatives
EP2519103B1 (en) Fungicide hydroximoyl-tetrazole derivatives
EP2185545B1 (en) Fungicide n-5-membered fused heteroaryl-methylene-n-cycloalkyl-carboxamide derivatives
EP2324011B1 (en) Fungicidal n-(2-pyridylpropyl)carboxamide derivatives and their oxa, aza and thia analogues
US8580799B2 (en) Fungicide hydroximoyl-heterocycles derivatives
US20130012546A1 (en) Fungicide hydroximoyl-tetrazole derivatives
WO2010015680A1 (en) Fungicide oxyalkylamide derivatives
EP2185548A1 (en) Fungicide 2-pyridyl-methylene-thio carboxamide or 2-pyridyl-methylene-n-substituted carboximidamide derivatives
EP2179990A1 (en) Fungicide oxyalkylamide derivatives

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20110711

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20120518

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: BAYER INTELLECTUAL PROPERTY GMBH

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20150620